<SEC-DOCUMENT>0001178913-24-001377.txt : 20240418
<SEC-HEADER>0001178913-24-001377.hdr.sgml : 20240418
<ACCEPTANCE-DATETIME>20240418165103
ACCESSION NUMBER:		0001178913-24-001377
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20240418
FILED AS OF DATE:		20240418
DATE AS OF CHANGE:		20240418

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CERAGON NETWORKS LTD
		CENTRAL INDEX KEY:			0001119769
		STANDARD INDUSTRIAL CLASSIFICATION:	RADIO & TV BROADCASTING & COMMUNICATIONS EQUIPMENT [3663]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-30862
		FILM NUMBER:		24854853

	BUSINESS ADDRESS:	
		STREET 1:		3 URI ARIAV ST.
		STREET 2:		PO BOX 112
		CITY:			ROSH HA AYIN
		STATE:			L3
		ZIP:			4810004810
		BUSINESS PHONE:		972-3-543-1000

	MAIL ADDRESS:	
		STREET 1:		3 URI ARIAV ST.
		STREET 2:		PO BOX 112
		CITY:			ROSH HA AYIN
		STATE:			L3
		ZIP:			4810004810

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GIGANET LTD
		DATE OF NAME CHANGE:	20000719
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>zk2431317.htm
<DESCRIPTION>6-K
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
      </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"><font style="font-size: 14pt; font-family: 'Times New Roman',Times,serif; background-color: rgb(255, 255, 255); font-weight: bold; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">SECURITIES AND EXCHANGE COMMISSION</font><br>
      Washington, D. C. 20549</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">FORM 6-K</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">REPORT OF&#160; FOREIGN&#160; PRIVATE&#160; ISSUER&#160; PURSUANT&#160; TO RULE 13a-16&#160; OR</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">15d-16&#160; UNDER THE&#160; SECURITIES&#160; EXCHANGE&#160; ACT&#160; OF&#160; 1934</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">For the month of April 2024</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">Commission File Number: 0-30862</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="za878fe0309e44f8a9f6975805ea8e2c4" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif; font-size: 16pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">&#160;CERAGON NETWORKS LTD.</div>
            <div style="text-align: center; line-height: 1.25;"><img width="288" height="2" src="image00002.jpg"></div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">(Translation of registrant&#8217;s name into English)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">3 Uri Ariav st., Rosh Ha&#8217;Ayin, Israel, 4810002</div>
            <div style="text-align: center; line-height: 1.25;"><img width="288" height="2" src="image00002.jpg"></div>
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">(Address of principal executive offices)</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"> <br>
    </div>
    <div style="line-height: 1.25;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25;">Form 20-F&#160; <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9746;</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Form 40-F <font style="font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</font></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): _____</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="line-height: 1.25;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): _____ &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">SIGNATURES</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-indent: 36pt; line-height: 1.25;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
      signed on its behalf by the undersigned, thereunto duly authorized.</div>
    <div style="line-height: 1.25;">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z9aae7e8319354d869ee20aef9caee85f" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">CERAGON NETWORKS LTD.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">Date: April 18, 2024</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">By: <u>/s/ Ronen Stein</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 50%; vertical-align: top;">
            <div style="line-height: 1.25;">Name: Ronen Stein<br>
              Title: Chief Financial Officer</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; text-align: center;">2<br style="line-height: 1.25;">
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <table cellspacing="0" cellpadding="0" id="z544cd6f9e65d4a1cb81acee1befe4768" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 10%; vertical-align: middle;">
            <div style="line-height: 1.25;"><u>Exhibit</u></div>
          </td>
          <td style="width: 90%; vertical-align: middle;">
            <div style="line-height: 1.25;"><u>Description</u></div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 90%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: middle;">
            <div style="line-height: 1.25;"><a href="exhibit_a.htm"><u>Exhibit A &#8211;</u></a></div>
          </td>
          <td style="width: 90%; vertical-align: middle;">
            <div style="line-height: 1.25; font-weight: bold;"><a href="exhibit_a.htm"><u>NOTICE
                  OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS</u></a></div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
          <td style="width: 90%; vertical-align: middle;">
            <div style="line-height: 1.25;">&#160;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 10%; vertical-align: middle;">
            <div style="line-height: 1.25;"><a href="exhibit_b.htm"><u>Exhibit B &#8211;</u></a></div>
          </td>
          <td style="width: 90%; vertical-align: middle;">
            <div style="line-height: 1.25; font-weight: bold;"><a href="exhibit_b.htm"><u>PROXY
                  CARD FOR THE 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS</u></a></div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25; text-align: center;">3<br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;">
      <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>exhibit_a.htm
<DESCRIPTION>EXHIBIT A
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: center; line-height: 1.25;"><u> </u>
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
    <div style="text-align: right; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"><u><font style="font-weight: bold;"> Exhibit A</font><br>
      </u></div>
    <div style="text-align: center; line-height: 1.25;"><u> <br>
      </u></div>
    <div style="text-align: center; line-height: 1.25;"><u> <br>
      </u></div>
    <div style="text-align: center; line-height: 1.25;"><u>CERAGON NETWORKS LTD</u></div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">___________________________________________</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">NOTICE OF 2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">___________________________________________</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">TO BE HELD ON MAY 23, 2024</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">
      <div style="line-height: 1.25;">Dear Shareholder,</div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Notice is hereby given that the 2024 Annual General Meeting of Shareholders (the &#8220;<font style="font-weight: bold;">Meeting</font>&#8221;) of Ceragon Networks Ltd (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;)

      will be held on Thursday, May 23, 2024 at 4:00 PM (Israel time), at the offices of the Company located at 3 Uri Ariav St., Bldg. A, 7<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> floor, Rosh Ha&#8217;ayin, Israel (Telephone number: + 972-3-543-1596). The following matters are on the
      agenda for the Meeting (collectively, the &#8220;<font style="font-weight: bold;">Proposals</font>&#8221;):</div>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z5a895ff41b714f7299ed8161a8dde51a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 28.35pt; vertical-align: top;">1.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>To re-elect each of Ilan Rosen, Efrat Makov, Yael Shaham, Shlomo Liran, Rami Hadar and David Ripstein, and to elect Robert Wadsworth, to serve on the Board of Directors of the Company (the &#8220;<font style="font-weight: bold;">Board</font>&#8221;)
              for a term of approximately three (3) years ending on the date of the annual general meeting that will be held in 2027;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="zcd9134b1cd9d4c459390cb6b5903587c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 28.35pt; vertical-align: top;">2.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>To approve certain compensation terms of the Company&#8217;s non-executive directors, including the grant of equity consideration, all, as part of their compensation for service as such;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z3bd120e4ea1f49c99e10733c378aff4b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 28.35pt; vertical-align: top;">3.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>To approve certain compensation terms for the Company&#8217;s Chief Executive Officer;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z62b29270de6b4238ae090403e137c9df" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 28.35pt; vertical-align: top;">4.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>To approve amendments to the Company's Articles of Association, including without limitations, to increase the share capital of the Company to Two Million Four Hundred Thousand New Israeli Shekels (NIS 2,400,000) divided into Two Hundred
              and Forty Million (240,000,000) Ordinary Shares of a nominal value of One Agora (NIS 0.01) each;</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="z7f733e484a5845c5bb8ed42630f56a81" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 28.35pt; vertical-align: top;">5.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>To approve the Company&#8217;s 2024 Equity Incentive Plan; and</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <table cellspacing="0" cellpadding="0" id="ze9d7c870be03440d90c25837bd81a900" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 28.35pt; vertical-align: top;">6.</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>To re-appoint Kost Forer Gabbay &amp; Kasierer, A Member of EY Global, as the Company&#8217;s independent auditor for the fiscal year ending December 31, 2024 and for the year commencing January 1, 2025 and until immediately following the next
              annual general meeting of shareholders, and to authorize the Board (with power of delegation to its Financial Audit Committee), to set the annual compensation of the independent auditor in accordance with the volume and nature of its
              services.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Our Board unanimously recommends that you vote &#8220;FOR&#8221; each of the Proposals.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Additionally, at the Meeting, shareholders will be provided with the opportunity to receive and consider the auditor&#8217;s report and the audited consolidated financial statements of the Company for the
      fiscal year ended December 31, 2023. This item will not involve a vote of the shareholders.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Only shareholders of record at the close of business on Tuesday, April 23, 2024, the record date for determining those shareholders eligible to vote at the Meeting, are entitled to receive notice of,
      and to vote at, the Meeting (including any postponements or adjournments thereof).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Proposals 1, 2.C, 4, 5 and 6 require the affirmative vote of the holders of a majority of the voting power represented at the Meeting in person or by proxy and voting thereon.</div>
    <div style="text-align: justify; line-height: 1.25;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Proposals 2.A, 2.B and 3 require the affirmative vote of the holders of a majority of the voting power represented at the Meeting in person or by proxy and voting thereon; provided that, the majority
      of the shares voted in favor of said proposals are not held by &#8220;controlling shareholders&#8221; or shareholders with &#8220;personal interest&#8221; in the approval of such proposals, not taking into account any abstention, or that the total number of shares referred
      to above that voted against these proposals, does not exceed two percent of the aggregate voting rights in the Company &#160;(&#8220;<font style="font-weight: bold;">Disinterested Majority</font>&#8221;), as described in more detail under Item 2.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Whether or not you plan to attend the Meeting, you are urged to promptly complete, date and sign the enclosed proxy card and to mail it in the enclosed envelope, which requires no postage if mailed
      in the United States, at your earliest convenience and in any event no later than 4:00 PM (Israel time) on Wednesday, May 22, 2024. Execution of your proxy will not deprive you of your right to attend the Meeting and vote in person, and you will have
      the right to revoke your proxy any time before it is exercised by following the procedures set forth in the Proxy Statement enclosed herein.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">If you hold ordinary shares of the Company through a bank, broker or other nominee (i.e., in &#8220;street name&#8221;) which is one of our shareholders of record at the close of market on Tuesday, April 23,
      2024, or which appears in the participant listing of a securities depository on that date, you must follow the instructions included in the voting instruction form you receive from your bank, broker or nominee, and may also be able to submit voting
      instructions to your bank, broker or nominee by phone or via the Internet. Please be certain to have your control number from your voting instruction form ready for use in providing your voting instructions. If you hold your ordinary shares of the
      Company in &#8220;street name,&#8221; you must obtain a legal proxy from the record holder to enable you to participate in and to vote your ordinary shares of the Company at the Meeting (or to appoint a proxy to do so).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">We intend to hold the Meeting in person and all shareholders are cordially invited to attend the Meeting in person. However, we may decide to hold the Meeting virtually on the above date and time
      instead of in person, in which case an announcement of such change will be furnished with the Securities and Exchange Commission (&#8220;<font style="font-weight: bold;">SEC</font>&#8221;) on a Report on Form 6-K as promptly as practicable.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Joint holders of shares should note that, pursuant to Article 69(b) of the Articles of Association of the Company (the &#8220;<font style="font-weight: bold;">Articles</font>&#8221;), a notice may be given by
      the Company to the joint holders of a share by giving notice to the first of the joint holders named in the Register of Shareholders with respect to the shares, and any notice so given shall be sufficient notice to the other joint holders of such
      share(s).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Joint holders of shares should also note that, pursuant to Article 32(d) of the Articles, the vote of the first of the joint holders named in the Register of Shareholders with respect to the share(s)
      will be accepted to the exclusion of the vote(s) of the other joint holder(s).</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">Two or more shareholders, present in person or by proxy, entitled to vote and holding together ordinary shares conferring in the aggregate twenty-five percent (25%) or more of the voting power of the
      Company, shall constitute a quorum at the Meeting. If within an hour from the time appointed for the Meeting a quorum is not present, the Meeting will be rescheduled for the following week and accordingly, will stand adjourned until Thursday, May 30,
      2024, at the same time and place. At such adjourned Meeting, any two (2) shareholders present in person or by proxy, shall constitute a quorum.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">The last date for submitting a request to include a proposal in accordance with Section 66(b) of the Israeli Companies Law, 5759-1999 as supplemented by the Israeli Companies Regulations (Relief for
      Companies with Shares Registered for Trade in a Stock Exchange Outside of Israel) (the &#8220;<font style="font-weight: bold;">Foreign Listed Regulations</font>&#8221;), is Tuesday, April 23, 2024. A copy of the Proxy Statement (which includes the full version
      of the proposed resolutions) and a proxy card is being distributed to shareholders and also furnished to the SEC, under cover of Form 6-K. Shareholders are also able to review the Proxy Statement at the &#8220;Investor Relations&#8221; portion of our website
      www.ceragon.com/investors or at our headquarters at 3 Uri Ariav st., PO Box 112, Rosh Ha&#8217;Ayin, Israel, 4810002, upon prior notice and during regular working hours (telephone number: +972- 3-543-1596) until the date of the Meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; text-align: center;">- ii -<br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Whether or not you plan to attend the Meeting, it is important that your ordinary shares of the Company be represented and voted at the Meeting. Accordingly, after reading the
      Notice of Meeting of Shareholders and the Proxy Statement, please sign, date and mail the proxy card in the envelope provided. Detailed proxy voting instructions will be provided both in the Proxy Statement and in the proxy card.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: justify; line-height: 1.25;">We urge all of our shareholders to review our annual report for 2023 on Form 20-F filed with the SEC, which is available on our website at www.ceragon.com/investors or on the SEC&#8217;s website at
      www.sec.gov.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25;">We look forward to greeting as many of you as can attend the Meeting.</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">By Order of the Board of Directors,</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Sincerely</div>
    <div style="line-height: 1.25;">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">&#160;/s/ Ilan Rosen</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Ilan Rosen, Chairman of the Board of Directors</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="text-align: center; line-height: 1.25;">April 18, 2024</div>
    <div style="line-height: 1.25">&#160;</div>
    <div style="line-height: 1.25; text-align: center;">- iii - </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div class="BRPFPageHeader">
      <div style="line-height: 1.25;"><br style="line-height: 1.25;">
      </div>
      <div style="line-height: 1.25;">
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERAGON NETWORKS LTD</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25;">3 Uri Ariav St., Bldg. A, 7<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> floor, Rosh Ha&#8217;ayin, Israel</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">_______________________</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROXY STATEMENT</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25;">_______________________</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">2024 ANNUAL GENERAL MEETING OF SHAREHOLDERS</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">To Be Held on May 23, 2024</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
          </div>
        </div>
        <div style="text-align: justify; line-height: 1.25;">This Proxy Statement is furnished to the holders of Ordinary Shares, NIS 0.01 nominal value (the &#8220;<font style="font-weight: bold;">Ordinary Shares</font>&#8221; or &#8220;<font style="font-weight: bold;">Shares</font>&#8221;),

          of Ceragon Networks Ltd (&#8220;<font style="font-weight: bold;">we</font>,&#8221; &#8220;<font style="font-weight: bold;">Ceragon</font>&#8221; or the &#8220;<font style="font-weight: bold;">Company</font>&#8221;) in connection with the solicitation by the Board of Directors of
          the Company of proxies for use at the Company&#8217;s 2024 Annual General Meeting of Shareholders (the &#8220;<font style="font-weight: bold;">Meeting</font>&#8221;), or at any postponements or adjournments thereof.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The Meeting will be held on Thursday, May 23, 2024, at 4:00 PM (Israel time), at the offices of the Company, 3 Uri Ariav St., Bldg. A, 7<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> floor, Rosh Ha&#8217;ayin, Israel.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">PURPOSE OF THE ANNUAL GENERAL MEETING</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">It is proposed that at the Meeting, resolutions be adopted as follows:</div>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z52e687ca505a4ab68817153bed65be30" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 28.35pt; vertical-align: top;">1.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>To re-elect each of Ilan Rosen, Efrat Makov, Yael Shaham, Shlomo Liran, Rami Hadar and David Ripstein, and to elect Robert Wadsworth, to serve on the Board of Directors of the Company (the &#8220;<font style="font-weight: bold;">Board</font>&#8221;)

                  for a term of approximately three (3) years ending on the date of the annual general meeting that will be held in 2027;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zc1769962291747f2b72c4716e57e212c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 28.35pt; vertical-align: top;">2.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>To approve certain compensation terms of the Company&#8217;s non-executive directors, including the grant of equity consideration, all, as part of their compensation for service as such;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z32551d17f49a4a98a77bc392cdf912bf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 28.35pt; vertical-align: top;">3.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>To approve certain compensation terms for the Company&#8217;s Chief Executive Officer;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" id="ze58d52e2fa55440696c78a7e99876ef6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 28.35pt; vertical-align: top;">4.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>To approve amendments to the Company's Articles of Association, including without limitations, to increase the share capital of the Company to Two Million Four Hundred Thousand New Israeli Shekels (NIS 2,400,000) divided into Two
                  Hundred and Forty Million (240,000,000) Ordinary Shares of a nominal value of One Agora (NIS 0.01) each;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z7eb58adf779b4a7f88a4b02c3c59820f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 28.35pt; vertical-align: top;">5.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>To approve the Company&#8217;s 2024 Equity Incentive Plan; and</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z7223356155894921b7e158f03f5d377c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 28.35pt; vertical-align: top;">6.</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>To re-appoint Kost Forer Gabbay &amp; Kasierer, A Member of EY Global, as the Company&#8217;s independent auditor for the fiscal year ending December 31, 2024 and for the year commencing January 1, 2025 and until immediately following the
                  next annual general meeting of shareholders, and to authorize the Board (with power of delegation to its Financial Audit Committee), to set the annual compensation of the independent auditor in accordance with the volume and nature of its
                  services.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Additionally, at the Meeting, shareholders will be provided with the opportunity to receive and consider the auditor&#8217;s report and the audited consolidated financial statements of the Company for
          the fiscal year ended December 31, 2023. This item will not involve a vote of the shareholders.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">We intend to hold the Meeting in person and all shareholders are cordially invited to attend the Meeting in person. However, we may decide to hold the Meeting virtually on the above date and time
          instead of in person, in which case an announcement of such change will be furnished with the Securities and Exchange Commission (the &#8220;<font style="font-weight: bold;">SEC</font>&#8221;) on a Report on Form 6-K as promptly as practicable.</div>
        <div style="text-align: justify; line-height: 1.25;"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <!--PROfilePageNumberReset%Num%2%%%-->
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">RECORD DATE AND VOTING RIGHTS</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Only holders of record of Ordinary Shares at the close of business on&#160; Tuesday, April 23, 2024, the record date for determining those shareholders eligible to vote at the Meeting, will be
          entitled to notice of and to vote at the Meeting (including any adjournments or postponements thereof) (the &#8220;<font style="font-weight: bold;">Record Date</font>&#8221;). Each Ordinary Share issued and outstanding as of the close of market on the Record
          Date, is entitled to one vote on each of the Proposals to be presented at the Meeting.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">QUORUM</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Under our current Articles, two or more shareholders, present in person or by proxy, entitled to vote and holding together Ordinary Shares conferring in the aggregate twenty-five percent (25%) or
          more of the voting power of the Company, shall constitute a quorum at the Meeting. If within an hour from the time appointed for the Meeting a quorum is not present, the Meeting will be rescheduled for the following week and accordingly, will
          stand adjourned until Thursday, May 30, 2024, at the same time and place. At such adjourned Meeting, any two (2) shareholders present in person or by proxy, shall constitute a quorum.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;SHARES OUTSTANDING</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">As of April 16, 2024, we had 85,640,591 Ordinary Shares issued and outstanding (this amount does not include 3,481,523 ordinary shares held by the Company as treasury shares). Equinti
          Trust&#160;Company, LLC is the transfer agent and registrar for the Ordinary Shares.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROXY PROCEDURE</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">A form of proxy for use at the Meeting and a return envelope for the proxy are also enclosed.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">If specification is made by a shareholder on the form of proxy, the Shares represented thereby will be voted in accordance with such specification. If any other matters are presented at the
          Meeting, the persons named in the attached form of proxy shall vote all shares represented by all executed proxies in their best judgment. If no direction is indicated with respect to one or more of the resolutions on the proxy, the proxy will be
          voted &#8220;FOR&#8221; each such resolution. On all matters considered at the Meeting, abstentions and broker non-votes will be treated as neither a vote &#8220;FOR&#8221; nor &#8220;AGAINST&#8221; the matter, but they will be counted in determining if a quorum is present. Broker
          non-votes are votes that brokers holding shares of record for their clients are, pursuant to applicable stock exchange or other rules, precluded from casting in respect of certain non-routine proposals because such brokers have not received
          specific instructions from their clients as to the manner in which such shares should be voted on those proposals.</div>
        <div style="text-align: justify; line-height: 1.25;"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Shareholders may revoke the authority granted by their execution of proxies at any time before the effective exercise thereof by: (i) filing with the Company a written notice of revocation or
          duly executed proxy bearing a later date (but not less than twenty-four (24) hours prior to the time fixed for the Meeting); or (ii) voting in person at the Meeting.&#160; However, if a shareholder attends the Meeting and does not elect to vote in
          person, his or her proxy will not be revoked. If a proxy is properly executed and received not less than twenty-four (24) hours prior to the time fixed for the Meeting, Ordinary Shares represented by such proxy will be voted in the manner
          described above. If you hold your shares in &#8220;street name&#8221; and do not provide your broker with voting instructions for the Meeting, your broker will not be permitted to vote your shares on non-routine&#160;proposals, resulting in a &#8220;broker non-vote.&#8221;
          Therefore, it is important for a shareholder that holds ordinary shares through a bank or broker to instruct its bank or broker how to vote its shares.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Proxies for use at the Meeting are being solicited by the Board of Directors chiefly by mail;&#160;however, certain officers, directors, employees and agents of the Company, none of whom will receive
          additional compensation for such solicitation, may solicit proxies by telephone, electronic mail or other personal contact. We may also retain an independent contractor to assist in the solicitation of proxies. If retained for such services, we
          will pay the related costs. The Company will bear the cost for the solicitation of the proxies, including postage, printing and handling, and will reimburse the reasonable expenses of brokerage firms and others for forwarding material to, and
          obtaining authority to execute proxies from, beneficial owners of Shares.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Pursuant to the Companies Law as supplemented by the Foreign Listed Regulations, any shareholder or shareholders of the Company holding at least one&#160;percent&#160;(1%) or five&#160;percent&#160;(5%),&#160; of the
          voting rights of the Company, as required by the Companies Law as supplemented by Regulation 7A. of the Foreign Listed Regulations (the &#8220;<font style="font-weight: bold;">Proposing Shareholder(s)</font>&#8221;) may request that the Board of Directors
          include a matter on the&#160;agenda of a General Meeting to be held in the future, provided that the Board of Directors determines that the matter is appropriate to be considered at a General Meeting (a &#8220;<font style="font-weight: bold;">Proposal&#160;Request</font>&#8221;).

          In order for the Board of Directors to consider a Proposal&#160;Request and whether to include the matter stated therein in the agenda of a General Meeting, notice of the Proposal&#160;Request must be timely delivered in accordance with applicable law, and
          the Proposal&#160;Request must comply with the requirements of the Articles and any applicable law and stock exchange rules and regulations. The Proposal&#160;Request must be in writing, signed by the Proposing Shareholder(s)&#160;making such request,
          delivered, either in person or by registered mail, postage prepaid, to the Company&#8217;s offices at 3 Uri Ariav st., PO Box 112, Rosh Ha&#8217;Ayin, Israel, 4810002 c/o General Counsel. To be considered timely, a Proposal&#160;Request must be received by
          Thursday, April 25, 2024.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">In addition to any information required in accordance with applicable law, a Proposal&#160;Request must include the following: (i)&#160;the name, address, telephone number, fax number and email address of
          the Proposing Shareholder (or each Proposing Shareholder, as the case may be) and, if an entity, the name(s)&#160;of the person(s)&#160;that controls or manages such entity; (ii)&#160;the number of shares held by the Proposing Shareholder(s), directly or
          indirectly (and, if any of such shares are held indirectly, an explanation of how they are held and by whom), which shall be in such number no less than as is required to qualify as a Proposing Shareholder, accompanied by evidence satisfactory to
          the Company of the record holding of such shares by the Proposing Shareholder(s)&#160;as of the date of the Proposal&#160;Request; (iii)&#160;the matter requested to be included on the agenda of a Meeting, all information related to such matter, the reason that
          such matter is proposed to be brought before the Meeting, the complete text of the resolution that the Proposing Shareholder proposes to be voted upon at the Meeting, and a representation that the Proposing Shareholder(s)&#160;intend to appear in
          person or by proxy at the meeting; (iv)&#160;a description of all arrangements or understandings between the Proposing Shareholders and any other person(s)&#160;(naming such person or persons) in connection with the matter that is requested to be included
          on the agenda and a declaration signed by all Proposing Shareholder(s)&#160;of whether any of them has a personal interest in the matter and, if so, a description in reasonable detail of such personal interest; (v)&#160;a description of all Derivative
          Transactions (as defined below) by each Proposing Shareholder(s)&#160;during the previous Thirty-Six (36)&#160;month period, including the date of the transactions and the class, series and number of securities involved in, and the material economic terms
          of, such Derivative Transactions; and (vi)&#160;a declaration that all of the information that is required under the Companies Law and any other applicable law and stock exchange rules and regulations to be provided to the Company in connection with
          such matter, if any, has been provided to the Company. Furthermore, the Board of Directors, may, in its discretion, to the extent it deems necessary, request that the Proposing Shareholder(s)&#160;provide additional information necessary&#160;so as
          to&#160;include a matter in the agenda of a Meeting, as the Board of Directors may reasonably require.</div>
        <div style="text-align: justify; line-height: 1.25;"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">For the purposes hereof, a &#8220;Derivative Transaction&#8221; means any agreement, arrangement, interest or understanding entered into by, or on behalf or for the benefit of, any Proposing Shareholder or
          any of its affiliates or associates, whether of record or beneficial: (1) the value of which is derived in whole or in part from the value of any class or series of shares or other securities of the Company, (2) which otherwise provides any
          direct or indirect opportunity to gain or share in any gain derived from a change in the value of securities of the Company, (3) the effect or intent of which is to mitigate loss, manage risk or benefit from security value or price changes, or
          (4) which provides the right to vote or increase or decrease the voting power of, such Proposing Shareholder, or any of its affiliates or associates, with respect to any shares or other securities of the Company, which agreement, arrangement,
          interest or understanding may include, without limitation, any option, warrant, debt position, note, bond, convertible security, swap, stock appreciation right, short position, profit interest, hedge, right to dividends, voting agreement,
          performance-related fee or arrangement to borrow or lend shares (whether or not subject to payment, settlement, exercise or conversion in any such class or series), and any proportionate interest of such Proposing Shareholder in the securities of
          the Company held by any general or limited partnership, or any limited liability company, of which such Proposing Shareholder is, directly or indirectly, a general partner or managing member.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Should changes be made to any item on the agenda for the Meeting after the publication of this Proxy Statement, we will communicate the changes to our shareholders through the publication of a
          press release, a copy of which will be furnished with the SEC on a Report on Form 6-K.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">SHAREHOLDER ENGAGEMENT</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">We maintain an open and collaborative dialogue with our shareholders. Our relationship with our shareholders, is a vital part of our success, and our executive leadership team believes that
          active engagement with our investors is an important source of strategic insight. Direct and open shareholder engagement drives increased corporate accountability, improves decision making, and ultimately creates long-term value.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">During 2023, we expanded our investor relations activities proactively conducting shareholder outreach which included reaching out to major shareholders, including in person meetings, one-on-one
          calls or video conferences In addition to these conversations, we maintain ongoing dialogue with many of our investors through our investor relations program and have increased our effort to engage with stewardship and governance contacts
          throughout the year.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">BENEFICIAL OWNERSHIP OF SECURITIES BY PRINCIPAL</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">SHAREHOLDERS AND MANAGEMENT</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The following table sets forth certain information, as of&#160; April 16, 2024, regarding: (i) all persons or entities known to the Company to beneficially own more than 5% of the Company&#8217;s Ordinary
          Shares; (ii) each &#8220;office holder&#8221;<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup>, as such term is defined in the Companies Law, of the Company (the &#8220;<font style="font-weight: bold;">Office Holders</font>&#8221;) known to the Company to beneficially own more than 1% of the Company&#8217;s
          Ordinary Shares; and (iii) all Office Holders as a group.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The information contained herein has been obtained from the Company&#8217;s records or from information furnished by the individual or entity to the Company or disclosed in public filings with the SEC.
          Except where otherwise indicated, and except pursuant to community property laws, we believe, based on information furnished by such owners, that the beneficial owners of the Ordinary Shares listed below have sole investment and voting power with
          respect to such Ordinary Shares.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The shareholders listed below do not have any different voting rights from any of our other shareholders.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The SEC defines &#8220;beneficial ownership&#8221; of a security to mean the possession, directly or indirectly, of voting power and/or investment power over such security.&#160; The &#8220;Number of Ordinary Shares
          Beneficially Owned&#8221; in the table below includes Ordinary Shares that may be acquired upon the (i)&#160;the exercise of any option, warrant or right, (ii)&#160;the conversion of a security, (iii)&#160;the power to revoke a trust, discretionary account or similar
          arrangement, or (iv)&#160;the automatic termination of a trust, discretionary account or similar arrangement. In computing the number of shares beneficially owned by a person and the percentage ownership of that person, ordinary shares subject to
          exercise of options or other rights (as set forth above)&#160;that are either currently exercisable or will become exercisable within sixty (60) days as of April 16, 2024. The Ordinary Shares that may be issued under these options are deemed to be
          outstanding for the purpose of determining the percentage owned by the person or group holding the options but are not deemed to be outstanding for the purpose of determining the percentage of ownership of any other person or group shown in the
          table.</div>
        <div style="line-height: 1.25">&#160;</div>
        <hr noshade="noshade" align="left" style="background-color: #000000; border: 0px; height: 1px; width: 2in; margin-left: 0pt; margin-right: auto; color: #000000;">
        <table cellspacing="0" cellpadding="0" id="z4b3b8cc5e0694a7fa5e23411a503c7fd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: -30.6pt;"><br>
              </td>
              <td style="width: 28.35pt; vertical-align: top;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div>The term &#8220;Office Holder&#8221; as defined in the Companies Law includes a director, the chief executive officer, the chief business officer, the vice chief executive officer, the deputy chief executive officer, any other person fulfilling or
                  assuming any of the foregoing positions without regard to such person's title, and any manager who is directly subordinated to the chief executive officer.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">5</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <table cellspacing="0" cellpadding="0" id="z19b44f3956954c0abb2cbf1fce345990" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 58.07%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25;">Name of Beneficial Owner</div>
              </td>
              <td style="width: 20.58%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25;">Number of Ordinary Shares Beneficially Owned</div>
              </td>
              <td style="width: 21.34%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25;">Percentage of Ordinary Shares Beneficially Owned <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(1)</sup></div>
              </td>
            </tr>
            <tr>
              <td style="width: 58.07%; vertical-align: top;">
                <div style="line-height: 1.25; font-weight: bold;">Greater than 5% Shareholders</div>
              </td>
              <td style="width: 20.58%; vertical-align: top;">&#160;</td>
              <td style="width: 21.34%; vertical-align: top;">&#160;</td>
            </tr>
            <tr>
              <td style="width: 58.07%; vertical-align: top;">
                <div style="line-height: 1.25;">Zohar Zisapel Estate <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(2)</sup></div>
              </td>
              <td style="width: 20.58%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25;">7,117,174</div>
              </td>
              <td style="width: 21.34%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25;">9.67%</div>
              </td>
            </tr>
            <tr>
              <td style="width: 58.07%; vertical-align: top;">
                <div style="line-height: 1.25;">Joseph D. Samberg <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(3)</sup></div>
              </td>
              <td style="width: 20.58%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25;">8,280,000</div>
              </td>
              <td style="width: 21.34%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25;">8.31%</div>
              </td>
            </tr>
            <tr>
              <td style="width: 58.07%; vertical-align: top;">
                <div style="line-height: 1.25; font-weight: bold;">Office Holders</div>
                <div style="line-height: 1.25;">All Office Holders as a group consisting of 16 people <sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">(4)</sup></div>
              </td>
              <td style="width: 20.58%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25;">1,661,727</div>
              </td>
              <td style="width: 21.34%; vertical-align: top;">
                <div style="text-align: center; line-height: 1.25;">1.94%</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 8.04%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">(1)</div>
              </td>
              <td style="width: 91.96%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Based on 85,640,591&#160;Ordinary Shares issued and outstanding as of April 16, 2024 (this amount does not include 3,481,523 ordinary shares held by the Company as treasury shares).</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">(2)</div>
              </td>
              <td style="width: 91.96%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Includes (i) 3,694,986 ordinary shares held directly; (ii) 200,000 ordinary shares issuable upon the exercise of options granted to Mr. Zisapel exercisable as of April 16, 2024 or within
                  60 days thereafter; (iii) 1,101,245 ordinary shares held by Lomsha Ltd., an Israeli company that was controlled by Mr. Zisapel; (iv) 18,717 ordinary shares held by RAD Data Communications Ltd., an Israeli company of which Mr. Zisapel was
                  a principal shareholder and a director, and of which Mr. Zisapel and his late brother, Mr. Yehuda Zisapel, and Ms. Nava Zisapel, had shared voting and dispositive power; and (v) 2,102,226 ordinary shares held by Michael and Klil Holdings
                  (93) Ltd., an Israeli company that was controlled by Mr. Zisapel. The number of ordinary shares beneficially held by Zohar Zisapel&#8217;s Estate is based on a Schedule 13D/A filed by Mr. Zisapel with the SEC on February 22, 2021.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">(3)</div>
              </td>
              <td style="width: 91.96%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Joseph D. Samberg&#8217;s address is 1091 Boston Post Road, Rye, NY 10580.</div>
              </td>
            </tr>
            <tr>
              <td style="width: 8.04%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">(4)</div>
              </td>
              <td style="width: 91.96%; vertical-align: top;">
                <div style="text-align: justify; line-height: 1.25;">Each of the directors and senior management beneficially owns less than 1% of the outstanding ordinary shares as of April 16, 2024 (including options held by each such person and which
                  are vested or shall become vested within 60 days of April 16, 2024) and have therefore not been separately listed.</div>
              </td>
            </tr>

        </table>
        <div style="text-align: justify; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; line-height: 1.25;">For information relating to the compensation of our five most highly compensated Office Holders with respect to the year ended December 31, 2023, please see &#8220;Item 6. <font style="font-style: italic;">Directors, Senior Management and Employees</font> &#8211; B. <font style="font-style: italic;">Compensation</font> - <font style="font-style: italic;">b) Individual Compensation of Office Holders</font>&#8221; in our Annual Report for 2023,
          which was filed on Form 20-F with the SEC on March 21, 2024.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">Results of the Annual Meeting</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The preliminary voting results will be announced at the Meeting. The final voting results will be tallied by the Company&#8217;s General Counsel based on the information provided by the Company&#8217;s
          transfer agent or otherwise and will be published on a Form&#160;6-K&#160;that we will file with the SEC after the Meeting.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">Proxy Materials</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Copies of the proxy card, the notice of the&#160;Meeting&#160;and this Proxy Statement are available at&#160;www.ceragon.com/investors. Information about the Meeting can also be found on the&#160;&#8220;Investor
          Relations&#8221;&#160;section of our website. The contents of our and any other website are not incorporated by reference into this Proxy Statement.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">Assistance in Voting your Shares</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">If you have questions about how to vote your shares, you may contact Hadar Vismunski Weinberg, Chief Legal Officer at +972-54-888-5186.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">6</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL 1</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">ELECTION OF DIRECTORS</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Background</u></div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u> <br>
          </u></div>
        <div style="text-align: justify; margin-right: 4.3pt; line-height: 1.25;">Our Articles provide that the number of directors to serve on our Board shall be no less than five (5) and no more than nine (9) directors, unless otherwise resolved by our
          shareholders. Our directors are generally elected at the annual general meeting of shareholders for a term ending on the date of the third annual general meeting following the general meeting at which they were elected, unless earlier terminated
          in the event of such director&#8217;s death, resignation, bankruptcy, incapacity or removal.</div>
        <div style="text-align: justify; margin-right: 4.3pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; margin-right: 4.3pt; line-height: 1.25;">The Company is constantly pursuing enhancement of its corporate governance practices, which include, among other things, a continued Board refreshment, as further described
          below.</div>
        <div style="text-align: justify; margin-right: 4.3pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; margin-right: 4.3pt; line-height: 1.25;">At the 2021 annual general meeting of the Company&#8217;s shareholders, held on July 19, 2021 (the &#8220;<font style="font-weight: bold;">2021 AGM&#8221;), </font>our shareholders approved
          the election of seven (7) directors to serve as members of the Board for a term of approximately three (3) years, ending on the date of this Meeting. With the voluntary termination of service by Ms. Yael Langer, prior to the 2022 annual general
          meeting of the Company&#8217;s shareholders, held on October 3, 2022 (the &#8220;<font style="font-weight: bold;">2022 AGM</font>&#8221;), our shareholders approved the election of Ms. Efrat Makov to serve as director, in order to fill the vacancy created by the
          resignation of Ms. Langer, for a term of approximately two (2) years, ending on the date of this Meeting.</div>
        <div style="text-align: justify; margin-right: 4.3pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; margin-right: 4.3pt; line-height: 1.25;">On May 19, 2023, Mr. Zohar Zisapel, our previous Chairman of the Board, passed away. At the 2023 annual general meeting of the Company&#8217;s shareholders, held on September 6,
          2023 (the &#8220;<font style="font-weight: bold;">2023 AGM</font>&#8221;), our shareholders approved the election of Ms. Yael Shaham, to serve as director, in order to fill the vacancy created by the death of Mr. Zohar Zisapel, for a term of approximately
          one (1) year, ending on the date of this Meeting.</div>
        <div style="text-align: justify; margin-right: 4.3pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; margin-right: 4.3pt; line-height: 1.25;">Prior to this Meeting, Mr. Palti has informed the Board on his voluntary termination of service, effective as of the date of this Meeting.</div>
        <div style="text-align: justify; margin-right: 4.3pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; margin-right: 4.3pt; line-height: 1.25;">In accordance with Section 39(d) to our Articles, all directors shall be appointed together on the same annual general meeting, subject to any earlier termination of service,
          which shall be filled with an appointment of a substitute director for the remainder of such three-year term.</div>
        <div style="text-align: justify; margin-right: 4.3pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; margin-right: 4.3pt; line-height: 1.25;">According to the Companies Law, a person who does not possess the skills required and the ability to devote the appropriate time to the performance of the office of director
          in a company, taking into consideration, among other things, the special requirements and size of that company, shall neither be appointed as a director nor serve as a director in a public company. A public company shall not convene a general
          meeting the agenda of which includes the appointment of a director, and a director shall not be appointed, unless the candidate has submitted a declaration that he or she possesses the skills required and the ability to devote the appropriate
          time required for the performance of his or her duties as a director in the company (a &#8220;<font style="font-weight: bold;">Director Declaration</font>&#8221;).</div>
        <div style="text-align: justify; margin-right: 4.3pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; margin-right: 4.3pt; line-height: 1.25;">Further, a director who ceases to possess any qualification required under the Companies Law for holding the office of director or who becomes subject to any ground for
          termination of his/her office must inform the company immediately and his/her office shall terminate upon such notice.</div>
        <div style="text-align: justify; margin-right: 4.3pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>General</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-style: italic;">Re-Election and Election of Directors</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Following the recommendation of such nominees to the Board by the Company&#8217;s Nomination Committee, in accordance with the rules of the Nasdaq Global Select Market (the &#8220;<font style="font-weight: bold;">Nasdaq Rules</font>&#8221;), it is proposed that each of Mr. Ilan Rosen, Ms. Efrat Makov, Ms. Yael Shaham, Mr. Shlomo Liran, Mr. Rami Hadar and Mr. David Ripstein be re-elected, and that Mr. Robert Wadsworth be elected, to serve as our
          directors. If re-elected or elected (as the case may be), each of the above-mentioned nominees will serve for a term of approximately three (3) years, ending on the date of the annual general meeting that will be held in 2027.</div>
        <div style="text-align: justify; line-height: 1.25;"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">7</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The Company has received a Director Declaration from each of the nominees for service as directors. The Company is not aware of any reason why Mr. Ilan Rosen, Ms. Efrat Makov, Ms. Yael Shaham,
          Mr. Shlomo Liran, Mr. Rami Hadar, Mr. David Ripstein and Mr. Robert Wadsworth, if re-elected or elected (as the case may be), should be unable to serve as directors.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Further, shareholders should note that each of the nominees proposed for re-election has maintained a high level of participation in our Board and committees meetings, as applicable, throughout
          his or her previous term of service. The Company does not have any understanding or agreement with respect to the future election of any of the proposed nominees.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">As for the new nominee to our Board, Mr. Robert Wadsworth the Company believes that he possess vast experience in private equity, corporate financing, and merger and acquisitions activities.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-style: italic;">Directors&#8217; Independency</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; line-height: 1.25;">Under the Nasdaq Rules, the majority of our directors are required to be independent. The independence criteria under the Nasdaq Rules excludes, among others, any person who is: (i) a current
            or former (at any time during the past three years) employee of the Company or its affiliates; or (ii) a person who has accepted or who has an immediate family who accepted any compensation from the Company in excess of $120,000 during any
            period of twelve consecutive months (at any time during the past three years) other than compensation for board or board committee service. In addition, under the Companies Law, an &#8220;independent director&#8221; is either an external director or a
            director appointed or classified as such who meets the same non-affiliation criteria as an external director, as determined by the company&#8217;s audit committee, and who has not served as a director of the company for more than nine consecutive
            years. For these purposes, ceasing to serve as a director for a period of two years or less would not be deemed to sever the consecutive nature of such director&#8217;s service. However, as our shares are listed on the Nasdaq Global Select Market, we
            may also, in accordance with the Foreign Listed Regulations, classify directors who qualify as independent directors under the relevant non-Israeli rules, as &#8220;independent directors&#8221; under the Companies Law. Our Board has determined that each of
            Mr. Ilan Rosen, Ms. Efrat Makov, Ms. Yael Shaham, Mr. Shlomo Liran, Mr. Rami Hadar, Mr. David Ripstein and Mr. Robert Wadsworth, qualifies for service as an &#8220;independent director&#8221;, as defined by the Nasdaq Rules, and our Audit Committee
            determined that each therefore also qualifies as an &#8220;independent director&#8221; under the Companies Law, pursuant to the relief provided in the Foreign Listed Regulations&#160;In addition, the Foreign Listed Regulations provide that &#8220;independent
            directors&#8221; may be elected for additional terms that do not exceed three years each, beyond the nine consecutive years, permitted under the Companies Law, provided that, if the director is being re-elected for an additional term or terms beyond
            the nine consecutive years (i) the audit committee and board of directors must determine that, in light of the director&#8217;s expertise and special contribution to the board of directors and its committees, the re-election for an additional term is
            to the company&#8217;s benefit; (ii) the director must be re-elected by the required majority of shareholders and subject to the terms specified in the Companies Law. Since Mr. Shlomo Liran is proposed to be elected for a fourth period of a
            three-year service, our Board and Audit Committee determined that, in light of his expertise and special contribution to the Board and its committees, his re-election for an additional term is to the Company&#8217;s benefit.</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
        <div style="text-align: justify; line-height: 1.25;">The following is a brief biography of each of the proposed nominees:</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Ilan Rosen</font> has served as our director since July 2021 and as the Chairman of our Board of Directors since July 23, 2023. Mr. Rosen
          currently serves as Managing Director of HarbourVest Partners LLC, a global private equity firm with more than 700 employees, that manages about $75 billion worth of investments in various private equity strategies around the globe. Mr. Rosen
          additionally has served as a board member of the &#8220;Nazareth District Water and Sewage municipal authority LTD&#8221; since 2019. From 1997-2012 Mr. Rosen served as Chairman of the Board of Tdsoft LTD which later merged into VocalTec. In the years
          1996-2003 Mr. Rosen served as VP of Investments at Teledata Communications, where he was an active Chairman of various Teledata subsidiaries. From 1993-1996 he served as the Chief Executive Officer of Adsha Development Ltd. From 1989-1993 Mr.
          Rosen worked as a Senior Investment Manager at the Bank Hapoalim Investment Company. In the years 1985-1989 he worked as an economic consultant at A. Twerski Economic Consulting. Mr. Rosen holds a B.Sc. (cum laude) in Mechanical Engineering from
          Tel Aviv University in 1979 and an MBA from Tel Aviv University in 1986.</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">8</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Shlomo Liran</font> has served as our director since August 2015, after gaining experience in senior management positions, including in the
          telecommunication industry.&#160;In October 2016 Mr. Liran was appointed as the Chief Executive Officer of Spuntech Industries Ltd. From July 2014 until January 2015, Mr. Liran served as the Chief Executive Officer of Hadera Paper Ltd. From 2010 to
          2013, Mr. Liran served as the Chief Executive Officer of Avgol Nonwovens Ltd. During the years 2008 and 2009 Mr. Liran served as the Chief Executive Officer of Ericsson Israel Ltd., and from 2004 to 2007 he served as Chief Executive Officer of
          TRE (Scandinavian cellular network) in Sweden and in Denmark. From 2000 to 2003, he served as Chief Executive Officer of YES Satellite Multi-Channel TV. Prior to that, Mr. Liran spent thirteen years in Strauss as CEO (1995-2000), General Manager
          of the Dairy Division (1991-1995) and VP Operations (1987-1991). Mr. Liran holds a B.Sc. in Industrial Engineering from the Technion, an M. Eng. System Analysis from University of Toronto, Canada and an AMP-ISMP advanced management program from
          the Harvard Business School.</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Efrat Makov</font> has served as our director since October 2022. Ms. Makov has extensive telecom and public company director experience. Ms.
          Makov is currently serving as a director of Allot ltd., iSPAC 1 Ltd. and B Communications Ltd. Ms. Makov previously served as a director of BioLight Life Sciences Ltd., Kamada Ltd. and Anchiano Therapeutics Ltd. Previously, she served as the
          Chief Financial Officer of Alvarion, an Israeli-based global provider of autonomous wi-fi networks, and as the Chief Financial Officer of Aladdin Knowledge Systems. Formerly, she served as Vice President of Finance at Check Point Software
          Technologies. Between 1993 and 2000&#160;Ms. Makov worked in public accounting for Arthur Andersen LLP in its New York, London and Tel Aviv offices. Ms. Makov holds a B.A. degree in accounting and economics from Tel Aviv University and is a Certified
          Public Accountant in Israel and the United States.</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Rami Hadar </font>has served as our director since July 2021. Mr. Hadar serves as a Managing Partner in Claridge Israel, as well as serves on
          the board of its portfolio companies: AlgoSec, Gigaspaces, Cloudify, Shopic and D-Fend. In the years 2006 to 2014, Mr. Hadar served as Chief Executive Officer and board member of Allot Communications. Early in his career Mr. Hadar co-founded and
          served as the Chief Executive Officer of CTP Systems (micro cellular networks) until its acquisition by DSP Communications. Mr. Hadar continued with DSPC&#8217;s executive management team for two years, and subsequently the company was acquired by
          Intel. Thereafter, Mr. Hadar co-founded Ensemble Communications, a pioneer in the broadband wireless space and the WiMax standard, where he served as Executive Vice President, Sales and Marketing. Following that, Mr. Hadar served as Chief
          Executive Officer of Native Networks where he was instrumental in orchestrating the company&#8217;s ultimate acquisition by Alcatel. Mr. Hadar holds a B.Sc. in Electrical Engineering from the Technion.</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">David Ripstein</font> has served as our director since July 2021. Mr. Ripstein has three decades of experience in senior management positions
          in Israel&#8217;s telecommunications industry and Israel Defense Force technology and intelligence units. From June 2022 to January 2023 Mr. Ripstein served as the Chief Executive Officer of SatixFy Ltd. From 2017 to 2022, Mr. Ripstein served as the
          President and Chief Executive Officer of GreenRoad Technologies Ltd., a global leader in fleet safety telematics. In 2016 Mr. Ripstein served the Chief Executive Officer of Spotoption Technologies a fintech software provider. From 2000-2015, Mr.
          Ripstein served in various positions in RADCOM, a Nasdaq-traded (RDCM) provider of service assurance solutions, first for six years as a General Manger and then for nine years as its President &amp; Chief Executive Officer. Prior to RADCOM, Mr.
          Ripstein co-founded two technology startups and served for 10 years as the head of a large R&amp;D engineering group within the Israel Defense Forces-Intelligence Unit. Mr. Ripstein holds a B.Sc. in Electrical Engineering from the Technion.</div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">9</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"> <br>
        </div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Yael Shaham</font> has served as our director since September 2023, Ms. Yael Shaham has more than 25 years of experience in management and
            strategic leadership roles, and brings a wealth of knowledge from across the technology and business landscape. Ms. Shaham currently serves as a member of the Board of Clalit Health Services, where she contributes her rich experience and
            knowledge in digital transformation and future IT technologies. Ms. Shaham is also a member of the board of Advisors at Veego, where her product experience plays a critical role in the development of Product Strategy and Go-to-Market
            initiatives. In addition, Ms. Shaham serves as a Board Member at Glassbox (TASE:GLBX), where her responsibilities include the role of Chairwoman of Remuneration and Audit committees, along with membership in the Financial Statements committee,
            helping to shape the company's governance and overall performance. In her previous role as General Manager of the Enterprise &amp; Learning Division at Kaltura (NASDAQ:KLTR), she led multiple go-to-market teams to increase ARR while playing a
            key role in successfully guiding the company's IPO process. At Amdocs (NASDAQ:DOX), Ms. Shaham served as the General Manager of the Network Division, IT &amp; Operations Division, and Revenue Management Division. Her strategic vision and
            expertise contributed to revenue growth, successful M&amp;A integrations, and a quantitative increase in the company's perceived brand value. Ms. Shaham is also a member of the Israel Board of Directors Team of the Government Companies
            Authority. She holds an MA in Organizational Sociology (cum laude) and BA in Computer Science and Sociology (summa cum laude), both from Bar Ilan University and served as a Major in the Israeli Air Force.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; text-indent: 36pt; line-height: 1.25;"><font style="font-style: italic;">Robert Wadsworth</font> is a 35-year veteran of the VC and PE industry. He is a founding partner of HarbourVest Partners, the successor
            entity of Hancock Venture Partners, where he had last served as a senior partner overseeing global direct investment activity and a member of the firm's Executive Management Committee. Mr. Wadsworth&#8217;s prior experience additionally includes
            management consulting with Booz, Allen &amp; Hamilton, where he specialized in the areas of operations strategy and manufacturing productivity. At present, Mr. Wadsworth serves as a founding partner of both W3 Capital, LLC, a family investment
            firm and as a founding partner of New Harbour Partners, a small enterprise private equity firm.&#160; He currently serves on the Board of Directors of AGL Credit, Whisker Labs, Spiro, and Direct Commerce - all private enterprises.&#160;&#160; And while he is
            no longer an active member of HarbourVest, Mr. Wadsworth continues to serve on that firm's supervisory committee. Mr. Wadsworth earned a BS (magna cum laude) in Systems Engineering and Computer Science from the University of Virginia in 1982
            and an MBA (with distinction) from Harvard Business School in 1986. Mr. Wadsworth serves as a trustee of the University of Virginia Engineering School, St. Stephens and St. Agnes School and as a board member of Tenacity - a non profit program
            supporting middle school children attending Boston public schools.&#160; </div>
        </div>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Required Vote</u></div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;">An affirmative vote of the holders of a majority of the voting power represented at the Meeting in person or by proxy, and voting thereon, is required for the re-election of Mr. Ilan Rosen, Ms.
            Efrat Makov, Ms. Yael Shaham,&#160; Mr. Shlomo Liran, Mr. Rami Hadar, and Mr. David Ripstein and for the election of Mr. Robert Wadsworth to our Board. The re-election or election of each of these nominees, shall be voted upon separately at the
            Meeting.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;">It is proposed that at the Meeting the following resolutions be adopted:</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">RESOLVED</font> that: Mr. Ilan Rosen be, and he hereby is, re-elected to the Board, for a term of approximately three (3) years ending on the date of the
            Annual General Meeting that will be held in 2027;</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">FURTHER RESOLVED</font> that: Ms. Efrat Makov be, and she hereby is, re-elected to the Board, for a term of approximately three (3) years ending on the date of
            the Annual General Meeting that will be held in 2027;</div>
          <div style="text-align: justify; line-height: 1.25;"> <br>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">10</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">FURTHER RESOLVED</font> that: Ms. Yael Shaham be, and she hereby is, re-elected to the Board, for a term of approximately three (3) years ending on the date of
            the Annual General Meeting that will be held in 2027;</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">FURTHER RESOLVED</font> that: Mr. Shlomo Liran be, and he hereby is, re-elected to the Board of Directors, for a term of approximately three (3) years ending
            on the date of the Annual General Meeting that will be held in 2027;</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;">&#160;&#8220;<font style="font-weight: bold;">FURTHER RESOLVED</font> that: Mr. Rami Hadar be, and he hereby is, re-elected to the Board, for a term of approximately three (3) years ending on the date of
            the Annual General Meeting that will be held in 2027;</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">FURTHER RESOLVED</font> that: Mr. David Ripstein be, and he hereby is, re-elected to the Board, for a term of approximately three (3) years ending on the date
            of the Annual General Meeting that will be held in 2027; and</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">FURTHER RESOLVED</font> that: Mr. Robert Wadsowrth be, and he hereby is, elected to the Board, for a term of approximately three (3) years ending on the date
            of the Annual General Meeting that will be held in 2027.&#8221;</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Board Recommendation</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The Board of Directors recommends a vote &#8220;FOR&#8221; approval of the proposed resolutions.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; margin-right: 0.2pt; line-height: 1.25; font-style: italic;">As each of the nominees for re-election has a personal interest in the foregoing proposed resolutions regarding his or her respective re-election, each of
          them refrained from making a recommendation with respect to his or her own re-election.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">11</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL 2</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">TO APPROVE CERTAIN COMPENSATION TERMS OF THE COMPANY&#8217;S NON-</div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">EXECUTIVE DIRECTORS, INCLUDING THE GRANT OF EQUITY CONSIDERATION, ALL, </div>
          <div style="text-align: center; line-height: 1.25; font-weight: bold;">AS PART OF THEIR COMPENSATION FOR SERVICE AS SUCH</div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Background</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">According to the Companies Law, compensation paid to our directors require, in general, the approval of our Compensation Committee, Board of Directors and shareholders, in that order.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; line-height: 1.25; font-style: italic;">Cash Compensation for Service as Directors</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;">Subject to the approval of their election and re-election for service as directors of the Company, as applicable, our directors will receive equal cash remuneration (except for (i) Mr. Robert
            Wadsworth, who shall be entitled to receive an in-person participation fee also for his participation by electronic means in in-person meetings , and (ii) Mr. Rosen, who will be entitled to an increased annual fee, as described below). These
            amounts include annual fee, per-meeting participation fee for participation in meetings of the Board and its committees, and reimbursement of travel expenses for participation in a meeting which is held outside of their place of residence, in
            the following amounts (indexed to Consumer Price Index in accordance with the Remuneration Regulations (as defined below)): NIS 112,000 (approximately $29,708 based on the representative NIS/USD exchange rate of NIS 3.77/$1.00 published by the
            Bank of Israel on April 16, 2024 (the &#8220;<font style="font-weight: bold;">Exchange Rate</font>&#8221;)) as annual fee, NIS 3,500 (approximately $928, based on the Exchange Rate) as participation fee, per meeting, for an in person participation in
            meetings of the Board and its committees, NIS 2,100 (approximately $557, based on the Exchange Rate) as participation fee, per meeting, for participation in meetings of the Board and its committees by electronic means and NIS 1,750
            (approximately $464, based on the Exchange Rate) for each written resolution.</div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">The above-mentioned cash remuneration is in line with our Compensation Policy, which was last amended at the 2023 AGM (the &#8220;<font style="font-weight: bold;">Compensation
            Policy</font>&#8221;), according to which each of the Company&#8217;s directors is entitled to receive cash fees that include annual and participation fees.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; line-height: 1.25;">As these amounts are in the range between the fixed amounts of the annual and participation fees, as set forth in regulations promulgated under the Companies Law in connection with compensation
            to external directors (the &#8220;<font style="font-weight: bold;">Remuneration Regulations</font>&#8221;), and the maximum amounts of such fees set forth in the Foreign Listed Regulations, they are exempt from shareholder approval, in accordance with the
            Israeli Companies Regulations (Relief From Related Party Transactions), 2000.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25; font-style: italic;">Insurance, Exemption and Indemnification</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
        <div style="text-align: justify; line-height: 1.25;">In addition, if elected or re-elected, as applicable, our directors would be covered by any D&amp;O liability insurance in effect as of the date of their election and thereafter purchased by the
          Company from time to time in accordance with the provision of the Compensation Policy. Also, if elected, they would be granted by the Company with exemption and indemnification letters consistent with those previously provided to the directors of
          the Company.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25; font-weight: bold;"><u>General</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; line-height: 1.25;">In order to attract and retain the best qualified candidates to our Board, and similar to the practice previously set by our shareholders with respect to the remuneration of Board members, our
            Compensation Committee and Board of Directors have approved, and resolved to recommend to our shareholders to approve, the grant of equity awards and additional compensation terms, as detailed below, to each of Mr. Ilan Rosen, Ms. Efrat Makov,
            Ms. Yael Shaham, Mr. Shlomo Liran, Mr. Rami Hadar, Mr. David Ripstein, and Mr. Robert Wadsworth subject to their election or re-election to the Board of Directors, with respect to their three-year terms of service as directors.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">12</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <div style="line-height: 1.25;">
          <table cellspacing="0" cellpadding="0" id="z2aac0459038a4f148c42d8510538b511" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 17.85pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>To Mr. Rosen, Chairman of the Board of Directors, an increased amount of NIS 238,000&#160; (approximately $63,129 based on the Exchange Rate; indexed to Consumer Price Index in accordance with the Remuneration Regulations) as annual fee
                    (the &#8220;<font style="font-weight: bold;">Chairman Annual Fee</font>&#8221;), due to his ongoing involvement with the Company, as the Chairman of the Board of Directors, as determined by our compensation Committee and Board. Mr. Rosen&#8217;s
                    participation fees will not be changed and remain equal to those of the other members of the Board of Directors. The Chairman Annual Fee is in excess of the annual cash fee amount listed under the Remuneration Regulations, as
                    supplemented by the Foreign Listed Regulations, and it exceeds the annual fee amount referred to in our Compensation Policy.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25">&#160;</div>
          <table cellspacing="0" cellpadding="0" id="z8f7532d48d0547b39703095253c3c779" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 17.85pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>Mr. Robert Wadsworth, our new nominee independent director, will be paid an in-person participation fee also for in-person Board meetings in which he participates by electronic means, as determined by our compensation Committee and
                    Board, since he is the only director residing outside of Israel (&#8220;<font style="font-weight: bold;">Mr. Wadsworth&#8217;s Participation Fee</font>&#8221;). Mr. Wadsworth&#8217;s Participation Fee exceeds the participation fees referred to in our
                    Compensation Policy, with respect to the fees that will be paid to him for participation by electronic means.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25">&#160;</div>
          <table cellspacing="0" cellpadding="0" id="zfd4ff04487e847c681b70f7388ef3592" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 17.85pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>To each of Ms. Efrat Makov, Ms. Yael Shaham, Mr. Shlomo Liran, Mr. Rami Hadar, Mr. David Ripstein, and Mr. Robert Wadsworth, non-executive directors of the Company, an annual grant of equity, on the date of this Meeting of
                    shareholders of the Company and subject to his or her election or continuous service, be granted with annual equity awards based on the mechanism and under the terms detailed below, without the need for further approval, to be granted
                    at the date of this Meeting, and upon the first and second anniversaries of this Meeting (i.e., on May 23, 2025, and May 23, 2026) (each, a &#8220;<font style="font-weight: bold;">Grant Date</font>&#8221;), subject to his or her continuous service
                    as our director.</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25">&#160;</div>
        </div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25; font-style: italic;">Mechanism and Terms</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
        <table cellspacing="0" cellpadding="0" id="zc8e0988fdbc14c51a402aecfbf72ae84" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(a)</td>
              <td style="width: auto; vertical-align: top;">
                <div>Each of our non-executive directors shall be granted an equal value mix of options to purchase Shares (the &#8220;<font style="font-weight: bold;">Options</font>&#8221;) and Restricted Share Units (&#8220;<font style="font-weight: bold;">RSUs</font>&#8221;)
                  (the Options and the RSUs together, the &#8220;<font style="font-weight: bold;">Annual Equity Award</font>&#8221;);</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zfec925d51f2f47a0a8b6d2a07d1319e7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(b)</td>
              <td style="width: auto; vertical-align: top;">
                <div>The value of the Annual Equity Award shall be 75,000 USD (&#8220;<font style="font-weight: bold;">Annual Equity Value</font>&#8221;);</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zc48c504391de48eab45398895476e712" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(c)</td>
              <td style="width: auto; vertical-align: top;">
                <div>The actual number of Options and RSUs to be granted each year, bearing the foregoing Annual Equity Value, shall be determined based on the average closing price per Share as quoted on the NASDAQ Stock Market during the 30 consecutive
                  trading days preceding the Grant Date (the &#8220;<font style="font-weight: bold;">Market Value</font>&#8221;); and</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z6b22e02d89604f87a6a66b96b206a6c5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(d)</td>
              <td style="width: auto; vertical-align: top;">
                <div>In case a non-executive director is appointed in between annual general meetings, in accordance with our Articles &#8211; the Annual Equity Award will be pro-rated according to the part of the year that has passed since the previous annual
                  general meeting of shareholders.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" id="ze1d123a8ca914ba080b41d7b9a3b0d23" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(e)</td>
              <td style="width: auto; vertical-align: top;">
                <div>Exercise Price: The exercise price of the Options will be equal to the Market Value plus a 10% premium, and the RSUs shall have an exercise price of NIS 0.01 per share, which is the par value of each Share;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z1695c8b98ade47f482e6de2bab9b01ce" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(f)</td>
              <td style="width: auto; vertical-align: top;">
                <div>If approved by our shareholders, the Annual Equity Award granted each year, as detailed above, will be fully vested on the Grant Date. The exercise price for the proposed grants shall be equal to the average closing price of the
                  Company&#8217;s Shares on the Nasdaq Global Select Market for the period equal to thirty (30) consecutive trading days immediately preceding the Grant Date of each portion of the total grant, provided that with respect to Mr. Wadsworth, our
                  director nominee who is a U.S resident, we may adjust this calculation method to comply with the applicable 409A regulations. In addition, subject to an earlier expiry in accordance with the terms of the Option Plan (as defined below),
                  the Annual Equity Award will expire upon the earlier of (i) six (6) years after the date of grant, or (ii) at such time as the closing price of the Company&#8217;s ordinary shares on Nasdaq falls below fifty percent (50%) of the exercise price
                  detailed above and remains in such price or in a lower price for a period of at least 90 days (the &#8220;<font style="font-weight: bold;">Knockout</font>&#8221;), in which case the options shall be cancelled automatically.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">13</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25"> <br>
        </div>
        <table cellspacing="0" cellpadding="0" id="z1feb33050786401c868569842bdfca94" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(g)</td>
              <td style="width: auto; vertical-align: top;">
                <div>The Directors Equity Grant will be made under the Company&#8217;s 2024 Equity Incentive Plan (the &#8220;<font style="font-weight: bold;">2024 Plan</font>&#8221;) and under the Capital Gains Route of Section 102(b)(2) of the Israeli Income Tax Ordinance
                  (the &#8220;<font style="font-weight: bold;">Ordinance</font>&#8221;).</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z15c11ff51c014363a4444e21a082866c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top;">(h)</td>
              <td style="width: auto; vertical-align: top;">
                <div>The grant of the Annual Award is in line with the Compensation Policy, according to which, each of the Company&#8217;s non-executive directors is entitled to receive equal annual equity-based compensation, which value shall not exceed
                  $150,000 (per annum).</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">
          <table cellspacing="0" cellpadding="0" id="z2addeb30b035459c977869adc02a38b5" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 17.85pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>To Mr. Rosen, our Chairman of the Board, an annual grant of equity in equal terms to the above Annual Award, provided however that the Annual Equity Value of Mr. Rosen&#8217;s Annual Award shall be $112,500 (the &#8220;<font style="font-weight: bold;">Chairman Annual Award</font>&#8221;, and together with the Annual Award, the &#8220;<font style="font-weight: bold;">Directors Equity Grant</font>&#8221;). All other terms and conditions of the Annual Award shall apply to the Chairman Annual
                    Award, <font style="font-style: italic;">mutatis mutandis</font>. The Compensation Committee and Board are of the opinion that, it would be appropriate to compensate Mr. Rosen with the grant of an increased equity grant in comparison
                    to the equity consideration granted to the other non-executive members of the Board, taking into account, among others, the considerable amount of time required from him in order to fulfill his Board activities as a Chairman and his
                    contribution to the Company&#8217;s success. The grant of the Chairman Annual Award is in line with the Compensation Policy, according to which, the Chairman of the Board of Directors of the Company is entitled to receive an annual
                    equity-based compensation of up to 3 times the annual equity-based compensation of the other directors (see below).</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25">&#160;</div>
        </div>
        <div style="text-align: justify; line-height: 1.25;">The proposed value of the Directors Equity Grant detailed above was examined and evaluated by our Compensation Committee and Board in accordance with a peer group study; the peer group study is a
          compensation and benefit examination, included peer companies selected to provide an appropriate comparative model, based on appropriate similarities taking into account a number of factors, including: market capitalization, type of industry,
          location of listing of securities, level of revenues, number of employees, geographical considerations and other factors that are considered relevant for comparison. Following due consideration of the type and value of the Directors Equity Grant,
          as well as the full compensation packages, granted to directors serving in companies included in the study, our Compensation Committee and Board have determined that the value of the total compensation paid to our directors, including the value
          of the proposed equity awards, is below the median range of total director compensation provided by our peer companies.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">When considering the proposed Directors Equity Grant, our Compensation Committee and Board analyzed all factors and considerations required under our Compensation Policy and the Companies Law,
          including, <font style="font-style: italic;">inter alia</font>, the responsibilities and duties of our directors,&#160;the estimation of their expected contribution and the importance of our directors to the future growth and success of the Company.
          Our Compensation Committee and Board of Directors believe that the Directors Equity Grant detailed above is in the best interests of the Company, as: (i) the Company competes on qualified individuals to serve on its Board, and therefore needs to
          provide them with an adequate compensation package, which is aligned with the common practice implemented by our peers; (ii) the Directors Equity Grant detailed above aligns the interests of our directors with those of our shareholders; (iii) the
          Directors Equity Grant detailed above will provide, together with the cash compensation and existing equity consideration (as applicable), an adequate recognition for the time, attention and expertise required by our directors; and (iv) the
          Directors Equity Grant detailed above has a long term incentive value, while taking into account the interests of the Company&#8217;s shareholders and their dilution level. In this respect, our Compensation Committee and Board remain committed to
          maintaining low levels of dilution, below the 10% threshold, with respect to any proposed and/or outstanding equity-based compensation plans (currently at approximately 8.52%).</div>
        <div style="text-align: justify; line-height: 1.25;"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">14</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="text-align: justify; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25; font-weight: bold;"><u>Required Vote</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">An affirmative vote of the holders of a majority of the voting power represented at the Meeting in person or by proxy and voting thereon, is required for the approval of the Directors Equity
          Grant detailed above.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The affirmative vote of the holders of a majority of the voting power represented at the Meeting in person or by proxy and voting thereon, is required for the approval of the Chairman Annual Fee
          and Mr. Wadsworth&#8217;s Participation Fee; provided that a Disinterested Majority of the shares voted in favor of this proposal.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The Companies Law, as supplemented by the Foreign Listed Regulations, requires that each shareholder voting on a proposed resolution requiring a Disinterested Majority inform the Company whether
          or not he or she is a controlling shareholder or has a personal interest in the proposed resolutions. Under the Companies Law, in general, a person will be deemed to be a controlling shareholder if that person has the power to direct the
          activities of the company, otherwise than by reason of being a director or other office holder of the company, and a person is deemed to have a personal interest if any member of the shareholder&#8217;s immediate family, or the immediate family of a
          shareholder&#8217;s spouse, has a personal interest in the adoption of the proposals. In addition, you are deemed to have a personal interest if a company, other than Ceragon, which is affiliated with you, has a personal interest in the adoption of the
          proposals. Such company is a company in which you or a member of your immediate family serves as a director or CEO, has the right to appoint a director or the CEO, or owns five percent (5%) or more of the outstanding shares. However, you are not
          deemed to have a personal interest in the adoption of the proposals if your interest in such proposal arises solely from your ownership of our shares, or to a matter that is not related to a relationship with a controlling shareholder.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Please note that we consider it highly unlikely that any of our shareholders is a controlling shareholder or has a personal interest in this proposal</font>.&#160;
          However, as required under the Companies law, as supplemented by the Foreign Listed Regulations, you should actively inform Ceragon whether you are a controlling shareholder or have a personal interest in this proposal.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; line-height: 1.25;">It is proposed that at the Meeting the following resolutions be adopted:</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
        <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">RESOLVED</font>, to approve the payment of the Chairman Annual Fee to Mr. Ilan Rosen, our Chairman of the Board.&#8221;</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">FURTHER RESOLVED</font>, to approve payment of Mr. Wadsworth&#8217;s Participation Fee to Mr. Robert Wadsworth, our newly appointed non-executive director.&#8221;</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">FURTHER RESOLVED</font>, to approve the grant of the Chairman Equity Grant to the Company&#8217;s non-executive directors, in the amounts and upon terms as described
          in this Proposal 2 of the Proxy Statement.&#8221;</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Board Recommendation</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The Board of Directors recommends a vote &#8220;FOR&#8221; approval of the proposed resolutions.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-style: italic;">As all members of the Board of Directors have a personal interest in the foregoing proposed resolution concerning the Directors Equity Grant, they each refrained from making a
          recommendation with respect to the applicable resolution relevant to them. Mr. Rosen has a personal interest in the foregoing proposed resolution concerning the Chairman Annual Fee, he refrained from making a recommendation with respect to the
          applicable resolution.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">15</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25"> <br>
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL 3</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">APPROVAL OF CERTAIN COMPENSATION TERMS FOR THE COMPANY&#8217;S CHIEF </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">EXECUTIVE OFFICER</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Background</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; line-height: 1.25;">Under the Companies Law, arrangements regarding the compensation of a chief executive officer (&#8220;<font style="font-weight: bold;">CEO</font>&#8221;) of a publicly traded company should generally be
            consistent with such Company&#8217;s compensation policy and require the prior approval of the company&#8217;s compensation committee, board of directors and shareholders (provided that, the majority of the shares voted in favor of this proposal are not
            held by &#8220;controlling shareholders&#8221; or shareholders with &#8220;personal interest&#8221; in the approval of such proposal, as detailed below), in that order.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;">Following the approval of our Compensation Committee and Board, we now seek our shareholders&#8217; approval for the terms of office and employment proposed for Mr. Arazi in his capacity as the
            Company&#8217;s Chief Executive Officer.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;">Under his existing employment agreement, our CEO, Mr. Doron Arazi, is entitled to a gross annual base salary of NIS 1,080,000 (approximately $286,472, based on the Exchange Rate) (the &#8220;<font style="font-weight: bold;">Base Salary</font>&#8221;), plus customary fringe&#160;benefits which include, among others, managers&#8217; insurance, education fund, car expenses, long-term disability and life insurance. In addition, Mr. Arazi is entitled to a
            performance-based annual cash bonus and to an annual equity grant.</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">Following the approval of our Compensation Committee and Board of Directors, we now seek our shareholders&#8217; approval for Mr. Arazi&#8217;s revised compensation terms, for his
          services as our CEO, all as detailed below.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Proposed Compensation Terms</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; line-height: 1.25;">Following are the principal terms of office and employment proposed for Mr. Arazi in his position as the Company&#8217;s CEO:</div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <div style="margin-right: 3.25pt; line-height: 1.25; font-weight: bold;">Annual Base Salary</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; line-height: 1.25;">The Base Salary of Mr. Arazi was last approved by our shareholders at the 2021 AGM. Mr. Arazi will be entitled to a revised gross annual base salary of NIS 1,242,000 (approximately $329,443,
            based on the Exchange Rate) (the &#8220;<font style="font-weight: bold;">CEO Revised Based Salary</font>&#8221;), plus customary fringe benefits which include, among others, managers&#8217; insurance, education fund, long-term disability and life insurance.</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
        <div style="margin-right: 3.25pt; line-height: 1.25; font-weight: bold;">2024 Cash Bonus Plan</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; line-height: 1.25;">Consistent with the Compensation Policy, and subject to the limitations set forth therein, the Company may determine, with respect to each year, the target and maximum annual cash bonuses, as
            well as related objectives and related weights, applicable thresholds and the formula for calculating the annual cash bonus payment to be granted to our CEO.</div>
          <div style="line-height: 1.25">&#160;</div>
          <div style="text-align: justify; line-height: 1.25;">Taking into account numerous factors, including the provisions of the Compensation Policy and other relevant information and materials presented to them, our Compensation Committee and Board of
            Directors have resolved, and are recommending that the shareholders approve, the following annual bonus plan for calendar year 2024 for our CEO, including the following related objectives, parameters, weights and terms, calculated in accordance
            with the following principles (altogether, the &#8220;<font style="font-weight: bold;">CEO Cash Bonus Plan</font>&#8221;):</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
        <div style="line-height: 1.25;">
          <table cellspacing="0" cellpadding="0" id="z2d6bb1501dce4ea0b6bbe5abf35ef12e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

              <tr>
                <td style="width: 18pt;"><br>
                </td>
                <td style="width: 18pt; vertical-align: top;">&#8226;</td>
                <td style="width: auto; vertical-align: top;">
                  <div>According to the CEO Cash Bonus Plan the &#8220;On-Target&#8221; bonus amount for the year 2024 it will be equal to ten (10) months&#8217; base salary (the &#8220;<font style="font-weight: bold;">On-Target Bonus</font>&#8221;).</div>
                </td>
              </tr>

          </table>
          <div style="line-height: 1.25">&#160;</div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">16</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div style="line-height: 1.25"> <br>
          </div>
        </div>
        <table cellspacing="0" cellpadding="0" id="zbdb44b8f34924428a0f449169dfc346f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>Financial Measurable Targets: Ninety percent (90%) of the targets forming part of the CEO Cash Bonus Plan will be measurable targets and will include financial measurable targets (the &#8220;<font style="font-weight: bold;">Financial
                    Measurable Targets</font>&#8221;). The proposed Financial Measurable Targets shall be as follows: seventy percent (70%) of the 2024 On Target Bonus shall be based on the Company&#8217;s non-GAAP operating profit targets, ten percent (10%) of the
                  2024 On Target Bonus shall be based on the Company&#8217;s cash flow targets, and ten percent (10%) of the 2024 On Target Bonus shall be based on the Company&#8217;s booking targets, all to be determined based on the Company&#8217;s financial results for
                  the year 2024. These targets were determined based on the Company&#8217;s 2024 annual business targets at the beginning of 2024, together with the targets determined for the annual bonus plans of the entire Company&#8217;s management.&#160;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zb4f429ff9d414f7d97bb9e98774d9336" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;"><br>
              </td>
              <td style="width: 18pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>Non-Measurable Criteria: ten percent (10%) of the targets forming part of the CEO Cash Bonus Plan will be non-measurable criteria, which shall be concluded by assessing the CEO performance during the year, his contribution to the
                  achievement of the Company's goals, and his evaluation by the Board of Directors.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <div style="margin-right: 4.5pt; line-height: 1.25;"><u>General Terms</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Our Compensation Committee and Board of Directors have set a minimum threshold score with respect to each of the Financial Measurable Targets, so that below a certain level of achievement,
          payment will not be made with respect to such Measurable Target, as well as a general plan threshold which is based on the achievement of a pre-determined measurable financial criteria, under which no annual cash bonus shall be paid to our CEO.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Further, our Compensation Committee and Board of Directors have resolved that the maximum annual bonus payment to our CEO will be capped at 200% of his On Target Bonus (the &#8220;<font style="font-weight: bold;">Maximum Payment Cap</font>&#8221;), which cap is in compliance with the Compensation Policy. Reaching the Maximum Payment Cap, in the opinion of the Compensation Committee and Board of Directors, is an extremely challenging
          task.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Subject to receipt of shareholders&#8217; approval of the above annual cash bonus for 2024 for Mr. Arazi (including the related objectives, weights and terms thereof), the Compensation Committee and
          the Board of Directors will determine, following their approval of the 2024 Company&#8217;s audited financial statements, and without the need for further shareholder approval, the actual bonus to be paid with respect to 2024 to Mr. Arazi, if any.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">2024 Equity Grant</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The 2024 annual CEO equity grant is comprised of (a) options to purchase 133,333 Ordinary Shares with a 10% premium above the fair market value exercise price (the &#8220;<font style="font-weight: bold;">Options</font>&#8221;), the value of which is estimated, as of the date of this Proxy Statement, and calculated based on the average closing price of the Company&#8217;s Ordinary Shares on the Nasdaq for the period equal to thirty (30) consecutive
          trading days prior to the filing date of this Proxy Statement, at approximately $205,155; and (b) 66,667 restricted share units (the &#8220;<font style="font-weight: bold;">RSUs</font>&#8221; and together with the Options the &#8220;<font style="font-weight: bold;">Annual CEO Equity Grant</font>&#8221;), the value of which is estimated, as of the date of this Proxy Statement, at approximately $205,155.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The ratio between the Options and the RSUs is 50%/50% in value.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The above values may vary until the date of the Meeting, as the proposed Annual CEO Equity Grant, which is calculated, among other things, based on the average closing price of the Company&#8217;s
          Ordinary Shares on the Nasdaq for the period equal to thirty (30) consecutive trading days prior to the date of this Proxy Statement. Taking into consideration the Annual CEO Equity Grant, the Company maintains a dilution level which is below the
          10% dilution threshold.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">17</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
          <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">The total value of the Annual CEO Equity Grant is estimated at $410,310, constituting approximately 125% of our CEO&#8217;s annual total compensation; such value is in line with
            the provisions of our Compensation Policy and is within the median range of the benchmark reviewed by the Compensation Committee and the Board of Directors, which consists of comparable companies. The additional terms under which the Annual CEO
            Equity Grant shall be provided are as follows:</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
        <table cellspacing="0" cellpadding="0" id="z41822b27e04048d8a1cf7daa6f7b71aa" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 21.3pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>The Annual CEO Equity Grant shall be granted on the date of this Meeting (the &#8220;<font style="font-weight: bold;">Grant Date</font>&#8221;);</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z2c70f5bf2c0146ed9446fd114e402e42" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 21.3pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>The exercise price of the Options shall be equal to the average closing price of the Company&#8217;s Shares on the Nasdaq for the period equal to thirty (30) consecutive trading days immediately preceding the Grant Date, plus a 10% premium;</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" id="zec6d2570a4c54a3eaea344fda940c536" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 21.3pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>The Annual CEO Equity Grant shall vest over a period of four (4) years, in four (4) equal tranches following the Grant Date, with a one-year cliff, so that on each anniversary of the Grant Date, 25% of the total grant shall vest
                  (subject to acceleration of vesting in the circumstances detailed below); and</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <table cellspacing="0" cellpadding="0" id="z728297c10d5b4935886415acc7d1910e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 21.3pt; vertical-align: top;">&#8226;</td>
              <td style="width: auto; vertical-align: top;">
                <div>The Annual CEO Equity Grant shall be granted pursuant to the 2024 Plan, and the grant shall be made through a trustee under the &#8220;Capital Gains Route&#8221; of Section 102(b)(2) of the Ordinance.</div>
              </td>
            </tr>

        </table>
        <div style="line-height: 1.25">&#160;</div>
        <div style="margin-right: 4.5pt; line-height: 1.25; font-style: italic;">Acceleration</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">The vesting of the Annual CEO Equity Grant will be subject to acceleration according to the following double trigger mechanism: in the event that by the date of the
            consummation of a Transaction (as defined in the Option Plan): (i) Mr. Arazi&#8217;s employment with the Company (or the surviving entity following a merger) is terminated not for (i) Cause (as defined in the Option Plan); or (ii) there is a change
            in Mr. Arazi&#8217;s position in the Company (or the surviving entity following merger) and Mr. Arazi is not offered to continue to be employed by the surviving entity in a senior position, equivalent to the position of the Company&#8217;s CEO prior to the
            Transaction, the vesting of all of the unvested equity awards included in the Annual CEO Equity Grant, as of such date, shall accelerate upon the consummation of the Transaction. Mr. Arazi shall undertake that in the event that he will sell any
            of the Annual CEO Equity Grant, the vesting of which accelerated as a result of this double trigger mechanism, he will remain employed by the Company (or the surviving entity following merger) for a six-month period following the consummation
            of the Corporate Transaction (subject to the Company&#8217;s or the surviving entity&#8217;s request) and the consideration received for such sale shall be held in escrow until the earlier of (i) the termination of Mr. Arazi&#8217;s employment, or (ii) the lapse
            of a six-month period following the consummation of the Transaction.</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Additional Considerations Taken by the Compensation Committee and the Board of Directors when approving the abovementioned compensation terms proposed to be paid and/or
            granted to our CEO, Mr. Arazi</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">When considering the compensation terms detailed above proposed to be paid and/or granted to Mr. Arazi, the Compensation Committee and Board of Directors analyzed all factors and considerations
          required under the Compensation Policy and the Companies Law, including, <font style="font-style: italic;">inter alia</font>: (i) the responsibilities and duties of Mr. Arazi, considering the size of the Company and the scope, complexity and
          nature of its operations; (ii) Mr. Arazi&#8217;s education, qualifications, expertise and extensive experience in the telecommunications industry in general, and his performance in his various roles in the past; (iii) the information included in the
          benchmark study presented to the Board of Directors, according to which the proposed compensation terms for Mr. Arazi are well below the average and median compensation terms of the chief executive officers&#160; of the Company&#8217;s Israeli peers, which
          is by itself lower than the average and median chief executive officers&#8217; compensation terms among peer companies in the U.S; (iv) market compensation trends; (v) the appropriate balance between the fixed components and the variable components
          comprising the proposed compensation, and the fact that the variable components are limited to maximums that are consistent with the requirement for a close link between payments to Mr. Arazi and the Company&#8217;s performance and increase of its
          profits, while protecting the interests of the Company and its shareholders; and (vi) examination of data regarding the ratio between the proposed compensation and the wages of the rest of the Company&#8217;s employees and, particularly, the ratio to
          the average wage and the median wage of such employees and the impact of the gaps between them on the labor relations in the Company, and determination that the said ratio is reasonable and will not adversely affect labor relations in the
          Company.</div>
        <div style="text-align: justify; line-height: 1.25;"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">18</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; line-height: 1.25;">Considering the set of parameters and considerations, as well as the arguments specified above, our Compensation Committee and Board of Directors determined that the proposed compensation terms
            for our Chief Executive Officer, Mr. Doron Arazi, are fair, reasonable and customary.</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Required Vote</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The affirmative vote of the holders of a majority of the voting power represented at the Meeting in person or by proxy and voting thereon, is required for the approval of the above compensation
          terms for Mr. Doron Arazi, the Company&#8217;s CEO; provided that a Disinterested Majority of the shares voted in favor of this proposal.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The Companies Law, as supplemented by the Foreign Listed Regulations, requires that each shareholder voting on a proposed resolution requiring a Disinterested Majority inform the Company whether
          or not he or she is a controlling shareholder or has a personal interest in the proposed resolutions. Under the Companies Law, in general, a person will be deemed to be a controlling shareholder if that person has the power to direct the
          activities of the company, otherwise than by reason of being a director or other office holder of the company, and a person is deemed to have a personal interest if any member of the shareholder&#8217;s immediate family, or the immediate family of a
          shareholder&#8217;s spouse, has a personal interest in the adoption of the proposals. In addition, you are deemed to have a personal interest if a company, other than Ceragon, which is affiliated with you, has a personal interest in the adoption of the
          proposals. Such company is a company in which you or a member of your immediate family serves as a director or CEO, has the right to appoint a director or the CEO, or owns five percent (5%) or more of the outstanding shares. However, you are not
          deemed to have a personal interest in the adoption of the proposals if your interest in such proposal arises solely from your ownership of our shares, or to a matter that is not related to a relationship with a controlling shareholder.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;"><font style="font-weight: bold;">Please note that we consider it highly unlikely that any of our shareholders is a controlling shareholder or has a personal interest in this proposal</font>.&#160;
          However, as required under the Companies law, as supplemented by the Foreign Listed Regulations, you should actively inform Ceragon whether you are a controlling shareholder or have a personal interest in this proposal.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; line-height: 1.25;">As set forth in the Companies Law, if our shareholders oppose the approval of the compensation package for Mr. Arazi, the Compensation Committee and Board of Directors may nevertheless approve
            such terms, in &#8220;special cases&#8221;, after having held another discussion regarding such terms, on the basis of detailed reasoning that considered the rationale behind the shareholders&#8217; opposition and after determining that such approval is in the
            best interests of the Company.</div>
          <div style="line-height: 1.25">&#160;</div>
        </div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Proposed Resolution</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">It is proposed that at the Meeting the following resolutions be adopted:</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">&#8220;<font style="font-weight: bold;">RESOLVED</font>, to approve the CEO Revised Based Salary, the CEO Cash Bonus Plan and the Annual CEO Equity Grant, all upon the terms described in this Proposal
          3 of the Proxy Statement.&#8221;</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Board Recommendation</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The Board of Directors recommends a vote &#8220;FOR&#8221; approval of the proposed resolutions.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">19</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL 4</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">APPROVAL OF AMENDMENTS TO THE COMPANY&#8217;S ARTICLES OF ASSOCIATION</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25; font-weight: bold;">Background</div>
        <div style="line-height: 1.25; font-weight: bold;"> <br>
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">Under the Companies Law, any amendment to a public company&#8217;s articles of association requires approval by the company&#8217;s shareholders. Under the Company&#8217;s existing Articles of
          Association (the &#8220;<font style="font-weight: bold;">Current</font>&#160;<font style="font-weight: bold;">Articles</font>&#8221;), a resolution adopted in a General Meeting by a simple majority of the voting power represented at the meeting in person or by
          proxy and voting thereon is required to approve any amendment to the Current Articles.</div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">The Current Articles were last amended in the 2016 annual general meeting of the Company&#8217;s shareholders, held on September 20, 2016 (the &#8220;<font style="font-weight: bold;">2016

            AGM</font>&#8221;). As part of our ongoing commitment to maintain corporate governance best practices, and adhere to changing market practices and regulatory environment, as well as gained experience with our Current Articles, we propose to amend
          selected articles within our Current Articles. These modifications aim to benchmark our corporate framework against market standards, enhance procedural efficiency established under our Current Articles, and address miscellaneous administrative
          updates for the purposes of corporate &#8220;housekeeping&#8221;, such as the correction of outdated references, clarification of ambiguous language, and the incorporation of various administrative updates that will improve the cogency and functionality of
          our Articles of Association, reflecting the ways in which our Company and market practice have evolved.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25; font-weight: bold;">General</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">The proposed main amendments to the Current Articles are described below and are marked in the revised version of the Current Articles attached to this Proxy Statement as <font style="font-weight: bold;"><u>Exhibit A</u></font> (the &#8220;<font style="font-weight: bold;">Amended Articles</font>&#8221;).</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"><u>Share Capital</u>: Under the Current Articles, our registered share capital is One Million Two Hundred Thousand New Israeli Shekels (NIS 1,200,000) divided into One
          Hundred and Twenty Million (120,000,000) Ordinary Shares of a nominal value of One Agora (NIS 0.01) each. As our issued share capital as of April 16, 2024, is 85,640,591 (this amount does not include 3,481,523 ordinary shares held by the Company
          as treasury shares), constituting 71.37% of the registered share capital, we seek to increase our share capital by One Million Two Hundred Thousand New Israeli Shekels (NIS 1,200,000). Following the proposed amendment, our registered share
          capital will consist of Two Million Four Hundred Thousand New Israeli Shekels (NIS 2,400,000) divided into Two Hundred and Forty Million (240,000,000) Ordinary Shares of a nominal value of One Agora (NIS 0.01) each (the &#8220;<font style="font-weight: bold;">Share Capital Increase</font>&#8221;). Our issued share capital as of April 16, 2024, constitutes 35.68% of the proposed increased registered share capital.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">Among other things, such Share Capital Increase will allow the Company to pursue effective capital raising through the potential issuances of additional equity (or securities
          convertible, exchangeable or exercisable into equity), maintain adequate equity incentives available for its employees, and other issuances of share capital which our Board may find to be advisable.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"><u>Record Date for General Meeting</u>: Currently, under Articles 20 of the Current Articles, our Board of Directors may fix (or authorize the officer(s) to fix), in advance
          a record date which shall not be earlier than ninety (90) days prior to the relevant shareholders&#8217; general meeting or other action. We propose removing the specific timeframe under our Current Articles, and refer to the applicable law
          requirements, as these may change from time to time.</div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">20</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"><u>Notice of General Meeting</u>: Corresponding the above amendment, under the Amended Articles we wish to clarify that the procedures relating to the convening of a
          shareholders&#8217; meeting, including general meeting notice publication timeframe, and the legal entity entitled to demand the convening of a general meeting, or issue an applicable notice or proxy card, will be in line with the Companies Law, as
          supplemented by the Foreign Listed Regulations. We believe that the establishment of certain Israeli law provisions in our Amended Articles serves our shareholders that will be provided with clearer view of the legal framework governing the
          Company&#8217;s corporate procedures.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"><u>Shareholder Proposal Procedure</u>: We wish to add Article 25A to our Amended Articles, which will regulate the procedure by which a shareholder is allowed to request the
          Board to add items to the agenda of a shareholders general meeting, or to demand the convening of a shareholders general meeting (collectively, a &#8220;<font style="font-weight: bold;">Proposing Shareholder</font>&#8221;). In such an event, a Proposing
          Shareholder will provide, among other things, contact information, share holdings&#8217; data, a description of the relevant matter, and describe arrangements and transactions relating to the matter and/or between the Proposing Shareholder and other
          Proposing Shareholders. Under the Companies Law, a Board of Directors is entitled to request information from a proposing shareholder, to be able to determine whether the proposed item to agenda is suitable to be discussed and voted at the
          applicable general meeting. This clarification is designed to establish clear guidelines by which the Board may reasonably articulate specific expectations or requirements of shareholders.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"><u>Quorum</u>: Section 26.(a) of our Current Articles requires the presence, in person or by proxy, of two or more shareholders holding shares conferring in the aggregate
          twenty-five percent (25%) of the voting power in our Company for a quorum to be deemed present at a general meeting of our shareholders. The previous quorum, prior to the above reduced quorum approved in the 2016 AGM, was thirty-three-point three
          percent (33.3%). As we currently experience higher shareholder participation and engagement, we propose to reinstate the quorum requirement to thirty-three-point three percent (33.3%).</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"><u>Directors Nomination Procedures</u>: In similarity to our Current Articles, under the Amended Articles, our directors are appointed at annual general meetings of our
          shareholders, for a three-year period. Our Amended Articles will further establish that the removal of Directors from office will be held at any annual general meetings of our shareholders (even before the lapse of the three years term), unlike
          the current situation, which allows the removal from office also in an extraordinary general meeting during the year. We believe that this amendment well balances between the ability to remove directors and the interest of keeping the company and
          Board focused during the year on the Company&#8217;s business. A removal in between annual general meetings, in an extraordinary general meeting of our shareholders, will be available in connection with removal for Cause (&#8220;Cause&#8221; shall mean the
          circumstances listed under Sections 226-226A to the Companies Law).</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">The Amended Articles further add clarity to the procedure of nomination to our Board of Directors, including establishing clear guidelines to the disclosure requirements from
          director nominees proposed by a Proposing Shareholder (an &#8220;<font style="font-weight: bold;">Additional Nominee</font>&#8221;). We believe that adding clarity to such procedures will allow for an increased visibility for our shareholders and potential
          director nominees.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">It is clarified that in case the Amended Articles are not approved - the Current Articles will remain in full force and effect.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25; font-weight: bold;">Required Vote</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">The affirmative vote of the holders of a majority of the voting power represented at the Meeting in person or by proxy, and voting thereon, is required for the<font style="font-weight: bold;">&#160;</font>approval of the Amended Articles.</div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">21</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25; font-weight: bold;">It is proposed that at the Meeting the following resolution be adopted:</div>
        </div>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">RESOLVED</font>, <font style="font-style: italic;">that the Amended Articles, in the form attached as <u>Exhibit A</u> to the Proxy
              Statement for the 2024 Annual General Meeting of Shareholders, including without limitation, the Share Capital Increase, be approved, and the Company's Current Articles be reinstated and replaced by such Amended Articles&#8221;</font>.</div>
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Board Recommendation</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The Board of Directors recommends a vote &#8220;FOR&#8221; approval of the proposed resolution.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">22</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL 5</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">ADOPTION OF 2024 EQUITY INCENTIVE PLAN</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Background</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">In general, under Rule 5635(c) of the Nasdaq Listing Rules, a Nasdaq-listed company is required to obtain shareholder approval for the adoption of, or material amendment to, an equity
          compensation plan under which employees, officers and directors may receive equity in the Company. Pursuant to this requirement, we obtained shareholder approval of our 2003 Share Option Plan. However, pursuant to an exception in the Nasdaq
          Listing Rules for foreign private issuers, we did not seek shareholder approval of the subsequent amendments to the 2003 Share Option Plan that extended the term of that plan. As described below, the Board has adopted a new 2024 Equity Incentive
          Plan, which is being presented to shareholders for approval in order to qualify such plan to grant &#8220;incentive stock options&#8221; pursuant to Section 422 of the U.S. Internal Revenue Code of 1986, as amended.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="line-height: 1.25; font-weight: bold;">General<br>
          <br>
        </div>
        <div style="text-align: justify; line-height: 1.25;">Our compensation committee, Board and our management all believe that the effective use of share-based long-term incentive compensation is vital to our continued ability to recruit, hire and
          retain the individuals required to successfully execute our business plans and achieve strong performance in the future by providing a direct link between compensation and long-term shareholder value creation. Our existing Amended and Restated
          Share Option and RSU Plan (the &#8220;<font style="font-weight: bold;">Existing Plan</font>&#8221;), was approved by our shareholders in September 2003 as the 2003 Share Option Plan for a term of ten years, was extended for an additional ten-year period by
          our Board in December 2012, and was further extended by our Board until December 31, 2024. Once the Existing Plan expires, no additional grants may be made under the Existing Plan, but outstanding grants under such plan will continue to be
          governed by the terms of the Existing Plan. In order to enable our Company to continue to achieve the foregoing goals related to share-based long-term incentive compensation after the expiration of the Existing Plan, our Compensation Committee
          and our Board have adopted the Company&#8217;s 2024 Equity Incentive Plan (defined as the &#8220;<font style="font-weight: bold;">2024 Plan</font>&#8221;). We have provided a summary of the material terms of the 2024 Plan below. The summary is provided for
          convenience only, and does not contain all information about the 2024 Plan. A copy of the complete text of the 2024 Plan is appended to this proxy statement as <font style="font-weight: bold;"><u>Exhibit B</u></font>, and the following
          description of the 2024 Plan is qualified in its entirety by reference to the full text of the 2024 Plan.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">Summary of 2024 Equity Incentive Plan</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Under the 2024 Plan, we may grant equity-based incentive awards to attract, motivate and retain the talent for which we compete.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"><font style="font-style: italic;">Authorized Shares</font>.&#160; Upon its effectiveness, the 2024 Plan will have a total of 500,000 Ordinary Shares reserved and initially
          available for issuance, including issuance as incentive stock options (within the meaning of Section 422 of the U.S. Internal Revenue Code of 1986, as amended (the &#8220;<font style="font-weight: bold;">Code</font>&#8221;)) (&#8220;Incentive Stock Options&#8221;).</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">23</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">In addition to the foregoing 500,000 Ordinary Shares initially available under the 2024 Plan, up to approximately 7,977,000 Ordinary Shares that underline outstanding awards
          under the Existing Plan (and which were also previously approved for issuance under the Existing Plan by our Board), may, (i) if the related award expires or is canceled, terminated, forfeited, repurchased or settled in cash in lieu of issuance
          of shares, for any reason, without having been exercised, or (ii) if permitted by us, if are tendered to pay (x) the exercise price of an award or (y) withholding tax obligations; will, in any such case, become available again for issuance under
          the 2024 Plan. Similarly, Ordinary Shares from among the initial 500,000 shares reserved under the 2024 Plan that become subject to an award and are ultimately not issued (for any of the foregoing reasons) will become available once again under
          the 2024 Plan.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"><font style="font-style: italic;">Administration</font>. A duly authorized committee of our Board (which, based on prior authorization by our Board, is currently our
          compensation committee), or, in the absence of any such committee or if required by law for any grant, the Board itself, will administer the 2024 Plan. Under the 2024 Plan, the administrator has the authority, subject to applicable law, to
          interpret the terms of the 2024 Plan and any award agreements or awards granted thereunder, designate recipients of awards, determine and amend the terms of awards and take all actions and make all other determinations necessary for the
          administration of the 2024 Plan.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"><font style="font-style: italic;">Eligibility</font>. The 2024 Plan provides for granting awards under various tax regimes, including, without limitation, in compliance with
          Section 102 of the Israeli Tax Ordinance (the &#8220;Ordinance&#8221;) and Section 3(i) of the Ordinance, and, for awards granted to employees subject to United States income tax, Section 422 of the Code, and for employees or service providers subject to
          Unites States income tax, including those who are deemed to be residents of the United States for tax purposes, and Section 409A of the Code.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"><font style="font-style: italic;">Awards</font>. The 2024 Plan provides for the grant of share options (including Incentive Stock Options), Ordinary Shares, Restricted
          Shares, Restricted Share Units, performance based awards, and other share-based awards to employees, directors, officers, consultants, advisors and any other persons or entities who provides services to the company or any parent, subsidiary, or
          affiliate thereof, subject to the terms and conditions of the 2024 Plan. Options granted under the 2024 Plan to our employees who are U.S. residents may qualify as Incentive Stock Options or may be non-qualified stock options , i.e., options that
          do not qualify as Incentive Stock Options.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"><font style="font-style: italic;">Grant and Exercise</font>. All awards granted pursuant to the 2024 Plan will be evidenced by an award agreement in a form approved, from
          time to time, by the administrator in its sole discretion. Unless otherwise determined by the administrator and stated in the award agreement, awards vest and become exercisable under the following schedule: 25% of the shares covered by the award
          vest on the first anniversary as of the date of grant, and 6.25% of the shares covered by the award shall vest upon the lapse of each subsequent three-month period thereafter over the course of the subsequent three years; provided that the
          grantee remains continuously as an employee, a director or a service provider to the Company through each such vesting date. The exercise period of an award will expire six years from the date of grant of the award, unless otherwise determined by
          the administrator and stated in the award agreement.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"><font style="font-style: italic;">Termination of Service</font>. In the event of termination of a grantee&#8217;s employment or service with the Company or any of its affiliates
          (including by reason of death or disability), different rules apply as to the length of time during which all vested and exercisable awards held by such grantee as of the date of termination may be exercised after such date of termination.</div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">Any awards which are unvested as of the date of such termination or which are vested but not then exercised within the applicable period following such date, will terminate
          and the shares covered by such awards shall again be available for issuance under the 2024 Plan.</div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">Notwithstanding any of the foregoing, if a grantee&#8217;s employment or services with us or any of our affiliates is terminated for &#8220;cause&#8221; (as defined in the 2024 Plan), all
          outstanding awards held by such grantee (whether vested or unvested) will terminate on the date of such termination and the shares covered by such awards shall again be available for issuance under the 2024 Plan. In the case of termination for
          cause, any shares issued upon exercise or (if applicable) vesting of awards, shall be subject to a right of repurchase as detailed in the 2024 Plan.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">24</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"><font style="font-style: italic;">Adjustments due to Transactions</font>. The 2024 Plan provides for appropriate adjustments to be made to the plan and to outstanding awards
          under the plan in the event of a share split, reverse share split, share dividend, distribution, recapitalization, combination, reclassification of our shares, consolidation, reorganization, cash dividend or other similar occurrences.</div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"> <br>
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">In the event of a sale of all, or substantially all, of our Ordinary Shares or assets, a merger, consolidation amalgamation, reorganization or similar transaction, or certain
          changes in the composition of the board of directors, or liquidation or dissolution, or such other transaction or circumstances that the Board determines to be a relevant transaction, then without the consent of the grantee or prior notice
          requirement, the administrator may make certain determinations as to the treatment of outstanding awards.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"><font style="font-style: italic;">Amendment and Termination</font>.&#160; The Board may suspend, terminate, modify or amend the 2024 Plan at any time; provided that no amendment
          of the 2024 Plan shall impair the rights of the grantee of any award granted, if and to the extent such rights are specifically set forth under the applicable award agreement, without such grantee&#8217;s consent. Shareholder approval of any amendment
          to the 2024 Plan will be obtained to the extent necessary to comply with applicable law or the extent that the Board determines that shareholder approval is appropriate and advisable. The administrator at any time and from time to time may modify
          or amend any award theretofore granted under the 2024 Plan, including any award agreement, to the extent necessary to ensure compliance with Section 424 of the Code and Section 409A of the Code.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;"><font style="font-style: italic;">Option Repricing</font>. The 2024 Plan generally allows us to reprice options that we grant under the plan subject to Board approval;
          provided that, as noted in our Compensation Policy, our policy is not to re-price the exercise price of any outstanding security granted to our executives, without prior approval of its shareholders. In addition, the exercise price per share of
          an existing award may be reduced by the Board by the amount of the dividend per share declared on our Ordinary Shares while the award is outstanding (with respect to grants under the &#8220;Capital Gains Route&#8221; of Section 102(b)(2) of the Ordinance
          this is subject to obtaining an appropriate tax ruling). That would enable a grantee to benefit from a dividend that we declare and that all of our shareholders receive.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25; font-weight: bold;">Required Vote</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">The affirmative vote of the holders of a majority of the voting power represented at the Meeting in person or by proxy, and voting thereon, is required for the<font style="font-weight: bold;">&#160;</font>approval of the 2024 Plan.</div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25; font-weight: bold;">It is proposed that at the Meeting the following resolution be adopted:</div>
        </div>
        <div style="line-height: 1.25;">
          <div style="line-height: 1.25;"><br style="line-height: 1.25;">
          </div>
        </div>
        <div style="line-height: 1.25;">
          <div style="text-align: justify; margin-right: 4.5pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">RESOLVED</font>, <font style="font-style: italic;">that the 2024 Equity Incentive Plan (a copy of which is attached hereto as Exhibit B),
              under which up to 500,000 ordinary shares will be reserved for issuance in the form of Incentive Stock Options&#160; be, and hereby is, adopted and approved in all respects.&#8221;</font></div>
        </div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Board Recommendation</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">The Board of Directors recommends a vote &#8220;FOR&#8221; approval of the proposed resolution.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">25</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">PROPOSAL 6</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">RE-APPOINTMENT OF INDEPENDENT AUDITOR</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Background</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">The Companies Law and our Articles provide that a certified accountant be appointed as an independent auditor of the Company at the annual general
          meeting of shareholders of the Company, and that the independent auditor serve in this position until immediately following the date of the next annual general meeting.</div>
        <div style="text-align: justify; line-height: 1.25; font-family: 'Times New Roman',Times,serif;"> <br>
        </div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>General</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">At the Meeting, the shareholders will be asked to re-appoint Kost Forer Gabbay &amp; Kasierer, A member firm of EY Global (&#8220;<font style="font-weight: bold;">Kost Forer</font>&#8221;), as the Company&#8217;s
          independent auditor for the fiscal year ending December 31, 2024 and for the year commencing January 1, 2025 and until immediately following the next annual general meeting of shareholders, and to authorize the Company&#8217;s Board of Directors, (with
          power of delegation to its Financial Audit Committee, to set the annual compensation of the independent auditor in accordance with the volume and nature of its services.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">Kost Forer has served as the Company&#8217;s independent auditor since 2002 and has no relationship with the Company or with any affiliate of the Company except as auditor, tax consultant and as a
          provider of other services that relate to transactional activities. Our Financial Audit Committee and the Board of Directors believe that such limited non-audit functions do not affect the independence of Kost Forer<font style="font-style: italic;">.</font></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">For information on the fees paid by the Company and its subsidiaries to the Kost Forer in each of the previous two fiscal&#160;years, please see&#160;&#8220;Item&#160;16C.&#160;Principal Accountant Fees and Services&#8221;&#160;in
          the Company&#8217;s Annual Report on Form&#160;20-F&#160;for the year ended December&#160;31, 2023, filed with the SEC on March 21, 2024.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">As a result of the combined provisions of the Israeli law, our Articles and the Sarbanes-Oxley Act of 2002, the appointment of the independent auditor requires the approval of the shareholders of
          the Company, and its compensation requires the approval of our Financial Audit Committee. The Company&#8217;s Financial Audit Committee&#160;and Board of Directors have reviewed and are satisfied with the performance of Kost Forer, and have recommended
          their re-appointment as the Company&#8217;s independent auditor for the fiscal year ending December 31, 2024 and for the year commencing January 1, 2025 and until immediately following the next annual general meeting of shareholders. Approval of that
          appointment is now being sought from the Company&#8217;s shareholders.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Required Vote</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The affirmative vote of holders of a majority of the voting power represented at the Meeting in person or by proxy and voting thereon, is required for the re-appointment of Kost Forer as the
          Company's independent auditor.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Proposed Resolution</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">It is proposed that at the Meeting the following resolution be adopted:</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; text-indent: 0pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">RESOLVED</font>, to re-appoint Kost Forer Gabbay &amp; Kasierer, A member firm of EY Global, as the independent auditor of the Company for the
          fiscal year ending December 31, 2024, and for the year commencing January 1, 2025 and until immediately following the next annual general meeting of shareholders and to authorize the Board of Directors (with power of delegation to the members of
          the Financial Audit Committee), to set the annual compensation of the independent auditor in accordance with the volume and nature of its services.&#8221;</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;"><u>Board Recommendation</u></div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25; font-weight: bold;">The Board of Directors recommends a vote &#8220;FOR&#8221; approval of the proposed resolution.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">26</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25;"><br style="line-height: 1.25;">
        </div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">RECEIPT AND CONSIDERATION OF THE AUDITOR&#8217;S REPORT AND</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-weight: bold;">THE AUDITED CONSOLIDATED FINANCIAL STATEMENTS</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">At the Meeting, our auditor&#8217;s report and the audited consolidated financial statements of the Company for the fiscal year ended December 31, 2023 will be presented. The Company will hold a
          discussion with respect thereto, as required by the Companies Law. <font style="font-weight: bold;">This item will not involve a vote of the shareholders</font>.</div>
        <div style="line-height: 1.25">&#160;</div>
        <div style="text-align: justify; line-height: 1.25;">The foregoing auditor&#8217;s report and the audited consolidated financial statements, as well as our Annual Report on Form 20-F for the year ended December 31, 2023 (filed with the SEC on March 21,
          2024), may be viewed on our website &#8211; <u>www.ceragon.com/investors/financial-information</u> or through the EDGAR website of the SEC at <u>www.sec.gov</u>. Except as noted above under &#8220;Beneficial Ownership of Securities by Principal
          Shareholders and Management&#8221; and under Proposal 6 &#8220;Re-Appointment of Independent Auditor&#8221;, none of the auditor&#8217;s report, audited consolidated financial statements, Annual Report on Form 20-F or the contents of our website form part of the proxy
          solicitation material.</div>
        <div style="line-height: 1.25; text-align: center;">&#160;<br>
        </div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">By Order of the Board of Directors,</div>
        <div style="line-height: 1.25; text-align: center;">&#160; <br>
        </div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">/s/ Ilan Rosen</div>
        <div style="line-height: 1.25; text-align: center;">&#160;</div>
        <div style="text-align: center; line-height: 1.25; font-family: 'Times New Roman',Times,serif;">Ilan Rosen, Chairman of the Board of Directors</div>
        <br>
        <div style="text-align: center; line-height: 1.25;">April 18, 2024</div>
        <div style="text-align: center; line-height: 1.25;"> <br>
        </div>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
          <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">27</font></div>
          <div style="page-break-after: always;" class="BRPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <div style="line-height: 1.25">&#160;
          <div>
            <div style="text-align: center; margin-right: 32.049pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;"><u>THE COMPANIES LAW</u></div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: center; margin-right: 33.55pt; margin-left: 31.15pt; line-height: 1.25;"><u>A COMPANY LIMITED BY SHARES</u></div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: center; margin-right: 159.35pt; margin-left: 158.55pt; line-height: 1.25;">ARTICLES OF ASSOCIATION OF</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: center; margin-right: 31.7pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;">CERAGON NETWORKS LTD.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: center; margin-right: 2.85pt; margin-left: 34pt; line-height: 1.25;">(as amended and restated on <strike>September 20,</strike></div>
            <div style="text-align: center; text-indent: 26.75pt; margin-left: 1.55pt; line-height: 1.25;"><strike>2016</strike><u>May 23, 2024)</u></div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: center; margin-right: 32.15pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;">GENERAL PROVISIONS</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">1.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Object and Purpose of the Company</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-indent: 36pt; margin-right: 12.85pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The object of the Company is to engage, directly or indirectly, in any lawful undertaking or business whatsoever.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 35.45pt; margin-right: 5.75pt; margin-left: 13.05pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In accordance with Section 11(a) of the <u>Israeli</u>&#160;Companies Law 5759-1999, <u>as amended from time to
                time (together with</u>&#160;the <u> regulations promulgated thereunder, as amended</u>&#160;<u>from time to time, the</u>&#160;&#8220;<font style="font-weight: bold; font-style: italic;">Companies Law</font>&#8221;), the Company may contribute a reasonable amount
              to a worthy cause.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">2.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Limitation of Liability</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.4pt; margin-left: 11pt; line-height: 1.25;">The liability of the shareholders is limited to the payment of the nominal value of the shares in the Company allotted to them and
              which remains unpaid, and only to that amount. If the Company&#8217;s share capital shall include at any time shares without a nominal value, the shareholders&#8217; liability in respect of such shares shall be limited to the payment of up to NIS 0.01
              for each such share allotted to them and which remains unpaid, and only to that amount.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">3.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Interpretation</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unless the subject or the context otherwise requires: words and expressions defined in the Companies Law in force on
              the date when these Articles or any amendment thereto, as the case may be, first became effective shall have the same meanings herein; words and expressions importing the singular shall include the plural and vice versa; words and expressions
              importing the masculine gender shall include the feminine gender; and words and expressions importing persons shall include bodies corporate.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The captions in these Articles are for convenience only and shall not be deemed a part hereof or affect the
              construction of any provision hereof.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="margin-left: 11pt; line-height: 1.25;">3A&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Amendment</u></div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The approval of a resolution adopted in a General Meeting approved by a simple majority of the voting power represented at the meeting
              in person or by proxy and voting thereon (&#8220;<font style="font-weight: bold; font-style: italic;">Shareholders&#8217; Resolution</font>&#8221;) is required to approve any amendment to these Articles of Association.</div>
            <div style="text-align: justify; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <!--PROfilePageNumberReset%Num%2%A - %%--><br>
            <div style="text-align: center; margin-right: 32.25pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;">SHARE CAPITAL</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">4.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Share Capital</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.65pt; margin-left: 11pt; line-height: 1.25;">The registered share capital of the Company is <strike>One</strike><u>Two</u>&#160;Million <strike>Two</strike><u>and Four</u>&#160;Hundred
              Thousand New Israeli Shekels (NIS <strike>1,200</strike><u>2,400</u>,000) divided into <strike>One</strike><u>Two</u>&#160;Hundred and <strike>Twenty</strike><u>Forty</u>&#160;Million (<strike>120</strike><u>240</u>,000,000) Ordinary Shares of a
              nominal value of One Agora (NIS 0.01) each.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">5.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Increase of Share Capital</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.45pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company may, from time to time, by a Shareholders Resolution, whether or not all the shares then authorized have
              been issued, and whether or not all the shares theretofore issued have been called up for payment, increase its share capital by the creation of new shares. Any such increase shall be in such amount and shall be divided into shares of such
              nominal amounts, and such shares shall confer such rights and preferences, and shall be subject to such restrictions, as such resolution shall provide.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.7pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except to the extent otherwise provided in such resolution, such new shares shall be subject to all the provisions
              applicable to the shares of the original capital.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">6.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Special Rights; Modifications of Rights</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Without prejudice to any special rights previously conferred upon the holders of existing shares in the Company, the
              Company may, from time to time, by a Shareholders&#8217; Resolution, provide for shares with such preferred or deferred rights or rights of redemption or other special rights and/or such restrictions, whether in regard to dividends, voting,
              repayment of share capital or otherwise, as may be stipulated in such resolution.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(i)&#160; If at any time the share capital is divided into different classes of shares, the rights attached to any class,
              unless otherwise provided by these Articles, may be modified or abrogated by the Company, by Shareholders Resolution, subject to the sanction of a resolution passed by a majority of the holders of the shares of such class present and voting
              at a separate General Meeting of the holders of the shares of such class.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The provisions of these Articles relating to General Meetings shall, <font style="font-style: italic;">mutatis
                mutandis</font>, apply to any separate General Meeting of the holders of the shares of a particular class.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unless otherwise provided by these Articles, the enlargement of an existing class of shares, or the issuance of
              additional shares thereof, shall not be deemed, for purposes of this Article 6(b), to modify or abrogate the rights attached to the previously issued shares of such class or of any other class.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">7.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Consolidation, Subdivision, Cancellation and Reduction of Share Capital</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-indent: 36pt; margin-right: 13pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company may, from time to time, by Shareholders Resolution (subject, however, to the provisions of Article 6(b) hereof and to <strike>applicable

                law):</strike><u>any applicable law and</u>&#160;<u>regulations, stock exchange rules or regulations and any listing rules (collectively, &#8220;Applicable</u>&#160;<u>Law&#8221; or &#8220;applicable law&#8221;):</u></div>
            <div style="text-indent: 36pt; margin-right: 13pt; margin-left: 11pt; line-height: 1.25;"><u> <br>
              </u></div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 2</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <br>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 9.75pt; margin-left: 11pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;consolidate and divide all or any of its issued or unissued share capital into shares of larger nominal value than its
              existing shares,</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;subdivide its shares (issued or unissued) or any of them, into shares of smaller nominal value than is fixed by these
              Articles of Association (subject, however, to the provisions of the Companies Law), and the Shareholders Resolution whereby any share is subdivided may determine that, as among the holders of the shares resulting from such subdivision, one or
              more of the shares may, as compared with the others, have any such preferred or deferred rights or rights of redemption or other special rights, or be subject to any such restrictions, as the Company has power to attach to unissued or new
              shares.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;cancel any shares which, at the date of the adoption of such resolution, have not been taken or agreed to be taken by
              any person, and diminish the amount of its share capital by the amount of the shares so canceled, or</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 9.35pt; margin-left: 11pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;reduce its share capital in any manner, and with and subject to any incident authorized, and consent required, by <u>applicable</u>&#160;law.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;With respect to any consolidation of issued shares into shares of larger nominal value, and with respect to any other
              action which may result in fractional shares, the Board of Directors may settle any difficulty which may arise with regard thereto, as it deems fit, including, <u>inter alia</u>, resort to one or more of the following actions:</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 9.75pt; margin-left: 11pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;determine, as to the holder of shares so consolidated, which issued shares shall be consolidated into each share of
              larger nominal value;</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;allot, in contemplation of or subsequent to such consolidation or other action, such shares or fractional shares
              sufficient to preclude or remove fractional share holdings;</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;redeem, in the case of redeemable preference shares, and subject to applicable law, such shares or fractional shares
              sufficient to preclude or remove fractional share holdings;</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 9.35pt; margin-left: 11pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;cause the transfer of fractional shares by certain shareholders of the Company to other shareholders thereof so as to
              most expediently preclude or remove any fractional shareholdings, and cause the transferees to pay the transferors the fair value of fractional shares so transferred, and the Board of Directors is hereby authorized to act as agent for the
              transferors and transferees with power of substitution for purposes of implementing the provisions of this sub-Article 7(b)(iv).</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: center; margin-right: 32.049pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;">SHARES</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">8.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Issuance of Share Certificates; Replacement of Lost Certificates</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share certificates shall be issued under the seal or stamp of the Company and shall bear the signatures of two
              Directors, or of any other person or persons authorized thereto by the Board of Directors.</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 3</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <br>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each <strike>member</strike><u>shareholder</u>&#160;shall be entitled to one numbered certificate for all the shares of any
              class registered in his name, and if reasonably requested by such <strike>member</strike><u>shareholder</u>, to several certificates, each for one or more of such shares.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.4pt; margin-left: 11pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A share certificate registered in the names of two or more persons shall be delivered to the person first named in the
              Registrar of <strike>Members</strike><u>Shareholders</u>&#160;in respect of such co- ownership.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.65pt; margin-left: 11pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If a share certificate is defaced, lost or destroyed, it may be replaced, upon payment of such fee, and upon the
              furnishing of such evidence of ownership and such indemnity, as the Board of Directors may think fit.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">9.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Registered Holder</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;">Except as otherwise provided in these Articles, the Company shall be entitled to treat the registered holder of any share as the
              absolute owner thereof, and, accordingly, shall not, except as ordered by a court of competent jurisdiction, or as required by statute, be bound to recognize any equitable or other claim to, or interest in such share on the part of any other
              person.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">10.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Allotment of Shares</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;">The unissued shares from time to time shall be under the control of the Board of Directors, who shall have the power to allot shares
              or otherwise dispose of them to such persons, on such terms and conditions (including inter alia terms relating to calls as set forth in Article 12(f) hereof), and either at par or at a premium, or, subject to the provisions of the Companies
              Law, at a discount, and at such times, as the Board of Directors may think fit, and the power to give to any person the option to acquire from the Company any shares, either at par or at a premium, or, subject as aforesaid, at a discount,
              during such time and for such consideration as the Board of Directors may think fit.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="margin-left: 11pt; line-height: 1.25;">10A.&#160;&#160;&#160;&#160;&#160;&#160; <u>Authority to </u><strike><u>pay</u></strike><u>Pay</u><u> Underwriters&#8217; Fees &amp; Commissions</u></div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-indent: 36pt; margin-left: 11pt; line-height: 1.25;">Subject to the provisions of the Companies Law the Company is authorized to pay underwriters&#8217; fees and commissions.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">11.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Payment in Installments</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.35pt; margin-left: 11pt; line-height: 1.25;">If by the terms of allotment of any share, the whole or any part of the price thereof shall be payable in installments, every such
              installment shall, when due, be paid to the Company by the then registered holder(s) of the share of the person(s) entitled thereto.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">12.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Calls on Shares</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board of Directors may, from time to time, make such calls as it may think fit upon <strike>members</strike><u>shareholders</u>&#160;in

              respect of any sum unpaid in respect of shares held by such <strike>members</strike><u>shareholders</u>&#160;which is not, by the terms of allotment thereof or otherwise, payable at a fixed time, and each <strike>member</strike><u>shareholder</u>&#160;shall



              pay the amount of every call so made upon him (and of each installment thereof if the same is payable in installments), to the person(s) and at the time(s) and place(s) designated by the Board of Directors, as any such time(s) may be
              thereafter extended and/or such person(s) or place(s) changed. Unless otherwise stipulated in the resolution of the Board of Directors (and in the notice hereafter referred to), each payment in response to a call shall be deemed to constitute
              a pro rata payment on account of all shares in respect of which such call was made.</div>
            <div><br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 4</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notice of any call shall be given in writing to the <strike>member</strike><u>shareholder</u>(s) in question not less
              than fourteen (14) days prior to the time of payment, specifying the time and place of payment, and designating the person to whom such payment shall be made, provided, however, that before the time for any such payment, the Board of
              Directors may, by notice in writing to such <strike>member</strike><u>shareholder</u>(s), revoke such call in whole or in part, extend such time, or alter such person and/or place. In the event of a call payable in installments, only one
              notice thereof need be given.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If, by the terms of allotment of any share or otherwise, any amount is made payable at any fixed time, every such
              amount shall be payable at such time as if it were a call duly made by the Board of Directors and of which due notice had been given, and all the provisions herein contained with respect to such calls shall apply to each such amount.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The joint holders of a share shall be jointly and severally liable to pay all calls in respect thereof and all interest
              payable thereon.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.4pt; margin-left: 11pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any amount unpaid in respect of a call shall bear interest from the date on which it is payable until actual payment
              thereof, at such rate (not exceeding the then prevailing debitory rate charged by leading commercial banks in Israel), and at such time(s) as the Board of Directors may prescribe.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.75pt; margin-left: 11pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Upon the allotment of shares, the Board of Directors may provide for differences among the allottees of such shares as
              to the amount of calls and/or the times of payment thereof.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">13.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Prepayment</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.3pt; margin-left: 11pt; line-height: 1.25;">With the approval of the Board of Directors, any <strike>member</strike><u>shareholder</u>&#160;may pay to the Company any amount not
              yet payable in respect of his shares, and the Board of Directors may approve the payment of interest on any such amount until the same would be payable if it had not been paid in advance, at such rate and time(s) as may be approved by the
              Board of Directors. The Board of Directors may at any time cause the Company to repay all or any part of the money so advanced, without premium or penalty. Nothing in this Article 13 shall derogate from the right of the Board of Directors to
              make any call before or after receipt by the Company of any such advance.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">14.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Forfeiture and Surrender</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If any <strike>member</strike><u>shareholder</u>&#160;fails to pay any amount payable in respect of a call, or interest
              thereon as provided for herein, on or before the day fixed for payment of the same, the Company, by resolution of the Board of Directors, may at any time thereafter, so long as the said amount or interest remains unpaid, forfeit all or any of
              the shares in respect of which said call had been made. Any expense incurred by the Company in attempting to collect any such amount or interest, including, inter alia, attorneys&#8217; fees and costs of suit, shall be added to, and shall, for all
              purposes (including the accrual of interest thereon), constitute a part of the amount payable to the Company in respect of such call.</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 5</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Upon the adoption of a resolution of forfeiture, the Board of Directors shall cause notice thereof to be given to such
              <strike>member</strike><u>shareholder</u>, which notice shall state that, in the event of the failure to pay the entire amount so payable within a period stipulated in the notice (which period shall not be less than fourteen (14) days and
              which may be extended by the Board of Directors), such shares shall be ipso facto forfeited, provided, however, that, prior to the expiration of such period, the Board of Directors may nullify such resolution of forfeiture, but no such
              nullification shall estop the Board of Directors from adopting a further resolution of forfeiture in respect of the non-payment of the same amount.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Whenever shares are forfeited as herein provided, all dividends theretofore declared in respect thereof and not
              actually paid shall be deemed to have been forfeited at the same time.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company, by resolution of the Board of Directors, may accept the voluntary surrender of any share.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any share forfeited or surrendered as provided herein shall become the property of the Company, and the same, subject
              to the provisions of these Articles, may be sold, re- allotted or otherwise disposed of as the Board of Directors thinks fit.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.35pt; margin-left: 11pt; line-height: 1.25;">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any <strike>member</strike><u>shareholder</u>&#160;whose shares have been forfeited or surrendered shall cease to be a <strike>member</strike><u>shareholder</u>&#160;in

              respect of the forfeited or surrendered shares, but shall, notwithstanding, be liable to pay, and shall forthwith pay, to the Company, all calls, interest and expenses owing upon or in respect of such shares at the time of forfeiture or
              surrender, together with interest thereon from the time of forfeiture or surrender until actual payment, at the rate prescribed in Article 12(e) above, and the Board of Directors, in its discretion, may enforce the payment of such moneys, or
              any part thereof, but shall not be under any obligation to do so. In the event of such forfeiture or surrender, the Company, by resolution of the Board of Directors, may accelerate the date(s) of payment of any or all amounts then owing by
              the <strike>member</strike><u>shareholder</u>&#160;in question (but not yet due) in respect of all shares owned by such <strike>member</strike><u>shareholder</u>, solely or jointly with another, and in respect of any other matter or transaction
              whatsoever.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board of Directors may at any time, before any share so forfeited or surrendered shall have been sold, re-allotted
              or otherwise disposed of, nullify the forfeiture or surrender on such conditions as it thinks fit, but no such nullification shall estop the Board of Directors from re-exercising its powers of forfeiture pursuant to this Article 14.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">15.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Lien</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except to the extent the same may be waived or subordinated in writing, the Company shall have a first and paramount
              lien upon all the shares registered in the name of each <strike>member</strike><u>shareholder</u>&#160;(without regard to any equitable or other claim or interest in such shares on the part of any other person), and upon the proceeds of the sale
              thereof, for his debts, liabilities and engagements arising from any cause whatsoever, solely or jointly with another, to or with the Company, whether the period for the payment, fulfillment or discharge thereof shall have actually arrived or
              not. Such lien shall extend to all dividends from time to time declared in respect of such share. Unless otherwise provided, the registration by the Company of a transfer of shares shall be deemed to be a waiver on the part of the Company of
              the lien (if any) existing on such shares immediately prior to such transfer.</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 6</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board of Directors may cause the Company to sell any shares subject to such lien when any such debt, liability or
              engagement has matured, in such manner as the Board of Directors may think fit, but no such sale shall be made unless such debt, liability or engagement has not been satisfied within fourteen (14) days after written notice of the intention to
              sell shall have been served on such <strike>member</strike><u>shareholder</u>, his executors or administrators.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.4pt; margin-left: 11pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The net proceeds of any such sale, after payment of the costs thereof, shall be applied in or toward satisfaction of
              the debts, liabilities or engagements of such <strike>member</strike><u>shareholder</u>&#160;(whether or not the same have matured), or any specific part of the same (as the Company may determine), and the residue (if any) shall be paid to the <strike>member</strike><u>shareholder</u>,
              his executors, administrators or assigns.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">16.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Sale after Forfeiture or Surrender or in Enforcement of Lien</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.45pt; margin-left: 11pt; line-height: 1.25;">Upon any sale of shares after forfeiture or surrender or for enforcing a lien, the Board of Directors may appoint some person to
              execute an instrument of transfer of the shares so sold and cause the purchaser&#8217;s name to be entered in the Register of <strike>Members</strike><u>Shareholders</u>&#160;in respect of such shares, and the purchaser shall not be bound to see to the
              regularity of the proceedings, or to the application of the purchase money, and after his name has been entered in the Register of <strike>Members</strike><u>Shareholders</u>&#160;in respect of such shares, the validity of the sale shall not be
              impeached by any person, and the remedy of any person aggrieved by the sale shall be in damages only and against the Company exclusively.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">17.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Redeemable Shares</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="margin-left: 11pt; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The Company may, subject to applicable law, issue redeemable shares and redeem the same.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">18.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div>[reserved]</div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: center; margin-right: 2.45pt; margin-left: 1.5pt; line-height: 1.25; font-weight: bold;">TRANSFER OF SHARES</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">19.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Effectiveness and Registration</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">No transfer of shares shall be registered unless a proper instrument of transfer (in form and substance satisfactory to the Board
              of Directors) has been submitted to the Company or its agent, together with any share certificate(s) and such other evidence of title as the Board of Directors may reasonably require. Until the transferee has been registered in the Register
              of <strike>Members</strike><u>Shareholders</u>&#160;in respect of the shares so transferred, the Company may continue to regard the transferor as the owner thereof. The Board of Directors, may, from time to time, prescribe a fee for the
              registration of a transfer.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 7</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">20.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Record Date for General Meetings</u></div>
                  </td>
                </tr>

            </table>
            <br>
            <div style="text-align: justify; margin-right: 9.2pt; margin-left: 11pt; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Notwithstanding any provision to the contrary in these Articles, for the determination of the <strike>members</strike><u>shareholders</u>&#160;entitled

              to receive notice of and to participate in and vote at a General Meeting, or to express consent to or dissent from any corporate action in writing, or to receive payment of any dividend or other distribution or allotment of any rights or to
              exercise any rights in respect of shares of the Company, the Board of Directors may fix (or authorize the officer(s) to fix), in <strike>advance, a record date, which, subject to applicable law, shall not be earlier than ninety (90) days
                prior to the General Meeting or other action, as the case may be.</strike><u>accordance with the</u>&#160;<u>Companies Law.</u>&#160;No persons other than holders of record of shares as of such record date shall be entitled to notice of and to
              participate in and vote at such General Meeting, or to exercise such other right, as the case may be. A determination of <strike>members</strike><u>shareholders</u>&#160;of record with respect to a General Meeting shall apply to any adjournment
              of such meeting, provided that the Board of Directors may fix a new record date for an adjourned meeting.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: center; margin-right: 33.65pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;">TRANSMISSION OF SHARES</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 35.95pt; vertical-align: top;">21.</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div><u>Decedents&#8217; Shares</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.3pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;In case of a share registered in the names of two or more holders, the Company may recognize the survivor(s) as the
              sole owner(s) thereof unless and until the provisions of Article 21(b) have been effectively invoked.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.15pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any person becoming entitled to a share in consequence of the death of any person, upon producing evidence of the
              grant of probate or letters of administration or declaration of succession (or such other evidence as the Board of Directors may reasonably deem sufficient that he sustains the character in respect of which he proposes to act under this
              Article or of his title), shall be registered as a <strike>member</strike><u>shareholder</u>&#160;in respect of such share, or may, subject to the regulations as to transfer herein contained, transfer such share.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">22.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Receivers and Liquidators</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company may recognize the receiver or liquidator of any corporate <strike>member</strike><u>shareholder</u>&#160;in
              winding-up or dissolution, or the receiver or trustee in bankruptcy of any <strike>member</strike><u>shareholder</u>, as being entitled to the shares registered in the name of such <strike>member</strike><u>shareholder</u>.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The receiver or liquidator of a corporate <strike>member</strike><u>shareholder</u>&#160;in winding-up or dissolution, or
              the receiver or trustee in bankruptcy of any <strike>member</strike><u>shareholder, or the executor&#160;in case of a deceased shareholder</u>, upon producing such evidence as the Board of Directors may deem sufficient that he
              sustains the character in respect of which he proposes to act under this Article or of his title, shall with the consent of the Board of Directors (which the Board of Directors may grant or refuse in its absolute discretion), be registered as
              a <strike>member</strike><u>shareholder</u>&#160;in respect of such shares, or may, subject to the regulations as to transfer herein contained, transfer such shares.</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 8</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <br>
            <div style="text-align: center; margin-right: 2.45pt; margin-left: 1.5pt; line-height: 1.25; font-weight: bold;">GENERAL MEETINGS</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">23.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Annual General Meeting</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.3pt; margin-left: 11pt; line-height: 1.25;">An Annual General Meeting shall be held once in every calendar year at such time (within a period of not more than fifteen (15)
              months after the last preceding Annual General Meeting) and at such place either within or <strike>without</strike><u>outside</u>&#160;the State of Israel as may be determined by the Board of Directors.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">24.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Extraordinary General Meetings</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">All General Meetings other than Annual General Meetings shall be called &#8220;Extraordinary General Meetings.&#8221; <u>Annual and
                Extraordinary General Meetings shall be referred to collectively</u>&#160;<u>as &#8220;</u><font style="font-weight: bold; font-style: italic;"><u>General Meeting(s)</u></font><u>&#8221;. </u>The Board of Directors may, whenever it thinks fit, convene an
              Extraordinary General Meeting at such time and place, within or without the State of Israel, as may be determined by the Board of Directors, <strike>and</strike><u>or as</u>&#160;shall be obliged to do so upon a requisition in writing in
              accordance with<strike> Sections 63(b)(1) or (2) and 63(c) of</strike>&#160;the Companies Law.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">25.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Notice of General Meetings</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.3pt; margin-left: 11pt; line-height: 1.25;">The Company shall publish <u>a </u>notice of a General Meeting <strike>at least twenty one (21) days</strike>&#160;prior to a General
              Meeting<strike> or more, if and to the extent and in the manner</strike><u>, as</u>&#160;required by <strike>applicable</strike>&#160;<strike>law.</strike><u>the Companies Law.</u>&#160;Notwithstanding the<u> provisions of the Israeli</u>&#160;Companies
              Regulations (Publication of Notice of General Meeting and Class Meeting in a Public Company<strike>) &#8211;</strike><u>), </u>2000, the Company shall not be required to deliver the notice to shareholders. The accidental omission to give notice of
              a <strike>meeting</strike><u>General Meeting</u>&#160;to any <strike>member</strike><u>shareholder</u>&#160;or the non <u>-</u>receipt of notice <u>of a General Meeting </u>by one of the <strike>members</strike><u>shareholders</u>&#160;shall not
              invalidate the proceedings at any <strike>meeting</strike><u>such General Meeting. A shareholder shall be permitted to publish a</u>&#160;<u>notice of a General Meeting or issue a proxy card only in the circumstances mentioned under</u>&#160;<u>Section

                64 of the Companies Law</u>.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="margin-left: 11pt; line-height: 1.25;"><u>25A.1.</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Shareholder Proposal</u></div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 70.9pt; margin-right: 9.1pt; margin-left: 5pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>Any shareholder or shareholders of the Company who is/are entitled to</u>&#160;<u>request, according and to the extent
                set forth under the Companies Law, that the Board of Directors</u>&#160;<u>include a matter on the agenda of a General Meeting (the &#8220;</u><font style="font-weight: bold; font-style: italic;"><u>Proposing Shareholder(s)</u></font><u>&#8221;), shall have</u>&#160;<u>the

                right to request that the Board of Directors shall include a matter on the agenda of a General</u>&#160;<u>Meeting, provided that the Board determines that the matter is appropriate to be considered at a</u>&#160;<u>General Meeting (a &#8220;</u><font style="font-weight: bold; font-style: italic;"><u>Proposal Request</u></font><u>&#8221;).</u></div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 70.9pt; margin-right: 9.15pt; margin-left: 5pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>The Proposal Request must comply with the requirements of and the timeline</u>&#160;<u>set by, these Articles, the
                Companies Law, and any applicable law. The Proposal Request must be</u>&#160;<u>in writing, signed by all the Proposing Shareholder(s) making such request, delivered, either in</u>&#160;<u>person or by certified mail, postage prepaid, and received by
                the Secretary (if serving), the Chief</u>&#160;<u>Executive Officer, and the Chairman of the Company. The announcement of an adjournment or</u>&#160;<u>postponement of a General Meeting shall not commence a new time period (or extend any time</u>&#160;<u>period)

                for the delivery of a Proposal Request as described above.</u></div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 70.9pt; margin-right: 9.1pt; margin-left: 5pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u> In addition to any information required to be included under any applicable</u>&#160;<u>law, a Proposal Request must
                include the following: (i) the name, address, telephone number and</u>&#160;<u>email address of the Proposing Shareholder (or each Proposing Shareholder, as the case may be)&#160; </u><u>and, if an entity, the name(s) of the person(s) that controls
                or manages such entity; (ii) the number</u>&#160;<u>of shares held by the Proposing Shareholder(s), directly or indirectly (and, if any of such shares are</u>&#160;<u>held indirectly, an explanation of how they are held and by whom), which shall be
                in such number</u>&#160;<u>no less than as is required to qualify as a Proposing Shareholder, accompanied by evidence</u>&#160;<u>satisfactory to the Company and the Board of Directors of the record holding of such shares by the</u>&#160;<u>Proposing
                Shareholder(s) as of the date of the Proposal Request, which complies with the</u>&#160;<u>Companies Law, and a representation that the Proposing Shareholder(s) intends to appear in person</u>&#160;<u>or by proxy at the General Meeting; (iii) the
                matter requested to be included on the agenda of a</u>&#160;<u>General Meeting, all information related to such matter and all supporting documentation, the reason</u>&#160;<u>that such matter is proposed to be brought before the General Meeting, the
                complete text of the</u>&#160;<u>resolution that the Proposing Shareholder proposes to be voted upon at the General Meeting, (iv) a</u>&#160;<u>description of all arrangements or understandings between the Proposing Shareholders and any other</u>&#160;<u>Person(s)

                (naming such Person or Persons) in connection with the matter that is requested to be</u>&#160;<u>included on the agenda and a declaration signed by all Proposing Shareholder(s) of whether any of</u>&#160;<u>them has a personal interest in the matter
                and, if so, a description in reasonable detail of such personal</u>&#160;<u>interest; (v) a description of all Derivative Transactions (as defined below) by each Proposing</u>&#160;<u>Shareholder(s) during the previous thirty six (36) month period,
                including the date of the transactions</u>&#160;<u>and the class, series and number of securities involved in, and the material economic terms of, such</u>&#160;<u>Derivative Transactions; and (vi) a declaration that all of the information that is
                required under the</u>&#160;<u>Companies Law and any other applicable law to be provided to the Company in connection with</u>&#160;<u>such matter, if any, has been provided to the Company.</u></div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 9</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 70.9pt; margin-right: 9.15pt; margin-left: 5pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160; <u>The Board of Directors, may, to the extent it deems necessary in its</u>&#160;<u>reasonable discretion, (a) request that
                the Proposing Shareholder(s) provide additional information</u>&#160;<u>and supporting documentation necessary so as to include a matter in the agenda of a General</u>&#160;<u>Meeting, as the Board of Directors may reasonably require and (b) revise
                the matter&#8217;s text as set</u>&#160;<u>forth under sub-item (c)(iii) above, to comply with the Companies Law.</u></div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.45pt; margin-left: 11pt; line-height: 1.25;"><u>A &#8220;Derivative Transaction&#8221; means any agreement, arrangement, interest or</u>&#160;<u>understanding entered into by, or on behalf or
                for the benefit of, any Proposing Shareholder or</u>&#160;<u>any of its affiliates or associates, whether of record or beneficial: (1) the value of which is</u>&#160;<u>derived in whole or in part from the value of any class or series of shares or
                other securities of</u>&#160;<u>the Company, (2) which otherwise provides any direct or indirect opportunity to gain or share</u>&#160;<u>in any gain derived from a change in the value of securities of the Company, (3) the effect or</u>&#160;<u>intent of
                which is to mitigate loss, manage risk or benefit from security value or price changes,</u>&#160;<u>or (4) which provides the right to vote or increase or decrease the voting power of, such</u>&#160;<u>Proposing Shareholder, or any of its affiliates
                or associates, with respect to any shares or other</u>&#160;<u>securities of the Company, which agreement, arrangement, interest or understanding may</u>&#160;<u>include, without limitation, any option, warrant, debt position, note, bond, convertible
                security,</u>&#160;<u>swap, stock appreciation right, short position, profit interest, hedge, right to dividends, voting</u>&#160;<u>agreement, performance-related fee or arrangement to borrow or lend shares (whether or not</u>&#160;<u>subject to payment,
                settlement, exercise or conversion in any such class or series), and any</u>&#160;<u>proportionate interest of such Proposing Shareholder in the securities of the Company held by</u>&#160;<u>any general or limited partnership, or any limited
                liability company, of which such Proposing</u>&#160;<u>Shareholder is, directly or indirectly, a general partner or managing member.</u></div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; margin-right: 9.45pt; margin-left: 11pt; line-height: 1.25;"><u>25A2.</u>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>The provisions set out in Article 25A1 shall apply to any shareholder or</u>&#160;<u>shareholders of the Company who is/are
                entitled to request, according and to the extent set forth</u>&#160;<u>under the Companies Law, that the Board of Directors convene an Extraordinary General</u>&#160;<u>Meeting, </u><font style="font-style: italic;"><u>mutatis mutandis</u></font><u>.</u></div>
            <div style="text-align: justify; margin-right: 9.45pt; margin-left: 11pt; line-height: 1.25;"><u> <br>
              </u></div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 10</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: center; margin-right: 33.8pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;">PROCEEDINGS AT GENERAL MEETINGS</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">26.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Quorum</u></div>
                  </td>
                </tr>

            </table>
            <br>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.65pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Two or more <strike>members</strike><u>shareholders</u>&#160;(not in default in payment of any sum referred to in Article
              32(a) hereof), present in person or by proxy and holding shares conferring in the aggregate <strike>twenty-five</strike><u>at least thirty-three</u>&#160;percent (<strike>25</strike><u>33</u>%) of the voting power of the Company (subject to rules
              and regulations, if any, applicable to the Company), shall constitute a quorum at General Meetings. No business shall be transacted at a General Meeting, or at any adjournment thereof, unless the requisite quorum is present when the meeting
              proceeds to business.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If within an hour from the time appointed for the meeting a quorum is not present, the meeting, if convened upon requisition
              under Sections 63(b)(1) or (2), 64 or 65 of the Companies Law, shall be dissolved, but in any other case it shall stand adjourned to the same day in the next week, at the same time and place, or to such day and at such time and place as the
              Chairman may determine with the consent of the holders of a majority of the voting power represented at the meeting in person or by proxy and voting on the question of adjournment. No business shall be transacted at any adjourned meeting
              except business which might lawfully have been transacted at the meeting as originally called. At such adjourned meeting, any two (2) <strike>members</strike><u>shareholders</u>&#160;(not in default as aforesaid) present in person or by proxy,
              shall constitute a quorum (subject to rules and regulations, if any, applicable to the Company).</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board of Directors may determine, in its discretion, the matters that may be voted upon at the <strike>meeting</strike><u>General

                Meeting</u>&#160;by proxy in addition to the matters listed in Section 87(a) to the Companies Law.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">27.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Chairman</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;">The Chairman, if any, of the Board of Directors, or any other Director or Office Holder of the Company which may be designated for
              this purpose by the Board of Directors, shall preside as Chairman at every General Meeting of the Company. If there is no such Chairman, or if at any <strike>meeting</strike><u>General Meeting</u>&#160;such Chairman is not present within fifteen
              (15) minutes after the time fixed for holding the meeting or is unwilling to act as Chairman, the <strike>members</strike><u>shareholders</u>&#160;present shall choose someone of their number to be Chairman. The office of Chairman shall not, by
              itself, entitle the holder thereof to vote at any General Meeting nor shall it entitle such holder to a second or casting vote (without derogating, however, from the rights of such Chairman to vote as a shareholder or proxy of a shareholder
              if, in fact, he is also a shareholder or such proxy).</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">28.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Adoption of Resolutions at General Meetings</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Unless otherwise indicated herein, a Shareholders Resolution shall be deemed adopted if approved by the holders of a
              majority of the voting power represented at the meeting in person or by proxy and voting thereon.</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<strike> A Shareholders Resolution approving a merger (as defined in the Companies</strike>&#160;<strike>Law) of the
                Company shall be deemed adopted if approved by the holders of a majority of the</strike>&#160;<strike>voting power represented at the meeting in person or by proxy and voting thereon.</strike></div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="margin-left: 47pt; line-height: 1.25;"><strike>(c</strike></div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.15pt; margin-left: 11pt; line-height: 1.25;"><u>(b</u>)&#160; Every question submitted to a General Meeting shall be decided by a show of hands, but if a written ballot is demanded
              by any <strike>member</strike><u>shareholder</u>&#160;present in person or by proxy and entitled to vote at the meeting, the same shall be decided by such ballot. A written ballot may be demanded before the proposed resolution is voted upon or
              immediately after the declaration by the Chairman of the results of the vote by a show of hands. If a vote by written ballot is taken after such declaration, the results of the vote by a show of hands shall be of no effect, and the proposed
              resolution shall be decided by such written ballot. The demand for a written ballot may be withdrawn at any time before the same is conducted, in which event another <strike>member</strike><u>shareholder</u>&#160;may then demand such written
              ballot. The demand for a written ballot shall not prevent the continuance of the meeting for the transaction of business other than the question on which the written ballot has been demanded.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.4pt; margin-left: 11pt; line-height: 1.25;">(<strike>d</strike><u>c</u>)&#160; A declaration by the Chairman of the meeting that a resolution has been carried unanimously, or
              carried by a particular majority, or lost, and an entry to that effect in the minute book of the Company, shall be conclusive evidence of the fact without proof of the number or proportion of the votes recorded in favor of or against such
              resolution.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 11</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">29.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Resolutions in Writing</u></div>
                  </td>
                </tr>

            </table>
            <br>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.4pt; margin-left: 11pt; line-height: 1.25;">A resolution in writing signed by all <strike>members</strike><u>shareholders</u>&#160;of the Company then entitled to attend and vote
              at General Meetings or to which all such <strike>members</strike><u>shareholders</u>&#160;have given their written consent (by letter, facsimile telecopier, telegram, telex or otherwise), or their oral consent by telephone (provided that a
              written summary thereof has been approved and signed by the Chairman of the Board of Directors of the Company) shall be deemed to have been unanimously adopted by a General Meeting duly convened and held.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">30.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Power to Adjourn</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Chairman of a General Meeting at which a quorum is present may, with the consent of the holders of a majority of
              the voting power represented in person or by proxy and voting on the question of adjournment (and shall if so directed by the meeting), adjourn the meeting from time to time and from place to place, but no business shall be transacted at any
              adjourned meeting except business which might lawfully have been transacted at the meeting as originally called.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.2pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;It shall not be necessary to give any notice of an adjournment, whether pursuant to Article 26(b) or Article 30(a),
              unless the meeting is adjourned for thirty (30) days or more in which event notice thereof shall be given in the manner required for the meeting as originally called.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">31.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Voting Power</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">Subject to the provisions of Article 32(a) and subject to any provision hereof conferring special rights as to voting, or
              restricting the right to vote, every <strike>member</strike><u>shareholder</u>&#160;shall have one vote for each share held by him of record, on every resolution, without regard to whether the vote hereon is conducted by a show of hands, by
              written ballot or by any other means.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">32.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Voting Rights</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;No <strike>member</strike><u>shareholder</u>&#160;shall be entitled to vote at any General Meeting (or be counted as a
              part of the quorum thereat), unless all calls and other sums then payable by him in respect of his<u>/her/its</u>&#160;shares in the Company have been paid, but this Article shall not apply to separate General Meetings of the holders of a
              particular class of shares pursuant to Article 6(b).</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.3pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A company or other corporate body being a member of the Company may, by resolution of its directors or any other
              managing body thereof, authorize any person to be its representative at any meeting of the Company. Any person so authorized shall be entitled to exercise on behalf of such <strike>member</strike><u>shareholder</u>&#160;all the power which the
              latter could have exercised if it were an individual shareholder. Upon the request of the Chairman of the meeting, written evidence of such authorization (in form acceptable to the Chairman) shall be delivered to him.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any <strike>member</strike><u>shareholder</u>&#160;entitled to vote may vote either personally or by proxy (who need not be
              a <strike>member</strike><u>shareholder</u>&#160;of the Company), or, if the <strike>member</strike><u>shareholder</u>&#160;is a company or other corporate body, by a representative authorized pursuant to Article 32(b).</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="margin-right: 13.2pt; margin-left: 11pt; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If two or more persons are registered as joint holders of any share, the vote of the senior who tenders a vote, in person or by proxy, shall be
              accepted to the exclusion of the vote(s) of the other joint holder(s); and for this purpose seniority shall be determined by the order in which the names stand in the Register of <strike>Members</strike><u>Shareholders</u>.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 12</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: center; margin-right: 32.049pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;">PROXIES</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">33.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Instrument of Appointment</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-indent: 36pt; margin-right: 12.35pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The instrument appointing a proxy shall be in writing and shall be substantially in the following form:</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="line-height: 1.25;">
              <div style="margin-left: 45pt;">&#8220;I<u> &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u>of<u> &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </u></div>
              <div style="margin-left: 45pt;">(Name of Shareholder)&#160;&#160;&#160;&#160; Address of Shareholder)</div>
              <div>
                <div style="line-height: 1.25; margin-left: 45pt;"><font style="font-family: 'Times New Roman',Times,serif;">being a</font> &#160; &#160; &#160;&#160; _________________ <font style="font-family: 'Times New Roman',Times,serif;">hereby appoint<strike></strike></font></div>
                <div style="line-height: 1.25; margin-left: 45pt;"><font style="font-family: 'Times New Roman',Times,serif;"><strike> member</strike><u>shareholde</u></font>&#160;<font style="font-family: 'Times New Roman',Times,serif;">(Name of the Company)</font> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
                  </div>
                <div style="line-height: 1.25; margin-left: 45pt;"><font style="font-family: 'Times New Roman',Times,serif;">r of________________of</font>______________ &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;
                    &#160; &#160; &#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </div>
                <div style="line-height: 1.25; margin-left: 45pt;"><font style="font-family: 'Times New Roman',Times,serif;">(Name of Proxy)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160; &#160; &#160; <font style="font-family: 'Times New Roman',Times,serif;">(Address of Proxy)</font></div>
                <div><br>
                </div>
                <div style="line-height: 1.25; font-family: 'Times New Roman',Times,serif; margin-left: 45pt;">as my proxy to vote for me and on my behalf at the General Meeting of the Company to be held on the______day of _____, <strike>19</strike><u>20&#160;
                    </u> and at any adjournment(s) thereof.</div>
                <div><br>
                </div>
                <div style="line-height: 1.25; margin-left: 90pt;"><u><font style="font-family: 'Times New Roman',Times,serif;">Signed this</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman',Times,serif;">day of&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; , <strike>19</strike>20&#160;.</font></u></div>
                <div style="line-height: 1.25; margin-left: 864pt;"><font style="font-family: 'Times New Roman',Times,serif;">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; &#160; &#160; </font><u><font style="font-family: 'Times New Roman',Times,serif;">&#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;
                      &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160; &#160;&#160; &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <br>
                    </font></u></div>
                <div style="line-height: 1.25; margin-left: 963pt;">(Signature of Appointer)&#8221;<font style="font-family: 'Times New Roman',Times,serif;">&#160;</font></div>
              </div>
            </div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="line-height: 1.25;">
              <div> </div>
            </div>
            <div style="text-align: justify; margin-right: 9.2pt; margin-left: 11pt; line-height: 1.25;">or in any usual or common form or in such other form as may be approved by the Board of Directors or required by applicable law. It shall be duly
              signed by the appointer or his duly authorized attorney or, if such appointer is a company or other corporate body, under its common seal or stamp or the hand of its duly authorized agent(s) or attorney(s).</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; margin-right: 9.45pt; margin-left: 11pt; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The instrument appointing a proxy (and the power of attorney or other authority, if any, under which such instrument has
              been signed) shall either be delivered to the Company (at its Registered Office, or at its principal place of business or at the offices of its registrar and/or transfer agent or at such place as the Board of Directors may specify) not less
              than twenty four (24) hours (or not less than forty eight (48) hours with respect to a meeting to be held outside of Israel) before the time fixed for the meeting at which the person named in the instrument proposes to vote, unless otherwise
              specified by the Board of Directors or required by applicable law.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 35.95pt; vertical-align: top;">34.</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div><u>Effect of Death of Appointor or Revocation of Appointment</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.4pt; margin-left: 11pt; line-height: 1.25;">A vote cast pursuant to an instrument appointing a proxy shall be valid notwithstanding the previous death of the appointing <strike>member</strike><u>shareholder</u>&#160;(or

              of his attorney-in-fact, if any, who signed such instrument), or the revocation of the appointment or the transfer of the share in respect of which the vote is cast, provided no written intimation of such death, revocation or transfer shall
              have been received by the Company or by the Chairman of the meeting before such vote is cast and provided, further, that the appointing <strike>member</strike><u>shareholder</u>, if present in person at said meeting, may revoke the
              appointment by means of a writing, oral notification to the Chairman, or otherwise; all of the above, unless otherwise specified by the Board of Directors or required by applicable law.</div>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 13</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div><br>
            <div style="text-align: center; margin-right: 32.25pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;">BOARD OF DIRECTORS</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">35.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Powers of Board of Directors</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 47pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">(a)</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>In General</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 9.3pt; margin-left: 11pt; line-height: 1.25;">The management of the business of the Company shall be vested in the Board of Directors, which may exercise all such powers and do
              all such acts and things as the Company is authorized to exercise and do, and are not hereby or by <u>applicable</u>&#160;law required to be exercised or done by the Company in General Meeting. The authority conferred on the Board of Directors by
              this Article 35 shall be subject to the provisions of the Companies Law, <strike>of</strike><u>any applicable</u>&#160;<u>law,</u>&#160;these Articles and any <strike>regulation or </strike>resolution consistent with these Articles adopted from time
              to time by the Company in <u>a </u>General Meeting, provided, however, that no such<strike> regulation</strike>&#160;<strike>or</strike>&#160;resolution shall invalidate any prior act done by or pursuant to a decision of the Board of Directors which
              would have been valid if such <strike>regulation or</strike>&#160;resolution had not been adopted.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 47pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">(b)</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Borrowing Power</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 9.3pt; margin-left: 11pt; line-height: 1.25;">The Board of Directors may from time to time, in its discretion, cause the Company to borrow or secure the payment of any sum or
              sums of money for the purposes of the Company, and may secure or provide for the repayment of such sum or sums in such manner, at such times and upon such terms and conditions in all respects as it thinks fit, and, in particular, by the
              issuance of bonds, perpetual or redeemable debentures, debenture stock, or any mortgages, charges, or other securities on the undertaking or the whole or any part of the property of the Company, both present and future, including its uncalled
              or called but unpaid capital for the time being.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 47pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">(c)</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Reserves</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;">The Board of Directors may, from time to time, set aside any amount(s) out of the profits of the Company as a reserve or reserves
              for any purpose(s) which the Board of Directors, in its absolute discretion, shall think fit, and may invest any sum so set aside in any manner and from time to time deal with and vary such investments, and dispose of all or any part thereof,
              and employ any such reserve or any part thereof in the business of the Company without being bound to keep the same separate from other assets of the Company, and may subdivide or redesignate any reserve or cancel the same or apply the funds
              therein for another purpose, all as the Board of Directors may from time to time think fit.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">36.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Exercise of Powers of Directors</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A meeting of the Board of Directors at which a quorum is present (in person, by means of a conference call or any
              other device allowing each director participating in such meeting to hear all the other directors participating in such meeting) shall be competent to exercise all the authorities, powers and discretions vested in or exercisable by the Board
              of Directors.</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
          </div>
          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 14</font></div>
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
          </div>
          <div><br>
            <br>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A resolution proposed at any meeting of the Board of Directors shall be deemed adopted if approved by a majority of the
              Directors present when such resolution is put to a vote and voting thereon.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.2pt; margin-left: 11pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A resolution in writing signed by all Directors then in office and lawfully entitled to vote thereon <strike>(as
                conclusively determined by the Chairman of the Audit Committee</strike>&#160;<strike>[&#8220;Va&#8217;adat Bikoret&#8221;], and in the absence of such determination - by the Chairman of the Board of</strike>&#160;<strike>Directors) </strike>or to which all such
              Directors have given their consent (by letter, telegram, telex, facsimile telecopier or otherwise), or their oral consent by telephone (provided that a written summary thereof has been approved and signed by the Chairman of the Board of
              Directors of the Company) shall be deemed to have been unanimously adopted by a meeting of the Board of Directors duly convened and held.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">37.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Delegation of Powers</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.45pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board of Directors may, subject to the provisions of the Companies Law, delegate any or all of its powers to
              committees, each consisting of two or more persons (all of whose <strike>members</strike><u>shareholders</u>&#160;must be Directors), and it may from time to time revoke such delegation or alter the composition of any such committee. Any
              Committee so formed (in these Articles referred to as a &#8220;Committee of the Board of Directors&#8221;), shall, in the exercise of the powers so delegated, conform to any regulations imposed on it by the Board of Directors. The meetings and
              proceedings of any such Committee of the Board of Directors shall, mutatis mutandis, be governed by the provisions herein contained for regulating the meetings of the Board of Directors, so far as not superseded by any regulations adopted by
              the Board of Directors under this Article. Unless otherwise expressly provided by the Board of Directors in delegating powers to a Committee of the Board of Directors, such Committee shall not be empowered to further delegate such powers.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Without derogating from the provisions of Article 50, the Board of Directors may, subject to the provisions of the
              Companies Law, from time to time appoint a Secretary to the Company, as well as officers, agents, employees and independent contractors, as the Board of Directors may think fit, and may terminate the service of any such person. <img width="9" src="image1.jpg">The Board of Directors may, subject to the provisions of the Companies Law, determine the powers and duties, as well as the salaries and emoluments, of all such persons, and may require security in such cases
              and in such amounts as it thinks fit.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board of Directors may from time to time, by power of attorney or otherwise, appoint any person, company, firm or
              body of persons to be the attorney or attorneys of the Company at law or in fact for such purpose(s) and with such powers, authorities and discretions, and for such period and subject to such conditions, as it thinks fit, and any such power
              of attorney or other appointment may contain such provisions for the protection and convenience of persons dealing with any such attorney as the Board of Directors may think fit, and may also authorize any such attorney to delegate all or any
              of the powers, authorities and discretions vested in him.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">38.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Number of Directors</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-indent: 36pt; margin-left: 11pt; line-height: 1.25;">The Board of Directors shall consist of up to <u>nine (</u>9<u>)</u>&#160;directors but no less than <u>five (</u>5<u>)</u> directors<strike> unless otherwise
                determined by Shareholder Resolution of the Company</strike>.</div>
            <div style="text-indent: 36pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 15</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <br>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">39.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Election and Removal of Directors</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.35pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If at any time, the Company shall be required to appoint <strike>independent or </strike>external directors <strike>such

              </strike>as <strike>a public director or directors of any other type as</strike><u>defined in</u>&#160;the <strike>may be required</strike>&#160;<strike>by law</strike><u>Companies Law</u>&#160;(&#8220;<font style="font-weight: bold;">External Directors</font>&#8221;)

              such directors shall serve on the Board according to the number required by <strike>law.</strike><u>the Companies Law.</u>&#160;External Directors will be appointed and removed pursuant to and shall be governed by the relevant provisions of the <strike>law</strike><u>Companies

                Law</u>&#160;which applies to External Directors. If permitted by <strike>applicable law,</strike><u>the Companies Law, such</u>&#160;External Directors will be appointed by the Board.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The <strike>members</strike><u>shareholders</u>&#160;of the Board of Directors shall be called Directors, and other than
              External Directors (who will be chosen and appointed, and whose term will expire, in accordance with <strike>applicable law</strike><u>the Companies Law</u>), they shall be appointed in accordance with the provisions of this Article.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Directors (other than the External Directors) shall be appointed by the Annual General Meeting and will serve for
              a term ending on the date of the third Annual General Meeting following the General Meeting at which such Director was elected, unless earlier terminated in the event of such director&#8217;s death, resignation or removal. .</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="margin-right: 13.2pt; margin-left: 11pt; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<strike>Directors</strike><u>All directors</u>&#160;(other than External Directors<strike>) appointed</strike>; in <u>such case, </u>&#160;the <strike>2012

                Annual General Meeting, in which shareholders approve the amendment of the </strike>&#160;<strike>Articles concerning the election and removal of directors (the "</strike><font style="font-weight: bold;"><strike>2012 Meeting</strike></font><strike>"),

                shall</strike><u>External</u>&#160;<u>Directors may</u>&#160;be appointed <strike>for a term ending on the date of the third Annual General Meeting</strike>&#160;<strike>following the 2012 Meeting (the "</strike><font style="font-weight: bold;"><strike>2015</strike><strike>
                  Meeting</strike></font><strike>"). Directors appointed in</strike><u>at</u>&#160;any Annual General Meeting<strike> following the 2012 </strike>&#160;<strike>Meeting and prior to the 2015 Meeting, shall be appointed for a term ending on the date
                of</strike>&#160;<strike>the 2015 Meeting. From the 2015 Meeting and onwards, all directors (other than External Directors</strike>) shall be appointed together on the same Annual General meeting, subject to any earlier termination of service,
              which <strike>shall</strike><u>may</u>&#160;be filled with an appointment of a substitute director for the remainder of such three-year term.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-indent: 3pt; margin-right: 22pt; margin-left: 11pt; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to Section (g) below, a Director appointed by the Annual General Meeting shall commence serving at the conclusion of the
              Annual General Meeting in which he or she was appointed.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; margin-right: 9.35pt; margin-left: 11pt; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Directors (other than External Directors) shall be elected at the Annual General Meeting by the vote of the holders of a
              majority of the voting power represented at such meeting in person or by proxy and voting on the election of Directors, and each Director shall serve, subject to Article 42 hereof, and according to the provisions of this Article 39. The
              shareholders shall be entitled<u> at any Annual General Meeting</u>&#160;to remove any Director(s) (other than external directors) from office prior to the lapse of its full term in office all subject to applicable law., <u>provided that the
                shareholders shall be entitled to remove Director(s) from office for Cause at any</u>&#160;<u>General Meeting. For the purposes hereof &#8220;</u><font style="font-weight: bold; font-style: italic;"><u>Cause</u></font><u>&#8221; shall mean the occurrence of
                any of the</u>&#160;<u>circumstances listed under Sections 226-226A to the Companies Law.</u></div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; margin-right: 9.4pt; margin-left: 11pt; line-height: 1.25;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; (g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Notwithstanding anything to the contrary herein, the term of a Director may commence at a later date than the date of the
              Shareholder Resolution electing such Director, if so specified in such Shareholder Resolution.</div>
            <div style="text-align: justify; margin-right: 9.4pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 16</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="text-align: justify; margin-right: 9.4pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="text-align: justify; margin-left: 11pt; line-height: 1.25;"><u>(i)&#160;&#160; Additional Nominee.</u></div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 30pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;"><u>Any Proposing Shareholder requesting to include on the agenda of an Annual General</u>&#160;<u>Meeting a nomination of a Person to be
                proposed to the Shareholders for election as Director</u>&#160;<u>(such person, an &#8220;</u><font style="font-weight: bold; font-style: italic;"><u>Additional Nominee</u></font><u>&#8221;), may so request provided that it complies with these</u>&#160;<u>Articles

                (including Articles 25.A.1 and 25.A.2), the Companies Law, and any other applicable</u>&#160;<u>law . Unless otherwise determined by the Board, a Proposal Request relating to Additional</u>&#160;<u>Nominee is deemed to be a matter that is appropriate
                to be considered only at an Annual General</u>&#160;<u>Meeting in which Directors are to be appointed in accordance with the provisions of these</u>&#160;<u>Articles. The Proposal Request relating to an Additional Nominee shall include all the</u>&#160;<u>information

                and supporting documentation required pursuant to Articles 25.A.1 and 25.A.2, all</u>&#160;<u>the information and supporting documentation required to be included such Proposal Request</u>&#160;<u>in accordance with these Articles, the Companies Law
                and any other applicable law , and shall</u>&#160;<u>also include: (i) the name, address, telephone number, fax number and email address of the</u>&#160;<u>Additional Nominee and all citizenships and residencies of the Additional Nominee; (ii) a</u>&#160;<u>description

                of all arrangements, relations or understandings between the Proposing</u>&#160;<u>Shareholder(s) or any of its affiliates and each Additional Nominee, including any Derivative</u>&#160;<u>Transaction; (iii) a declaration signed by the Additional
                Nominee that he or she consents to be</u>&#160;<u>named in the Company&#8217;s notices and proxy materials relating to the Annual General Meeting,</u>&#160;<u>if provided or published, and, if elected, to serve on the Board of Directors and to be named in</u>&#160;<u>the

                Company&#8217;s disclosures and filings, (iv) a declaration signed by each Additional Nominee</u>&#160;<u>as required under the Companies Law and any other applicable law and listing rules and</u>&#160;<u>regulations for the appointment of such an
                Additional Nominee and an undertaking that all of</u>&#160;<u>the information that is required under law and listing rules and regulations to be provided to the</u>&#160;<u>Company in connection with such an appointment has been provided (including,
                information in</u>&#160;<u>respect of the Additional Nominee as would be provided in response to the applicable disclosure</u>&#160;<u>requirements under Form 20-F, Form 10-K, Schedule 14A or any other applicable form or</u>&#160;<u>schedule prescribed by
                the U.S. Securities and Exchange Commission (the &#8220;</u><font style="font-weight: bold; font-style: italic;"><u>SEC</u></font><u>&#8221;); (v) a</u>&#160;<u>declaration made by the Additional Nominee of whether he or she meets the criteria for an</u>&#160;<u>independent

                director and/or External Director, if applicable, of the Company under the rules of</u>&#160;<u>the stock exchange on which the Company&#8217;s ordinary shares are then listed for trading, the</u>&#160;<u>Companies Law and/or under any applicable law, and
                if not, then an explanation of why not;</u>&#160;<u>and (vi) any other information required at the time of submission of the Proposal Request by</u>&#160;<u>applicable law. In addition, the Proposing Shareholder shall promptly provide (prior to and
                as a</u>&#160;<u>condition to including any requested Additional Nominee on the agenda for the applicable</u>&#160;<u>Annual General Meeting) any other information reasonably requested by the Company. The</u>&#160;<u>Board of Directors may refuse to
                acknowledge the nomination of any person not made in</u>&#160;<u>compliance with the foregoing. The Company shall be entitled to publish any information</u>&#160;<u>provided by a Proposing Shareholder pursuant to this Articles, and the Proposing
                Shareholder</u>&#160;<u>shall be responsible for the accuracy and completeness thereof.</u></div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">40.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Qualification of Directors</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-indent: 36pt; margin-right: 6.7pt; margin-left: 11pt; line-height: 1.25;">No person shall be disqualified to serve as a Director by reason of his not holding shares in the Company or by reason of his having served as a Director
              in the past.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">41.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Continuing Directors in the Event of Vacancies</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;">In the event of one or more vacancies in the Board of Directors, <u>as set forth under Articles</u>&#160;<u>39(f) and 42,</u>&#160;the
              continuing Directors may continue to act in every matter, and may temporarily fill any such vacancy until the next Annual General Meeting, provided, however, that if they number less than the minimum number provided for pursuant to Article 38
              hereof, they may only act in an emergency, and may call <strike>a</strike><u>an Annual</u>&#160;General Meeting of the Company for the purpose of electing Directors to fill any or all vacancies, so that at least a majority of the number of
              Directors provided for pursuant to Article 38 hereof are in office as a result of said meeting.</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 17</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">42.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Vacation of Office</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The office of a Director shall be vacated, ipso facto, upon his death, or if he be found lunatic or become of unsound
              mind, or if he becomes bankrupt, or, if the Director is a company, upon its winding-up.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The office of a Director shall be vacated by his written resignation. Such resignation shall become effective on the
              date fixed therein, or upon the delivery thereof to the Company, whichever is later.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">43.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Remuneration of Directors</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;">No Director shall be paid any remuneration by the Company for his services as Director except as may be approved by the Company in
              accordance with applicable law, except for reimbursement of expenses incurred in relation to travelling to board meetings, and except for grant of options to acquire the Company&#8217;s shares.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">44.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Conflict of Interests</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;">Subject to the provisions of the Companies Law, the Company may enter into any contract or otherwise transact any business with any
              Director in which contract or business such Director has a personal interest, directly or indirectly; and may enter into any contract of otherwise transact any business with any third party in which contract or business a Director has a
              personal interest, directly or indirectly.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">45.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Alternate Directors</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.65pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A Director may, by written notice to the Company, appoint a natural person who is not a Director as an alternate for
              himself (in these Articles referred to as &#8220;Alternate Director&#8221;), remove such Alternate Director and appoint another Alternate Director in place of any Alternate Director appointed by him whose office has been vacated for any reason
              whatsoever. Unless the appointing Director, by the instrument appointing an Alternate Director or by written notice to the Company, limits such appointment to a specified period of time or restricts it to a specified meeting or action of the
              Board of Directors, or otherwise restricts its scope, the appointment shall be for an indefinite period, and for all purposes.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.65pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any notice given to the Company pursuant to Article 45(a) shall become effective on the date fixed therein, or upon
              the delivery thereof to the Company, whichever is later.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.65pt; margin-left: 11pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;An Alternate Director shall have all the rights and obligations of the Director who appointed him, provided, however,
              that he may not in turn appoint an alternate for himself (unless the instrument appointing him otherwise expressly provides), and provided further that an Alternate Director shall have no standing at any meeting of the Board of Directors or
              any committee thereof while the Director who appointed him is present.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.75pt; margin-left: 11pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;An Alternate Director shall alone be responsible for his own acts and defaults, and he shall not be deemed the agent
              of the Director(s) who appointed him.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.65pt; margin-left: 11pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The office of an Alternate Director shall be vacated under the circumstances, <font style="font-style: italic;">mutatis

                mutandis</font>, set forth in Article 42, and such office shall ipso facto be vacated if the Director who appointed such Alternate Director ceases to be a Director.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 18</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: center; margin-right: 34pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;">PROCEEDINGS OF THE BOARD OF DIRECTORS</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">46.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Meetings</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.4pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board of Directors may meet and adjourn its meetings and otherwise regulate such meetings and proceedings as the
              Board of Directors think fit. Notice of the meetings of the Board of Directors shall be given to each Director at the last address that the Director provided to the Company, or via telephone, facsimile or e-mail message; provided, however,
              that the Board of Directors may convene without giving such prior notice to all or any of the Directors, in circumstances permitted under the Companies Law.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Chairman of the Board of Directors may, at any time, convene a meeting of the Board of Directors, provided that a
              notice shall be given to all other Directors a reasonable time prior to the time set for such meeting. Any Director who is not the Chairman of the Board of Directors, may at any time, and the Secretary, upon the request of such Director,
              shall, convene a meeting of the Board of Directors, provided a notice shall be given to all other Directors a reasonable time, but not less than four (4) days, prior to the time set for such meeting<strike>;.</strike>. Subject to the terms of
              the Companies Law, and without derogating from provision of the last paragraph of Article 46(a) above), the failure to give notice to a Director in the manner required hereby may be waived.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">47.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Quorum</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.15pt; margin-left: 11pt; line-height: 1.25;">Until otherwise unanimously decided by the Board of Directors, a quorum at a meeting of the Board of Directors shall be constituted
              by the presence of a majority of the Directors then in office who are lawfully entitled to participate in the meeting (as conclusively determined by the Chairman of the Audit Committee and in the absence of such determination - by the
              Chairman of the Board of Directors), but shall not be less than two.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">48.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Chairman of the Board of Directors</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;">The Board of Directors may from time to time elect one of its <strike>members</strike><u>shareholders</u>&#160;to be the Chairman of the
              Board of Directors, remove such Chairman from office and appoint another in its place. The Chairman of the Board of Directors shall preside at every meeting of the Board of Directors, but if there is no such Chairman, or if at any meeting he
              is not present within fifteen (15) minutes of the time fixed for the meeting, or if he is unwilling to take the chair, the Directors present shall choose one of their number to be the chairman of such meeting.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">49.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Validity of Acts Despite Defects</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.3pt; margin-left: 11pt; line-height: 1.25;">Subject to the provisions of the Companies Law, all acts done bona fide at any meeting of the Board of Directors, or of a Committee
              of the Board of Directors, or by any person(s) acting as Director(s), shall, notwithstanding that it may afterwards be discovered that there was some defect in the appointment of the participants in such meetings or any of them or any
              person(s) acting as aforesaid, or that they or any of them were disqualified, be as valid as if there were no such defect or disqualification.</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.3pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 19</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: center; margin-right: 159.35pt; margin-left: 158.4pt; line-height: 1.25; font-weight: bold;"><strike>GENERAL MANAGER</strike></div>
            <div style="text-align: center; margin-right: 159.35pt; margin-left: 158.4pt; line-height: 1.25; font-weight: bold;"><strike></strike>&#160;<u>CHIEF EXECUTIVE</u></div>
            <div style="text-align: center; margin-right: 159.35pt; margin-left: 158.4pt; line-height: 1.25; font-weight: bold;"><u></u>&#160;<u>OFFICER</u></div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">50.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><strike><u>General Manager</u></strike><u>Chief Executive Officer</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">The Board of Directors may from time to time appoint one or more persons, whether or not Directors, as <strike>General Manager</strike><u>Chief


                Executive Officer</u>(s) of the Company and may confer upon such person(s), and from time to time modify or revoke, such title(s) (including Managing Director, Director General or any similar or dissimilar title) and such duties and
              authorities of the Board of Directors as the Board of Directors may deem fit, subject to such limitations and restrictions as the Board of Directors may from time to time prescribe. Such appointment(s) may be either for a fixed term or
              without any limitation of time, and the Board of Directors may from time to time (subject to the provisions of the Companies Law and of any contract between any such person and the Company) fix his or their salaries and emoluments, remove or
              dismiss him or them from office and appoint another or others in his or their place or places.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: center; margin-right: 32.2pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;">MINUTES</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">51.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Minutes</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Minutes of each General Meeting and of each meeting of the Board of Directors shall be recorded and duly entered in
              books provided for that purpose. Such minutes shall, in all events, set forth the names of the persons present at the meeting and all resolutions adopted thereat.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any minutes as aforesaid, if purporting to be signed by the chairman of the meeting or by the chairman of the next
              succeeding meeting, shall constitute prima facia evidence of the matters recorded therein.</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 20</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.5pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="text-align: center; margin-right: 32.25pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;">DIVIDENDS</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">52.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Declaration and Payment of Dividends</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">Subject to the provisions of the Companies Law, the Board of Directors may from time to time declare, and cause the Company to pay,
              such dividend as may appear to the Board of Directors to be justified. The Board of Directors shall determine, and may authorize, subject to applicable law, any of its directors and/or officers to determine, the time for payment of such
              dividends and the record date for determining the shareholders entitled thereto.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">53.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div>[Deleted]</div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">54.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Amount Payable by Way of Dividends</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.3pt; margin-left: 11pt; line-height: 1.25;">Subject to the rights of the holders of shares with special rights as to dividends, any dividend paid by the Company shall be
              allocated among the <strike>members</strike><u>shareholders</u>&#160;entitled thereto in proportion to their respective holdings of the shares in respect of which such dividend is being paid.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">55.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Interest</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="margin-left: 47pt; line-height: 1.25;">No dividend shall carry interest as against the Company.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">56.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Payment in Specie</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;">Upon the declaration of the Board of Directors, a dividend may be paid, wholly or partly, by the distribution of specific assets of
              the Company or by distribution of paid up shares, debentures or debenture stock of the Company or of any other companies, or in any one or more of such ways.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">57.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Capitalization of Profits, Reserves etc.</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="margin-left: 47pt; line-height: 1.25;">Upon the resolution of the Board of Directors, the Company -</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.45pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;may cause any moneys, investments, or other assets forming part of the undivided profits of the Company, standing to
              the credit of a reserve fund, or to the credit of a reserve fund for the redemption of capital, or in the hands of the Company and available for dividends, or representing premiums received on the issuance of shares and standing to the credit
              of the share premium account, to be capitalized and distributed among such of the shareholders as would be entitled to receive the same if distributed by way of dividend and in the same proportion, on the footing that they become entitled
              thereto as capital, or may cause any part of such capitalized fund to be applied on behalf of such shareholders in paying up in full, either at par or at such premium as the resolution may provide, any unissued shares or debentures or
              debenture stock of the Company which shall be distributed accordingly, in payment, in full or in part, of the uncalled liability on any issued shares or debentures or debenture stock; and</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.65pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;may cause such distribution or payment to be accepted by such shareholders in full satisfaction of their interest in
              the said capitalized sum.</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.65pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 21</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">58.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Implementation of Powers under Articles 56 and 57</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.1pt; margin-left: 11pt; line-height: 1.25;">For the purpose of giving full effect to any resolution under Articles 56 or 57, and without derogating from the provisions of
              Article 7(b) hereof, and subject to applicable law, the Board of Directors may settle any difficulty which may arise in regard to the distribution as it thinks expedient, and, in particular, may issue fractional certificates, and may fix the
              value for distribution of any specific assets, and may determine that cash payments shall be made to any <strike>members</strike><u>shareholders</u>&#160;upon the footing of the value so fixed, or that fractions of less value than the nominal
              value of one share may be disregarded in order to adjust the rights of all parties, and may vest any such cash, shares, debentures, debenture stock or specific assets in trustees upon such trusts for the persons entitled to the dividend or
              capitalized fund as may seem expedient to the Board of Directors.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">59.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Deductions from Dividends</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.3pt; margin-left: 11pt; line-height: 1.25;">The Board of Directors may deduct from any dividend or other moneys payable to any <strike>member</strike><u>shareholder</u>&#160;in
              respect of a share any and all sums of money then payable by him to the Company on account of calls or otherwise in respect of shares of the Company and/or on account of any other matter of transaction whatsoever.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">60.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Retention of Dividends</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.65pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board of Directors may retain any dividend or other moneys payable or property distributable in respect of a share
              on which the Company has a lien, and may apply the same in or toward satisfaction of the debts, liabilities, or engagements in respect of which the lien exists.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board of Directors may retain any dividend or other moneys payable or property distributable in respect of a share
              in respect of which any person is, under Articles 21 or 22, entitled to become a <strike>member</strike><u>shareholder</u>, or which any person is, under said Articles, entitled to transfer, until such person shall become a <strike>member</strike><u>shareholder</u>&#160;in

              respect of such share or shall transfer the same.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">61.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Unclaimed Dividends</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.4pt; margin-left: 11pt; line-height: 1.25;">All unclaimed dividends or other moneys payable in respect of a share may be invested or otherwise made use of by the Board of
              Directors for the benefit of the Company until claimed. The payment by the Directors of any unclaimed dividend or such other moneys into a separate account shall not constitute the Company a trustee in respect thereof, and any dividend
              unclaimed after a period of seven (7) years from the date of declaration of such dividend, and any such other moneys unclaimed after a like period from the date the same were payable, shall be forfeited and shall revert to the Company,
              provided, however, that the Board of Directors may, at its discretion, cause the Company to pay any such dividend or such other moneys, or any part thereof, to a person who would have been entitled thereto had the same not reverted to the
              Company.</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.4pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 22</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <br>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">62.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Mechanics of Payment</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;">Any dividend or other moneys payable in cash in respect of a share may be paid by check or warrant sent through the post to, or
              left at, the registered address of the person entitled thereto or by transfer to a bank account specified by such person (or, if two or more persons are registered as joint holders of such share or are entitled jointly thereto in consequence
              of the death or bankruptcy of the holder or otherwise, to any one of such persons or to his<u>/her</u>&#160;bank account), or to such person and at such address as the person entitled thereto may by writing direct. Every such check or warrant
              shall be made payable to the order of the person to whom it is sent, or to such person as the person entitled thereto as aforesaid may direct, and payment of the check or warrant by the banker upon whom it is drawn shall be a good discharge
              to the Company. Every such check or warrant shall be sent at the risk of the person entitled to the money represented thereby.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">63.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Receipt from a Joint Holder</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;">If two or more persons are registered as joint holders of any share, or are entitled jointly thereto in consequence of the death or
              bankruptcy of the holder or otherwise, any one of them may give effectual receipts for any dividend or other moneys payable or property distributable in respect of such share.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: center; margin-right: 31.95pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;">ACCOUNTS</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">64.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Books of Account</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.6pt; margin-left: 11pt; line-height: 1.25;">The Board of Directors shall cause accurate books of account to be kept in accordance with the provisions of the Companies Law and
              of any other applicable law. Such books of account shall be kept at the Registered Office of the Company, or at such other place or places as the Board of Directors may think fit, and they shall always be open to inspection by all Directors.
              No <strike>member</strike><u>shareholder</u>, not being a Director, shall have any right to inspect any account or book or other similar document of the Company, except as conferred by law or authorized by the Board of Directors or by a
              Shareholders Resolution.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">65.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Audit</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;">At least once in every fiscal year the accounts of the Company shall be audited and the correctness of the profit and loss account
              and balance sheet certified by one or more duly qualified auditors.</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">66.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Auditors</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;">The appointment, authorities, rights and duties of the auditor(s) of the Company, shall be regulated by applicable law. The Audit
              Committee of the Company shall have the authority to fix, in its discretion, the remuneration of the auditor(s) for the auditing services.</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 23</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: center; margin-right: 32.25pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;">BRANCH REGISTERS</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">67.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Branch Registers</u></div>
                  </td>
                </tr>

            </table>
            <br>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;">Subject to and in accordance with the provisions of the Companies Law and to all orders and regulations issued thereunder, the
              Company may cause branch registers to be kept in any place outside Israel as the Board of Directors may think fit, and, subject to all applicable requirements of law, the Board of Directors may from time to time adopt such rules and
              procedures as it may think fit in connection with the keeping of such branch registers.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: center; margin-right: 2.45pt; line-height: 1.25; font-weight: bold;">RIGHTS OF SIGNATURE, STAMP AND SEAL</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">68.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Rights of Signature, Stamp and Seal</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.55pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board of Directors shall be entitled to authorize any person or persons (who need not be Directors) to act and
              sign on behalf of the Company, and the acts and signature of such person(s) on behalf of the Company shall bind the Company insofar as such person(s) acted and signed within the scope of his or their authority.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 47pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">(b)</td>
                  <td style="width: auto; vertical-align: top;">
                    <div>The Company shall have at least one official stamp.</div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.35pt; margin-left: 11pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Board of Directors may provide for a seal. If the Board of Directors so provides, it shall also provide for the
              safe custody thereof. Such seal shall not be used except by the authority of the Board of Directors and in the presence of the person(s) authorized to sign on behalf of the Company, who shall sign every instrument to which such seal is
              affixed.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: center; margin-right: 32.2pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;">NOTICES</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">69.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Notices</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any written notice or other document may be served by the Company upon any <strike>member</strike><u>shareholder</u>&#160;either

              personally, <strike>or </strike>by facsimile transmission, <strike>or</strike><u>by email,</u>&#160;by sending it by prepaid mail (airmail or overnight air courier if sent to an address on a different continent from the place of mailing<strike>)</strike><u>),

                or by other electronic means,</u>&#160;addressed to such <strike>member</strike><u>shareholder</u>&#160;at his address as described in the Register of <strike>Members</strike><u>Shareholders</u>&#160;or such other address as he may have designated in
              writing for the receipt of notices and other documents. Such designation may include a broker or other nominee holding shares at the instruction of the shareholder. Proof that an envelope containing a notice was properly addressed, stamped
              and mailed shall be conclusive evidence that notice was given. A declaration of an authorized person on behalf of the stock transfer agent of the Company or other distribution agent stating that a notice was mailed to a shareholder will
              suffice as proof of notice for purposes of this Article. Any written notice or other document may be served by any <strike>member</strike><u>shareholder</u>&#160;upon the Company by tendering the same in person to the Secretary or the <strike>General

                Manager</strike><u>Chief Executive Officer</u>&#160;of the Company at the principal office of the Company, or by facsimile transmission<u>, or by email</u>, or by sending it by prepaid registered mail (airmail or overnight air courier if posted
              outside Israel) to the Company at its Registered Address. Any such notice or other document shall be deemed to have been served (i) in the case of mailing, two (2) business days after it has been posted (five (5) business days if sent
              internationally), or when actually received by the addressee if sooner than two days or five days, as the case may be, after it has been posted; (ii) in the case of overnight air courier, on the third business day following the day sent, with
              receipt confirmed by the courier, or when actually received by the addressee if sooner than three business days after it has been sent; (iii) in the case of personal delivery, on the date such notice was actually tendered in person to such <strike>member</strike><u>shareholder</u>&#160;(or

              to the Secretary or the General Manager);</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 9.25pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 24</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <br>
            <div style="text-align: justify; margin-right: 10.3pt; margin-left: 11pt; line-height: 1.25;">(iv) in the case of facsimile transmission, on the date on which the sender receives automatic electronic confirmation by the recipient&#8217;s facsimile
              machine that such notice was received by the addressee.<u>, and (v) in the case of email, on the date when actually received by the addressee</u>&#160;<u>or one (1) business day following the day on which such notice was sent, the earlier to
                occur.</u>&#160;If a notice is, in fact, received by the addressee, it shall be deemed to have been duly served, when received, notwithstanding that it was defectively addressed or failed, in some respect, to comply with the provisions of this
              Article 69(a).</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 10.6pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All notices to be given to the <strike>members</strike><u>shareholders</u>&#160;shall, with respect to any share to which
              persons are jointly entitled, be given to whichever of such persons is named first in the Register of <strike>Members</strike><u>Shareholders</u>, and any notice so given shall be sufficient notice to the holders of such share.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 10.7pt; margin-left: 11pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any <strike>member</strike><u>shareholder</u>&#160;whose address is not described in the Register of <strike>Members</strike><u>Shareholders</u>,
              and who shall not have designated in writing an address for the receipt of notices, shall not be entitled to receive any notice from the Company.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: center; margin-right: 33.55pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;">INSURANCE AND INDEMNITY</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 35.95pt; vertical-align: top;">70.</td>
                  <td style="width: auto; vertical-align: top; text-align: justify;">
                    <div><u>Exculpation, Indemnity and Insurance</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 10.25pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;For purposes of these Articles, the term &#8220;Office Holder&#8221; shall mean every Director and every officer of the Company,
              including, without limitation, each of the persons defined as &#8220;<font style="font-weight: bold; font-style: italic;">Nosei Misra</font>&#8221; in the Companies Law.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 10.2pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the provisions of the Companies Law, the Company may prospectively exculpate an Office Holder from all or
              some of the Office Holder&#8217;s responsibility for damage resulting from the Office Holder&#8217;s breach of the Office Holder&#8217;s duty of care to the Company.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="margin-right: 13.5pt; margin-left: 47pt; line-height: 1.25;">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the provisions of the Companies Law and the <u>Israeli</u>&#160;Securities Law, 5728- 1968 (the <strike>"</strike><u>&#8220;</u><font style="font-weight: bold; font-style: italic;">Securities Law</font><strike>"),</strike><u>&#8221;),</u>&#160;the Company may indemnify an Office Holder in respect of an obligation or expense specified below imposed on or incurred by the Office Holder in respect of an
              act performed in his capacity as an Office Holder, as follows: </div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 10.55pt; margin-left: 11pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a financial obligation imposed on him in favor of another person by a court judgment, including a compromise judgment
              or an arbitrator&#8217;s award approved by court;</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 10.3pt; margin-left: 11pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;reasonable litigation expenses, including attorney&#8217;s fees, incurred by the Office Holder as a result of an
              investigation or proceeding instituted against him by a competent authority which concluded without the filing of an indictment against him and without the imposition of any financial liability in lieu of criminal proceedings, or which
              concluded without the filing of an indictment against him but with the imposition of a financial liability in lieu of criminal proceedings concerning a criminal offense that does not require proof of criminal intent or in connection with a
              financial sanction (the phrases "proceeding concluded without the filing of an indictment" and "financial liability in lieu of criminal proceeding" shall have the meaning ascribed to such phrases in section 260(a)(1a) of the Companies Law);
              and</div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 10.3pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 25</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 83pt;"><br>
                  </td>
                  <td style="width: 36.45pt; vertical-align: top;">(iii)</td>
                  <td style="width: auto; vertical-align: top;">
                    <div>expenses, including reasonable litigation expenses and legal fees, incurred by an Office Holder in relation to a proceeding instituted against such Office Holder:</div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; margin-right: 10.6pt; margin-left: 11pt; line-height: 1.25;">(1) pursuant to the provisions of Chapter H'3 ("Imposition of Financial Sanctions by the Israeli Securities Authority") of the Securities Law, or (2)
              pursuant to the provisions of Chapter H'4 <strike>("</strike><u>(&#8220;</u>Imposition of Administrative Enforcement Measures by the Administrative Enforcement Committee<strike>")</strike><u>&#8221;)</u>&#160;of the Securities Law, or (3) pursuant to the
              provisions of Chapter I'1 <strike>("</strike><u>(&#8220;</u>Arrangement for the Avoidance of taking or Cessation of Proceedings, subject to Conditions<strike>")</strike><u>&#8221;)</u>&#160;of the Securities Law; and</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 10.5pt; margin-left: 11pt; line-height: 1.25;">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;reasonable litigation expenses, including attorneys&#8217; fees, expended by an Office Holder or charged to the Office
              Holder by a court, in a proceeding instituted against the Office Holder by the Company or on its behalf or by another person, or in a criminal charge from which the Office Holder was acquitted, or in a criminal proceeding in which the Office
              Holder was convicted of an offense that does not require proof of criminal intent; and</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 12.65pt; margin-left: 11pt; line-height: 1.25;">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Payment to an injured party, pursuant to section 52ND(a)(1)(a) of the Securities Law.</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 10.45pt; margin-left: 11pt; line-height: 1.25;">The Company may undertake to indemnify an Office Holder as aforesaid, (aa) prospectively, provided that, in respect of Article
              70(c)(i), the undertaking is limited to events which in the opinion of the Board of Directors are foreseeable in light of the Company&#8217;s actual operations when the undertaking to indemnify is given, and to an amount or criteria set by the
              Board of Directors as reasonable under the circumstances, and further provided that such events and amount or criteria are set forth in the undertaking to indemnify, and (bb) retroactively.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 10.55pt; margin-left: 11pt; line-height: 1.25;">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(1)&#160; Subject to the provisions of the Companies Law, the Company may enter into a contract for the insurance of all
              or part of the liability of any Office Holder imposed on the Office Holder in respect of an act performed in his capacity as an Office Holder, in respect of each of the following:</div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 83pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">(i)</td>
                  <td style="width: auto; vertical-align: top;">
                    <div>a breach of his duty of care to the Company or to another person;</div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 10.65pt; margin-left: 11pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a breach of his duty of loyalty to the Company, provided that the Office Holder acted in good faith and had
              reasonable cause to assume that such act would not prejudice the interests of the Company;</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 83pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">(iii)</td>
                  <td style="width: auto; vertical-align: top;">
                    <div>a financial obligation imposed on him in favor of another person.</div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 10.45pt; margin-left: 11pt; line-height: 1.25;">(2)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;without derogating from the aforementioned, subject to the provision of the Companies Law and the Securities Law, the
              Company may also enter into a contract to insure an Office Holder, in respect of each of the following:</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 10.6pt; margin-left: 11pt; line-height: 1.25;">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;expenses, including reasonable litigation expenses and legal fees, incurred by an Office Holder in relation to a
              proceeding instituted against such Office Holder:</div>
            <div style="text-align: justify; margin-right: 10.65pt; margin-left: 11pt; line-height: 1.25;">(1) pursuant to the provisions of Chapter H'3 ("Imposition of Financial Sanctions by the Israeli Securities Authority") of the Securities Law, or (2)
              pursuant to the provisions of Chapter H'4 ("Imposition of Administrative Enforcement Measures by the Administrative Enforcement Committee") of the Securities Law, or (3) pursuant to the provisions of Chapter I'1 ("Arrangement for the
              Avoidance of taking or Cessation of Proceedings, subject to Conditions") of the Securities Law; and</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 72pt; margin-right: 12.8pt; margin-left: 11pt; line-height: 1.25;">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;payment to an injured party, pursuant to section 52ND(a)(1)(a) of the Securities Law.</div>
            <br>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 10.45pt; margin-left: 11pt; line-height: 1.25;">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The provisions of Articles 70(a), 70(b) and 70(c) above are not intended, and shall not be interpreted, to restrict
              the Company in any manner in respect of the procurement of insurance and/or in respect of indemnification (i) in connection with any person who is not an Office Holder, including, without limitation, any employee, agent, consultant or
              contractor of the Company who is not an Office Holder, and/or (ii) in connection with any Office Holder to the extent that such insurance and/or indemnification is not specifically prohibited under law; provided that the procurement of any
              such insurance and/or the provision of any such indemnification shall be approved by the Audit Committee of the Company.</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 10.45pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 26</font></div>
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div style="line-height: 1.25;"><br style="line-height: 1.25;">
            </div>
            <div style="text-align: center; margin-right: 33.2pt; margin-left: 31.15pt; line-height: 1.25; font-weight: bold;">WINDING UP</div>
            <div style="line-height: 1.25">&#160;</div>
            <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                <tr>
                  <td style="width: 11pt;"><br>
                  </td>
                  <td style="width: 36pt; vertical-align: top;">71.</td>
                  <td style="width: auto; vertical-align: top;">
                    <div><u>Winding Up</u></div>
                  </td>
                </tr>

            </table>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 10.55pt; margin-left: 11pt; line-height: 1.25;">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;A resolution adopted in a General Meeting approved by <strike>[</strike>75<strike>%]</strike><u>%</u>&#160;of
              the voting shares represented at such meeting in person or by proxy is required to approve the winding up of the Company.</div>
            <div style="line-height: 1.25">&#160;</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 10.45pt; margin-left: 11pt; line-height: 1.25;">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If the Company be wound up, then, subject to applicable law and to the rights of the holders of shares with special
              rights upon winding up, the assets of the Company available for distribution among the <strike>members</strike><u>shareholders</u>&#160;shall be distributed to them in proportion to the nominal value of their respective holdings of the shares in
              respect of which such distribution is being made.</div>
            <div style="text-align: justify; text-indent: 36pt; margin-right: 10.45pt; margin-left: 11pt; line-height: 1.25;"> <br>
            </div>
            <div style="line-height: 1.25; text-align: center;">&#160;<font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">A - 27</font></div>
            <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
              <div style="page-break-after: always;" class="BRPFPageBreak">
                <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
            </div>
            <div>
              <div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERAGON NETWORKS LTD.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">2024 EQUITY INCENTIVE PLAN</div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
                </div>
                <div style="text-align: center; line-height: 1.25; font-weight: bold;">__________________________</div>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z139d78386cb8408ba0039ea60314808a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">1.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>PURPOSE OF THE PLAN</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">This Equity Incentive Plan, as amended from time to time, shall be known as the Ceragon Networks Ltd. 2024 Equity Incentive Plan (the &#8220;<font style="font-weight: bold;">Plan</font>&#8221;).


                  The Plan is intended to provide an incentive to retain, in the employment or procurement of service or directorship of Ceragon Networks Ltd. (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;), and its worldwide Affiliates (as defined
                  below), persons of training, experience, and ability, to attract new employees, directors or consultants whose services are considered valuable, to encourage the sense of proprietorship of such persons, and to stimulate the active
                  interest of such persons in the development and financial success of the Company by providing them with opportunities to purchase shares in the Company pursuant to a Plan approved by the Board of Directors of the Company (the &#8220;<font style="font-weight: bold;">Board</font>&#8221;).</div>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zb2d5634398434d4188af3883597ee85c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">2.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>DEFINED TERMS</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-right: 18pt; margin-left: 36pt; line-height: 1.25;">For the purposes of the Plan, the following terms shall have the following meanings:</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-right: 4.7pt; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">102(b) Track Election&#8221;</font> means the right of the Company to prefer either the &#8220;Capital Gain Track&#8221; (as set
                  under Section 102(b)(2)/(3) of the Ordinance), or the &#8220;Ordinary Income Track&#8221; (as set under Section 102(b)(1) of the Ordinance), but subject to the provisions of Section 102(g) of the Ordinance.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Affiliate</font>&#8221; means, with respect to the Company, a Parent or a Subsidiary, provided that with respect to Israeli Participants
                  and 102 Options such entity must be an entity which (i) is a Controlling Person of the Company, or (ii) any entity for which the Company is a Controlling Person, or (iii) any entity that is controlled by the same Controlling Person of the
                  Company and such entity, provided however, that any affiliate must be an &#8220;employing company&#8221; within the meaning of such term in Section 102 of the Ordinance with respect to 102 Awards.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Articles of Association</font>&#8221; means the Articles of Association of the Company, as in effect from time to time.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Award</font>&#8221; means an Option or Share Award and/or any other Share-based award and/or other right or benefit granted to a
                  Participant under the Plan.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Award Agreement</font>&#8221; means a written agreement between the Company and the Participant evidencing the grant of an Award, in such
                  form as the Board or the Committee shall from time to time approve.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Change in Board Event</font>&#8221; shall mean any time at which individuals who, as of the date of adoption of this Plan by the Board
                  (the &#8220;<font style="font-weight: bold;">Effective Date</font>&#8221;), constitute the Board (the &#8220;<font style="font-weight: bold;">Incumbent Board</font>&#8221;) cease for any reason to constitute at least a majority of the Board; provided, however,
                  that any individual becoming a director subsequent to the Effective Date whose election, or nomination for election by the Company&#8217;s shareholders, was approved by a vote of at least a majority of the directors then comprising the
                  Incumbent Board shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened
                  election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents by or on behalf of a person other than the Board.</div>
                <div style="line-height: 1.25">&#160;</div>
              </div>
              <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                <div style="page-break-after: always;" class="BRPFPageBreak">
                  <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
              </div>
              <!--PROfilePageNumberReset%Num%2%B - %%-->
              <div><br>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;"> <br>
                </div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Companies Law</font>&#8221; shall mean the Israel Companies Law, 5759-1999, and the regulations promulgated thereunder, all as amended
                  from time to time.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Controlling Person</font>&#8221; shall have the meaning ascribed to such definition under section 102(a) of the Ordinance, as may be
                  amended from time to time.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Employee</font>&#8221; means any individual who is a common-law employee of the Company and the Affiliates and who is an &#8220;employee&#8221;
                  within the meaning of Section&#160;3401(c) of the Code (as defined below) and regulations issued thereunder. For the purposes of Section 102 of the Ordinance shall include an officer of the Company, but exclude a Controlling Person, as such
                  definition may be amended from time to time under the Ordinance.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Exchange Act</font>&#8221; shall mean the U.S. Securities Exchange Act of 1934, as amended, and all regulations, guidance and other
                  interpretative authority issued thereunder.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Expiration Date</font>&#8221; means, subject to the provisions of Sections 11 and 12 of the Plan, (a) with respect to an Option, the date
                  which is six (6) years from the &#8220;<font style="font-weight: bold;">Date of Grant</font>&#8221; (i.e., the date determined by the Board to be the effective date of grant of the Options, or, if the Board has not determined such effective date, the
                  date of the resolution of the Board approving the grant of such Options; provided, however, that the Date of Grant shall not occur prior to the date on which the Company has obtained all approvals required in connection with the grant of
                  such Options), or in the event of grant of ISOs, five (5) years from the Date of Grant in the case of an Option held by a Ten Percent Shareholder; and (b) with respect to a Share Award, the time on which such Share Award expires in
                  accordance with Sections 11 and 12 of the Plan.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Fair Market Value</font>&#8221; shall mean, as of any date, the value of a Share or other securities, property or rights as determined by
                  the Board, in its discretion, subject to the following: (i) if, on such date, the Shares are listed on any securities exchange, the average closing sales price per Share at which the Shares are principally traded &#160;during the thirty (30)
                  day calendar period preceding the subject date (utilizing all trading days during such 30 calendar day period), as reported in The Wall Street Journal or such other source as the Company deems reliable; (ii) if, on such date, the Shares
                  are then quoted in an over-the-counter market, the average of the closing bid and asked prices for the Shares in that market&#160;during the thirty (30) day calendar period preceding the subject date (utilizing all trading days during such 30
                  calendar day period), as reported in The Wall Street Journal or such other source as the Company deems reliable; or (iii) if, on such date, the Shares are not then listed on a securities exchange or quoted in an over-the-counter market,
                  or in case of any other securities, property or rights, such value as the Board, in its sole discretion, shall determine, with full authority to determine the method for making such determination and which determination shall be
                  conclusive and binding on all parties, and shall be made after such consultations with outside legal, accounting and other experts as the Board may deem advisable; provided, however, that, if applicable, the Fair Market Value of the
                  Shares shall be determined in a manner that is intended to satisfy the applicable requirements of and subject to Section 409A of the Code, and with respect to Incentive Stock Options, in a manner that is intended to satisfy the applicable
                  requirements of and subject to Section 422 of the Code. The Board shall maintain a written record of its method of determining such value. If the Shares are listed or quoted on more than one established stock exchange or over-the-counter
                  market, the Board shall determine which is the principal exchange or market and utilize the price of the Shares on that exchange or market (determined as per the method described in clauses (i) or (ii) above, as applicable) for the
                  purpose of determining Fair Market Value.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Israeli Participants</font>&#8221; means Participants who are residents of the State of Israel or those who are deemed to be residents of
                  the State of Israel for purposes of the payment of tax.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Option(s)</font>&#8221; means option(s) to purchase Shares granted hereunder.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 2</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;"> <br>
                </div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Parent</font>&#8221; means any corporation (other than the Company) in an unbroken chain of corporations ending with the Company, if each
                  of the corporations other than the Company owns stock possessing a controlling interest in one of the other corporations in such chain. A corporation that attains the status of a Parent on a date after the adoption of the Plan shall be
                  considered a Parent commencing as of such date.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Participant</font>&#8221; means a person or entity to whom Awards are granted. Notwithstanding the foregoing, unless otherwise determined
                  by the Committee, each Participant shall be an &#8220;employee&#8221; as defined in the General Instructions to Form S-8 Registration Statement under the Securities Act (or any successor form thereto) at the time the Award is granted to the
                  Participant.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Restricted Share(s)</font>&#8221;&#8211; means a Share subject to certain restrictions, subject to the provisions of this Plan and the
                  applicable Award Agreement.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Restricted Share Unit(s)</font>&#8221;&#8211; means a contingent right to be issued one Share upon the applicable vesting date, subject to the
                  provisions of this Plan and the applicable Award Agreement.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Service</font>&#8221; means a Participant&#8217;s employment or engagement by or provision of services to the Company or an Affiliate,
                  including without limitation in the capacity of a director or an officer. Service shall be deemed terminated upon the effective date of termination of the employment/engagement relationship. A Participant&#8217;s Service shall not be deemed
                  terminated or interrupted solely as a result of a change in the capacity in which the Participant renders Service to the Company or an Affiliate (i.e., as an employee, officer, director, consultant, etc.); nor shall it be deemed
                  terminated or interrupted due solely to a change in the identity of the specific entity (out of the Company and its Affiliates) to which the Participant renders such Service, provided that there is no actual interruption or termination of
                  the continuous provision by the Participant of such Service to any of the Company and its Affiliates. Furthermore, a Participant&#8217;s Service with the Company or an Affiliate shall not be deemed terminated or interrupted as a result of any
                  paid vacation, sick leave, paid maternity leave, infant care leave, medical emergency leave, military reserve duty, or other bona fide leave of absence taken by the Participant and approved by the Company or such Affiliate by which the
                  Participant is employed or engaged, as applicable; <font style="font-style: italic;">provided, however</font>, that if any such leave exceeds three (3) months, then on the first (1st) day following such three (3)-month period of such
                  leave the Participant&#8217;s Service shall be deemed to have terminated unless the Participant&#8217;s right to return to Service with the Company or such Affiliate is secured by statute or contract. Notwithstanding the foregoing, unless otherwise
                  designated by the Company or any Affiliate, as the case may be, or required by law, time spent in &#8220;leave of absence&#8221; (whether paid or unpaid) shall not be treated as time spent providing Service for the purposes of calculating accrued
                  vesting rights under the vesting schedule of the Awards. Without derogating from the aforesaid, the Service of a Participant to an Affiliate shall also be deemed terminated in the event that such Affiliate for which the Participant
                  performs Service ceases to fall within the definition of a &#8220;Affiliate&#8221; under this Plan, effective as of the date said Affiliate ceases to be such. In all other cases in which any doubt may arise regarding the termination of a
                  Participant&#8217;s Service or the effective date of such termination, or the implications of absence from Service on vesting, the Board or Committee, in its discretion, shall determine whether the Participant&#8217;s Service has terminated and the
                  effective date of such termination and the implications, if any, on vesting.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Shares</font>&#8221; means Ordinary Shares of the Company, par value NIS 0.01 per share.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Share Award</font>&#8221; means the issuance of a Share, Restricted Share or Restricted Share Unit to a Participant, subject to the
                  provisions of this Plan and the applicable Award Agreement.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 3</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;"> <br>
                </div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">Subsidiary</font>&#8221; means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company,
                  if each of the corporations other than the last corporation in the unbroken chain owns stock possessing a controlling interest in one of the other corporations in such chain. A corporation that attains the status of a Subsidiary on a date
                  after the adoption of the Plan shall be considered a Subsidiary commencing as of such date.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.45pt; line-height: 1.25;">&#8220;<font style="font-weight: bold;">US Participants</font>&#8221; means Participants who are residents of the United States or those who are deemed to be residents of the
                  United States for purposes of the payment of tax.</div>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="ze54fa8d786e2401eb45424200f3a5293" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">3.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>RESERVED SHARES</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zb653e889fcef4568ae22c104f41f89cf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">3.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The Company has reserved sufficient authorized but unissued Shares for purposes of the Plan, subject to adjustment as provided in Sections 11 and 17 of the Plan. The aggregate number of Shares that may be issued under the Plan
                          upon the exercise of ISOs (as defined below) shall not exceed the Authorized Share Limit (as amended from time to time and as adjusted pursuant to Sections 11 and 17).</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zc46ffecbd10a435f9024f443886ebe1c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">3.2</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Notwithstanding the aforesaid, in the event that any outstanding Awards granted hereunder shall for any reason expire or be canceled prior to its exercise or relinquishment in full, such number of expired or terminated Awards
                          shall automatically increase the number of Shares available for allocation hereunder, and such increase shall not be deemed as amendment to this Plan. In addition, any Shares which are retained by the Company upon exercise of an
                          Award in order to satisfy the exercise or purchase price for such Award or any withholding taxes due with respect to such exercise or purchase (including for example when effecting a "Net Exercise") shall be treated as not issued
                          and shall continue to be available under the Plan. The Shares shall bear such rights and restrictions as set forth under the Articles of Association, as currently in effect and as may from time to time be amended or replaced in
                          accordance with applicable law, without the consent of any Participants (notwithstanding anything else here to the contrary). Any Shares which may remain unissued, and which are not subject to outstanding Awards at the termination
                          of the Plan shall cease to be reserved for the purpose of the Plan, but until termination of the Plan the Company shall at all times reserve a sufficient number of Shares to meet the requirements of the Plan. Should any Award for
                          any reason expire or be canceled prior to its exercise or relinquishment in full, the Shares therefore subject to such Award may again be subjected to an Award under the Plan.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z44790a4711ef46f9a99cae1d915e2f86" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">3.3</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Awards granted hereunder to US Participants may or may not contain such terms as will qualify such Awards as &#8220;incentive stock options&#8221; (&#8220;<font style="font-weight: bold;">ISOs</font>&#8221;) within the meaning of Section 422(b) of the
                          United States Internal Revenue Code of 1986, as amended (the &#8220;<font style="font-weight: bold;">Code</font>&#8221;). Awards that do not contain terms that will qualify them as ISOs shall be referred to herein as &#8220;non-qualified stock
                          options&#8221; (&#8220;<font style="font-weight: bold;">NQSOs</font>&#8221;). Each Award Agreement shall state whether such Award will or will not be treated as an ISO. Any ISO granted under this Plan shall contain such terms and conditions,
                          consistent with this Plan, as the Company may determine to be necessary to qualify such Award as an &#8220;incentive stock option&#8221; under Section 422 of the Code and no ISO shall be granted unless such Award, when granted, qualifies as
                          an &#8220;incentive stock option&#8221; under Section 422 of the Code. Any ISO granted under the Plan may be modified by the Company to disqualify such Award from treatment as an &#8220;incentive stock option&#8221; under Section 422 of the Code.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 4</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="z742ab8e85c9740dd9a7faa29007118d3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">3.4</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Awards granted hereunder to Israeli Participants may or may not contain such terms as will qualify such Awards for the special tax treatment under Section 102(b) of the Israeli Tax Ordinance (New Version), 5721-1961, as amended
                          (the &#8220;<font style="font-weight: bold;">Ordinance</font>&#8221;), and the Income Tax Rules (Tax Benefits in Share Issuances to Employees) 5763-2003 (the &#8220;<font style="font-weight: bold;">Rules</font>&#8221;) (&#8220;<font style="font-weight: bold;">102



                            Awards</font>&#8221;) and may be granted in one of the following tax tracks, subject to any applicable restrictions and limitations as provided in applicable law regarding the eligibility of Israeli Participants to each of the
                          following tax tracks, based on their relationship towards the Company:</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zbddf8be86d7045b28d7dde4dd4af9010" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 36pt; vertical-align: top;">(a)</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>&#8220;<font style="font-weight: bold;">102(b) Award</font>&#8221; &#8211; an Award granted through a trustee and intended to qualify, under the provisions of Section 102(b) of the Ordinance, as either &#8220;<font style="font-weight: bold;">Capital
                            Gain Award</font>&#8221; for the special tax treatment under Section 102(b)(2)/(3) of the Ordinance pursuant to which income resulting from the sale of shares derived from Capital Gain Awards is taxed as capital gain, or &#8220;<font style="font-weight: bold;">Ordinary Income Award</font>&#8221; for the special tax treatment under Section 102(b)(1) of the Ordinance pursuant to which income resulting from the sale of shares derived from Ordinary Income Awards is
                          taxed as ordinary income.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="ze7fb7a7e00924ef2a847ebeb1aec1934" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 36pt; vertical-align: top;">(b)</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>&#8220;<font style="font-weight: bold;">Other 102 Award</font>&#8221; &#8211; an Award granted under the terms of Section 102 of the Ordinance, excluding Section 102(b) Awards.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z17c7d6a1273745f69b5a83498ca1322e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 36pt; vertical-align: top;">(c)</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>&#8220;<font style="font-weight: bold;">3(i) Award</font>&#8221; &#8211; an Award granted under the terms of Section 3(i) of the Ordinance to persons which do not qualify as &#8220;employees&#8221; under the provisions of Section 102 of the Ordinance.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zf1254c211a394941b538916e46a34ff1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">3.5</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>This Plan contemplates issuances to Participants in various jurisdictions and under various tax regimes with respect to which the Board or the Committee (as defined below) is empowered, but is not required, to make the
                          requisite adjustments in this Plan and set forth the relevant conditions in a Sub-Plan to this Plan or in the Company&#8217;s agreement with the Participant in order to comply with the requirements of such other tax regimes. Awards
                          granted to non-Israeli and non US Participants, shall be granted in accordance with the applicable laws of each Participant&#8217;s nationality state and/or in accordance with the terms and conditions set forth in its respective Award
                          Agreement as prescribed by the Board or the Committee.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z09eb0c5616a44f8a91764e31e57ae950" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">3.6</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>With respect to 102 Awards, if and to the extent any action or the exercise or application of any provision hereof or authority granted hereby is conditioned or subject to obtaining a ruling or tax determination from the
                          Israeli Tax Authority (&#8220;<font style="font-weight: bold;">ITA</font>&#8221;), to the extent required by applicable law, then the taking of any such action or the exercise or application of such section or authority with respect to 102
                          Awards shall be conditioned upon obtaining such ruling or tax determination, and, if obtained, shall be subject to any condition set forth therein; it being clarified that there is no obligation to apply for any such ruling or tax
                          determination (which shall be in the sole discretion of the Committee) and no assurance is made that if applied any such ruling or tax determination will be obtained (or the conditions thereof).</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z49bab2ad257346ccb01e617c55ac6efa" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">4.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>ADMINISTRATION OF THE PLAN</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z833156e3e06e463598afdfe4ad4c0d33" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">4.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>To the extent permitted under applicable law, the Company&#8217;s Articles of Association and any other governing document of the Company, this Plan shall be administered by a committee established or appointed by the Board (the &#8220;<font style="font-weight: bold;">Committee</font>&#8221;). In the event that the Board does not appoint or establish a committee to administer this Plan, or if otherwise required by applicable law, this Plan shall be administered by the
                          Board. In the event that an action necessary for the administration of this Plan is required under applicable law to be taken by the Board without the right of delegation, or if such action or power was explicitly reserved by the
                          Board in appointing, establishing, and empowering the Committee, then such action shall be so taken by the Board. Even if such a Committee was appointed or established, the Board may take any actions that are stated to be vested
                          in the Committee, and shall not be restricted or limited from exercising all rights, powers and authorities under this Plan or applicable law. All references herein to the Committee shall be construed as references to the Board to
                          the extent that the Board is administering the Plan or otherwise taking any actions that are stated to be vested in the Committee. Subject to applicable laws, any member of such Committee shall be eligible to receive Awards under
                          the Plan while serving on the Committee, unless otherwise specified herein.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 5</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="z48e27b50f4aa46088db5fa1c6ac58aef" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">4.2</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Subject to the provisions of applicable law and the Articles of Association, the Board or the Committee shall have full power and authority to (i) designate participants in the Plan; (ii) approve the form(s) of agreement(s)
                          used under the Plan; (iii) determine the terms and provisions of respective Award Agreements (which need not be identical) including, but not limited to, the number of Shares to be covered by each Award, the vesting schedule, any
                          restrictions, provisions concerning the time or times when, and the extent to which, the Awards may be exercised, the payment method, the method for satisfaction of any tax withholding obligation arising in connection with the
                          Awards or such Shares, or other terms and conditions of the Award; (iv) modify or amend any terms of the Awards, taking into account market best practices and ISS policy guidelines including without limitation, the exercise period
                          (including extending the time for exercising any Option, but not beyond the original ten-year term), vesting schedule (including the acceleration of the right of a Participant to exercise, in whole or in part, any previously
                          granted Award) and the exercise price (provided that discounts, if any, may be mitigated by performance criteria); (v) determine the Fair Market Value of the Shares in accordance with Section 2 above; (vi) designate the specific
                          tax classification of the Awards, including as Ordinary Income Awards, as Capital Gain Awards, as Other 102 Awards, as 3(i) Awards, as ISOs or as NQSO; (vii) interpret the provisions and supervise the administration of the Plan;
                          (viii) amend the Plan from time to time in order to qualify for tax benefits applicable under U.S. and Israel laws; (ix) adopt and administer sub-plans, including without limitation the determination, if the Board sees fit to so
                          determine, that to the extent any terms of such sub-plan are inconsistent with the terms of this Plan, the terms of such sub-plan shall prevail; (x) make a 102(b) Track Election (subject to the limitations set under Section 102(g)
                          of the Ordinance); (xi) in order to fulfill the purposes of the Plan and without amending the Plan, to modify grants of Awards to Participants who are foreign nationals or employed outside of the United States of America or the
                          State of Israel in order to recognize differences in local law, tax policies, or customs; and (xii) determine any other matter which is necessary or desirable for, or incidental to administration of the Plan. In determining the
                          number of Shares covered by the Awards to be granted to each recipient, the Board or the Committee may consider, among other things, the nature of services provided by the recipient, the recipient&#8217;s salary and/or duration of his
                          service or employment by the Company.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zb9f1f9b29c474698abf4a47c41dc5a01" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">4.3</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Subject to the provisions of the Articles of Association, all decisions and selections made by the Board or the Committee pursuant to the provisions of the Plan shall be made by a majority of its members except that no member
                          of the Board or the Committee shall vote on, or be counted for quorum purposes, with respect to any proposed action of the Board or the Committee relating to any Award to be granted to that member. Any decision reduced to writing
                          and signed by all of the members who are authorized to make such decision shall be fully effective as if it had been made by a majority at a meeting duly held.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z8f5f236cd9c044a59f2c513f624e7f64" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">4.4</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The interpretation and construction by the Committee of any provision of the Plan or of any Award thereunder shall be final and conclusive unless otherwise determined by the Board.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z0a4320e2d1b54eb296649d39d3ca2b43" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">4.5</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Subject to the provisions of applicable law and the Articles of Association, each member of the Board or the Committee may be indemnified and held harmless by the Company against any cost or expense (including counsel fees)
                          reasonably incurred by him, or any liability (including any sum paid in settlement of a claim with the approval of the Company) arising out of any act or omission to act in connection with the Plan unless arising out of such
                          member&#8217;s own fraud or bad faith, to the extent permitted by applicable law, and in such amounts and subject to such conditions, as may be decided by the Board. Such indemnification, if applicable, shall be in addition to any
                          rights of indemnification the member may have as a director or otherwise under the Articles of Association, any agreement, any vote of shareholders or disinterested directors, insurance policy or otherwise.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 6</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="zaf74276e71f94048be2bdc9e4d01e58d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">5.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>DESIGNATION OF PARTICIPANTS</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z47bb852781914c2abb58189a73569aed" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">5.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The persons eligible for participation in the Plan as recipients of Awards shall include any employees, officers, directors and consultants of the Company or of any Affiliate of the Company provided however, that a US employee
                          or consultant shall not be eligible to receive&#160;ISOs or NQSO hereunder unless such employee or consultant is a natural person, renders bona fide services to the Company or any&#160;Affiliate,&#160;and such services are not in connection with
                          the offer or sale of securities in a capital raising transaction and do not directly or indirectly promote or maintain a market for the Company&#8217;s securities. The grant of an Award hereunder shall neither entitle the recipient
                          thereof to participate nor disqualify him from participating in, any other grant of Awards pursuant to this Plan or any other equity incentive plan of the Company or any of its affiliates. Notwithstanding any provisions to the
                          contrary herein, no ISO shall be granted to any individual otherwise eligible to participate in the Plan who is not an Employee of the Company or any Affiliate, on the date of granting of such ISO. No 102 Awards shall be granted
                          to any individual who is not an Employee of the Company or of an Affiliate of the Company, or who otherwise would not qualify as an &#8220;employee&#8221; under Section 102(a) of the Ordinance.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="ze3781eb5467346749eb42218406dedc3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">6.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>TRUSTEE FOR 102(B) AWARDS</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z0439a2e16863470ba671c0816290cda7" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">6.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The 102(b) Awards which shall be granted to Participants and/or any Shares issued upon exercise of any Options and/or any other Shares received subsequently following any realization of rights resulting from a 102(b) Award or
                          rights resulting from Shares issued upon exercise of a 102(b) Award, shall be issued to a Trustee nominated by the Board and approved in accordance with the provisions of Section 102 of the Ordinance (the &#8220;<font style="font-weight: bold;">Trustee</font>&#8221;). The Board shall determine and approve the terms of engagement of the Trustee, and shall be authorized to designate from time to time a new Trustee and replace either of them at its
                          sole discretion, and in the event of replacement of any existing Trustee, to instruct the transfer of all Awards and Shares held by such Trustee at such time to its successor. The 102(b) Awards and/or any Shares issued upon
                          exercise of any Options will be held by the Trustee for the benefit of the Participants for a period of not less than the minimum period permitted by applicable law without disqualifying such 102(b) Awards from treatment under
                          Section 102(b) of the Ordinance. The Trustee will hold such Awards or Shares resulting from the exercise thereof in accordance with the provisions of the Ordinance and the Rules promulgated thereunder, the trust agreement and any
                          other instructions the Board may issue to him/it from time to time (so long as they do not contradict the Ordinance and the Rules promulgated thereunder). Thereafter, the Trustee will transfer the Awards or the Shares, as the case
                          may be, to the Participant upon his/her demand, subject to any deduction or withholding required under the Ordinance, the Rules, or any other applicable law.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z69151252a9d04f25b2843c6d5a3cbf37" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">6.2</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Anything to the contrary notwithstanding, the Trustee shall not release any 102(b) Awards which were not already exercised into Shares by the Participant or release any Shares issued upon exercise of such Awards prior to the
                          full payment of the Participant&#8217;s tax liabilities arising from such Awards which were granted to him and/or any Shares issued upon exercise of such Awards.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zd92ed5164ef6463bb73d75e7d8702d33" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">6.3</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Upon receipt of a 102(b) Award, the Participant will sign an Award Agreement which shall be deemed as Participant&#8217;s undertaking to exempt the Trustee from any liability in respect of any action or decision duly taken and bona
                          fide executed in relation with the Plan, or any Award or Share granted to him thereunder.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zfcc1460141944d76b6b72c08e435d3c3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">6.4</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Subject to applicable law, the Board shall be entitled to revise, amend or replace the terms of the trust agreement with the Trustee, to the extent that same (i) do not adversely affect any rights of Participant under any valid
                          and outstanding Award, which are expressly provided for in the respective Award Agreement with such Participant, or (ii) is necessary or desirable in the light of any change or replacement of Section 102 of the Ordinance.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 7</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="z01872a9336cd430480ca70e86ed1128e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">6.5</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Any and all rights resulting from the 102(b) Awards and/or any Shares issued upon exercise of such Awards and/or any other Shares received subsequently following any realization of rights resulting from a 102(b) Award, shall be
                          issued or distributed, as the case may be, to the Trustee and held thereby. Such rights will not be sold or transferred until the lapse of the minimum period permitted by applicable law, and such rights shall be subject to the
                          taxation track which is applicable to such Share Awards or Shares issued pursuant to the exercise of Options hereunder. Notwithstanding the aforesaid, Shares issued pursuant to the exercise of 102(b) Awards hereunder or rights
                          resulting from such 102(b) Awards may be sold or transferred, and the Trustee may release such Shares issued pursuant to the exercise of Options (or Share Awards) or rights from trust, prior to the lapse of the minimum period
                          permitted by applicable law, provided however, that tax is paid or withheld in accordance with Section 102 of the Ordinance and/or Section 7 of the Rules, and/or any other provision in any other section of the Ordinance and any
                          regulation, ruling, procedure and clarification promulgated thereunder, that will be relevant, from time to time.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="za8c9c33eb7ca4029935a3c750777aa36" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">6.6</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Each Award Agreement evidencing 102(b) Awards shall include (i) an approval and acknowledgment by the Participant of the agreement of the Company with the Trustee (as may be amended from time to time), (ii) a declaration that
                          the Participant is familiar with the provisions of Section 102 and the &#8220;Capital Gain Track&#8221; (if applicable) and (iii) an undertaking not to sell or transfer the Share Awards and/or the Shares issued pursuant to the exercise of
                          Options prior to the lapse of the period in which the Options and/or such Shares are held in trust, unless the Participant pays all taxes, which may arise in connection with such sale and/or transfer (as provided in Section 6.5
                          above). Notwithstanding the above, if any such sale or transfer occurs during the restricted period, the sanctions under Section 102 of the Ordinance and under any rules or regulation or orders or procedures promulgated thereunder
                          shall apply to and shall be borne by such Participant.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z1daed9187283446cba7647ee6d8ff812" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">7.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>GRANT OF OPTIONS</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z434482364ac14eee837c82127d6ae3cf" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">7.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Each Award Agreement shall state a number of the Shares to which the Option relates and the type of Option granted thereunder (an Ordinary Income Award, Capital Gain Award, Other 102 Award, a 3(i) Award, an ISO, an NQSO, a
                          generally nonqualified option or other type of Award as applicable), the exercise price per Share, the vesting schedule to which such Option shall become exercisable the Expiration Date (as defined below), the exercise period, and
                          may include other terms as determined by the Board. US Participants shall be eligible only for grants of ISOs and/or NQSOs. Notwithstanding any other provision of the Plan, the aggregate Fair Market Value (determined as of the
                          date an ISO is granted) of the Shares with respect to which ISOs are exercisable for the first time by a Participant during any calendar year (under the Plan and any other &#8220;incentive stock option&#8221; plans of the Company or any
                          Affiliates shall not exceed $100,000 (or such other amount as may be prescribed by the Code from time to time); <font style="font-style: italic;">provided, however</font>, that if the exercisability or vesting of an ISO is
                          accelerated as permitted under the provisions of this Plan and such acceleration would result in a violation of the limit imposed by this Section 7.1, such acceleration shall be of full force and effect but the number of Shares
                          that exceed such limit shall be treated as having been granted pursuant to a NQSO; and provided, further, that the limits imposed by this Section 7.1 shall be applied to all outstanding ISOs (under the Plan and any other
                          &#8220;incentive stock option&#8221; plans of the Company or any Affiliates in chronological order according to the dates of grant. In the event a Participant receives an Option intended to be an ISO which is subsequently determined not to
                          comply with the requirements of the Code for ISOs, the Option shall be amended, if necessary, in accordance with the Code and applicable Treasury Regulations and rulings to preserve, as the first priority, to the maximum possible
                          extent, the status of the Option as an ISO and to preserve, to the maximum possible extent, the number of Shares subject to the Option. Options may be granted at any time after this Plan has been approved by the Company, subject
                          to any further shareholder approval required under Section 102 of the Ordinance or the Rules, in case of 102(b) Awards, or of the U.S. Treasury, in case of ISOs and other applicable law.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 8</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="z969eff59782d40238452a9125c6d3f89" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">7.2</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The exercise price of each Share subject to a new Option to be granted or any portion thereof shall be determined by the Board or the Committee in its sole and absolute discretion in accordance with applicable law, subject to
                          any guidelines as may be determined by the Board from time to time. The exercise price per Share covered by each ISO and NQSO shall be not less than 100% of the Fair Market Value of the Company&#8217;s shares on the date the Option is
                          granted; provided, however, that no ISO shall be granted to an individual otherwise eligible to participate in the Plan who owns (within the meaning of Section 424(d) of the Code), at the time the Option is granted, more than ten
                          percent (10%) of the total combined voting power of all classes of shares of the Company or any Affiliates (a&#160; &#8220;<font style="font-weight: bold;">Ten Percent Shareholder</font>&#8221;), unless, at the time such ISO is granted, the
                          exercise price per Share subject to the Option is at least 110% of the Fair Market Value of a Share on the date such ISO is granted, and the ISO by its terms is not exercisable after the expiration of five (5) years from such date
                          of grant.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zb8359e16e0a4440a9e454eca283d9936" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">7.3</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Options shall be exercised by the Participant (a) by way of an exercise order submitted via the online service operated and maintained by the Company or any of its service providers, or (b) or in any other manner as the
                          Committee shall prescribe from time to time. The notice shall specify the number of Shares with respect to which the Option is being exercised and shall include such other representations and agreements as required by the Company.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z4a880fdd1d0f45c584f53fba5c0829a1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">7.4</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The exercise price shall be paid in full with respect to each Share, at the time of exercise and as a condition therefor, either (i) in cash, (ii) if the Company&#8217;s shares are listed for trading on any securities exchange or
                          over-the-counter market, and if the Committee so determines, all or part of the exercise price and any withholding taxes may be paid by the delivery (on a form prescribed by the Company) of an irrevocable direction to a securities
                          broker approved by the Company to sell Shares and to deliver all or part of the sales proceeds to the Company or the Trustee, (iii) to the extent applicable, by applying the Net Exercise mechanism set forth in Section 7.5 below,
                          or (iv) in such other manner as the Committee shall determine, which may include procedures for cashless exercise. The application of Net Exercise mechanism with respect to any 102 Awards shall be subject to obtaining a ruling
                          from the ITA, to the extent required by applicable law.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z4e496d44e35c48c284a0c8abed1b452c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">7.5</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Notwithstanding the provisions of Sections 7.3 and 7.4 above, the Board or the Committee may determine (and, in the case of an ISO or a 102 Option, shall be determined at the time of grant) that in lieu of payment of the
                          exercise price in cash, the Participant may elect to receive Shares equal to the aggregate value of the Options (or the portion thereof being exercised) by written notice of such election to the Company, in which event the Company
                          shall issue to the Participant, for no additional consideration, that number of Shares computed using the following formula:&#160;</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zbe9fe8517ebc4fc0bacdb14768efb28b" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 33.23%; vertical-align: top;">
                        <div style="text-align: right; line-height: 1.25;">&#160;</div>
                      </td>
                      <td style="width: 8.21%; vertical-align: top;">
                        <div style="text-align: center; line-height: 1.25;">X =</div>
                      </td>
                      <td style="width: 14.84%; vertical-align: top; border-bottom: #000000 2px solid;">
                        <div style="text-align: center; line-height: 1.25;">Y (A &#8211; B)</div>
                      </td>
                      <td style="width: 8.74%; vertical-align: top;">
                        <div style="text-align: right; line-height: 1.25;">&#160;</div>
                      </td>
                      <td style="width: 8.74%; vertical-align: top;">
                        <div style="text-align: right; line-height: 1.25;">&#160;</div>
                      </td>
                      <td style="width: 8.74%; vertical-align: top;">
                        <div style="text-align: right; line-height: 1.25;">&#160;</div>
                      </td>
                      <td style="width: 8.74%; vertical-align: top;">
                        <div style="text-align: right; line-height: 1.25;">&#160;</div>
                      </td>
                      <td style="width: 8.74%; vertical-align: top;">
                        <div style="text-align: right; line-height: 1.25;">&#160;</div>
                      </td>
                    </tr>
                    <tr>
                      <td style="width: 33.23%; vertical-align: top;">
                        <div style="text-align: right; line-height: 1.25;">&#160;</div>
                      </td>
                      <td style="width: 8.21%; vertical-align: top;">&#160;</td>
                      <td style="width: 14.84%; vertical-align: top;">
                        <div style="text-align: center; line-height: 1.25;">A</div>
                      </td>
                      <td style="width: 8.74%; vertical-align: top;">
                        <div style="text-align: right; line-height: 1.25;">&#160;</div>
                      </td>
                      <td style="width: 8.74%; vertical-align: top;">
                        <div style="text-align: right; line-height: 1.25;">&#160;</div>
                      </td>
                      <td style="width: 8.74%; vertical-align: top;">
                        <div style="text-align: right; line-height: 1.25;">&#160;</div>
                      </td>
                      <td style="width: 8.74%; vertical-align: top;">
                        <div style="text-align: right; line-height: 1.25;">&#160;</div>
                      </td>
                      <td style="width: 8.74%; vertical-align: top;">
                        <div style="text-align: right; line-height: 1.25;">&#160;</div>
                      </td>
                    </tr>

                </table>
                <div style="margin-left: 31.5pt; line-height: 1.25;"> <br>
                </div>
                <div style="margin-left: 31.5pt; line-height: 1.25;">Where</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-indent: -36pt; margin-left: 108pt; line-height: 1.25;">X =&#160; &#160;The number of Shares to be issued to the Participant.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-indent: -36pt; margin-left: 108pt; line-height: 1.25;">Y =&#160; &#160;The number of Shares, as adjusted to the date of calculation, underlying the number of vested Options being exercised.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-indent: -36pt; margin-left: 108pt; line-height: 1.25;">A =&#160; &#160;The Fair Market Value of one (1) Share (on the exercise date).</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-indent: -36pt; margin-left: 108pt; line-height: 1.25;">B =&#160; &#160;The exercise price.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: -0.55pt; margin-left: 36pt; line-height: 1.25;">Upon the completion of the calculation, if X is a negative number, then X shall be deemed to equal 0 (zero). The Company shall comply with Section
                  304 of the Companies Law or otherwise collect the aggregate par value of the Shares upon exercise, in a manner prescribed the Board.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 9</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="z63eedc6283e747dfa9d0d66798f3ccef" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">7.6</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Vesting of Options may be time-based or performance-based, in the discretion of the Committee and the Board. Unless otherwise prescribed by the Committee or the Board and specified in the Award Agreement, (a) the Options shall
                          vest over a period of four (4) years (provided that in case of executives, the vesting commencement date shall not be earlier than 12 months prior to the Date of Grant) as follows: (i) 25% of the Shares underlying the Option shall
                          vest upon the lapse of twelve (12) months as of the Date of Grant of the Options, and (ii) the remaining 75% of the Shares underlying the Option shall thereafter vest over the following three (3) year-period, such that an equal
                          amount of such remaining Options, shall vest upon the lapse of each full three (3) months (in such three (3) years) (i.e. 100% of the Options will be vested after four (4) years, all provided that Participant continues to provide
                          Service to the Company at each vesting date). Without derogating from the foregoing, the Board shall have the exclusive authority to accelerate the periods for exercising an Option, or to initially include an acceleration
                          provision in an Award Agreement&#160; (including a &#8220;double trigger&#8221; acceleration).</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Options may be exercised by the Participant in whole at any time or in part from time to time, to the extent that the Options become vested and exercisable, prior
                  to the Expiration Date, and provided that, subject to the provisions of Section 11 below and unless the Board or Committee resolves otherwise, the Participant is providing Services to the Company or any of its Affiliates, at all times
                  during the period beginning with the granting of the Option and ending upon the date of exercise.</div>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="ze51b03bc08f241e0bbd9007cc28e715d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">8.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>RESTRICTED SHARE UNITS</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zbcff87b6b74b4cd0850456b489fb3682" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">8.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The Board or the Committee will determine to whom an offer will be made to purchase Restricted Share Units and the terms of such offer including the number of Restricted Share Units, the purchase price to be paid by the
                          Participant (if any), the type of Award granted thereunder (whether an Ordinary Income Award, Capital Gain Award, Other 102 Award or a 3(i) Award), the restrictions to which Restricted Share Units are subject, and all other terms
                          and conditions of the Share Award. The Restricted Share Units granted pursuant to the Plan, shall be evidenced by a written Award Agreement between the Company and the Participant, in such form as the Board or the Committee shall
                          from time to time approve.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z1b80fa44b48a4e25b5f99c451df2ccb2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">8.2</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Vesting of Restricted Share Units may be time-based or performance-based, in the discretion of the Committee and the Board. Unless otherwise prescribed by the Committee or the Board and specified in the Award Agreement, (a) the
                          Restricted Share Units shall vest over a period of four (4) years as follows: (i) 25% of the Shares underlying the Restricted Share Units shall vest upon the lapse of twelve (12) months as of the Date of Grant of the Restricted
                          Share Units, and (ii) the remaining 75% of the Shares underlying the Restricted Share Units shall thereafter vest over the following three (3) year-period, such that an equal amount of such remaining Restricted Share Units, shall
                          vest upon the lapse of each full three (3) months (in such three (3) years) (i.e. 100% of the Restricted Share Units will be vested after four (4) years, all provided that Participant continues to provide Service to the Company at
                          each vesting date). Without derogating from the foregoing, the Board shall have the exclusive authority to accelerate the periods for the settlement of Restricted Share Units, or to initially include an acceleration provision in
                          an Award Agreement (including a &#8220;double trigger&#8221; acceleration).</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z2225926dab7a4a25b77925aa0a64b4b2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">8.3</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Restricted Share Units may be granted at any time after this Plan has been approved by the Company, subject to any further approval or consent required under Section 102 of the Ordinance or the Rules, in case of 102(b) Awards.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 10</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="zd15f19533aab490c8ffe352066377b0b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">8.4</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The Participant shall not possess or own any ownership rights in the Shares underlying the Restricted Share Units and no rights as a shareholder shall exist prior to the actual issuance of Shares in the name of the Participant.
                          Following vesting of the Restricted Share Units, the Company shall issue Shares within reasonable time in the name of the Participant, subject to compliance with applicable law and payment of any tax liability associated with such
                          issuance. The issuance of Shares upon vesting shall be subject to the payment of the par value of the Shares by the Participant (or otherwise compliance with Section 304 of the Companies Law).</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zc32d0ea5a3594bf78d8753669af268d6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">8.5</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Notwithstanding anything to the contrary set forth herein, any Restricted Share Units granted under this Plan that are not exempt from the requirements of Section&#160; 409A of the Code shall contain such restrictions or other
                          provisions so that such Restricted Share Units will comply with the requirements of Section 409A of the Code, if applicable to the Participant. Such restrictions, if any, shall be determined by the Committee and contained in the
                          Award Agreement evidencing such Restricted Share Units.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z55f0f1bc61f0464f8d4df4b7ede0f406" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">9.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>RESTRICTED SHARES</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z687dee170d464b09bc57325d82f44a66" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">9.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The Board or the Committee will determine to whom an offer will be made to purchase Restricted Shares and the terms of such offer including the number of Restricted Shares, the purchase price to be paid by the Participant (if
                          any), the type of Award granted thereunder (whether an Ordinary Income Award, Capital Gain Award, Other 102 Award or a 3(i) Award), the restrictions to which Restricted Shares are subject, and all other terms and conditions of the
                          Share Award, subject to the following terms and conditions. The Restricted Shares granted pursuant to the Plan, shall be evidenced by a written Award Agreement between the Company and the Participant, in such form as the Board or
                          the Committee shall from time to time approve.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z04857c63106f4992bf1a68897b4cd96c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">9.2</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Share Awards may be granted at any time after this Plan has been approved by the Company, subject to any further approval or consent required under Section 102 of the Ordinance or the Rules, in case of 102(b) Awards.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z7d26eb543d1a40d38f8ae6ba9e03b3d4" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">9.3</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Beginning on the Date of Grant and subject to the execution of an Award Agreement and the payment of the purchase price for the Restricted Shares (if any), the Participant shall become a shareholder of the Company with respect
                          to all Restricted Shares and shall have all of the rights of a shareholder, including the right to receive distributions made with respect to such shares, including regular cash dividends (except as otherwise provided by the
                          Board); provided, however, that in the absence of a Board action to the contrary, any Shares or any other property (other than regular cash distributions) distributed as a dividend or otherwise with respect to any Restricted
                          Shares as to which the restrictions have not yet lapsed shall be subject to the same restrictions as the shares covered by such Restricted Shares, as further detailed in the applicable Award Agreement. The issuance of Restricted
                          Shares shall be subject to the payment of the par value of the Restricted Shares by the Participant (or otherwise compliance with Section 304 of the Companies Law).</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z83baf5ef90c3438a90e88f51353fbf5d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">9.4</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The Participant shall not be permitted to transfer, sell, pledge, or otherwise dispose of Restricted Shares granted under the Plan prior to the lapse of the restrictions as detailed in the Award Agreement (the &#8220;<font style="font-weight: bold;">Restriction Period</font>&#8221;). If the Restriction Period expires without a prior forfeiture of the Restricted Shares, certificates for Shares attributable to such Restricted Shares shall be delivered to
                          the Participant (or, if certificates were previously issued, replacement certificates shall be delivered upon return of the previously issued certificates). All legends shall be removed from said certificates at the time of
                          delivery to the Participant, except as otherwise required by applicable law, applicable agreements to which the Participant is bound, or other limitations imposed by the Board. Notwithstanding the foregoing, actual certificates
                          shall not be issued to the extent that book entry recordkeeping is used.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 11</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="z55cfd641efc24e5081d5a685ce2b67d3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">9.5</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Subject to such exceptions as may be determined by the Committee, if the Participant&#8217;s continuous Service to the Company or any Affiliate thereof shall terminate (for any reason prior to the expiration of the Restriction Period
                          of an Award or prior to the timely payment in full of the purchase price of any Restricted Shares), any Restricted Shares remaining subject to vesting or with respect to which the purchase price has not been paid in full, shall
                          thereupon be forfeited, transferred to, and redeemed, repurchased or cancelled by, as the case may be, in any manner as set forth in Section 12.3(i) through (v), subject to applicable law and the Participant shall have no further
                          rights with respect to such Restricted Shares.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z2f33fcdf5ac0424dafba2cd74f189f7d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">9.6</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Vesting of Restricted Shares may be time-based or performance-based, as described under Section 10 below, in the discretion of the Committee and the Board. Unless otherwise prescribed by the Committee or the Board and specified
                          in the Award Agreement, (a) the Restricted Shares shall vest over a period of four (4) years (provided that in case of executives, the vesting commencement date shall not be earlier than 12 months prior to the Date of Grant) as
                          follows: (i) 25% of the Restricted Shares shall vest upon the lapse of twelve (12) months as of the Date of Grant of the Restricted Shares, and (ii) the remaining 75% of the Restricted Shares shall thereafter vest over the
                          following three (3) year-period, such that an equal amount of such remaining Restricted Shares, shall vest upon the lapse of each full three (3) months (in such three (3) years) (i.e. 100% of the Restricted Shares will be vested
                          after four (4) years, all provided that Participant continues to provide Service to the Company at each vesting date). Notwithstanding, and unless otherwise prescribed by the Committee or the Board and specified in the Award
                          Agreement, Performance Based Awards shall vest over a period of four (4) years (provided that in case of executives, the vesting commencement date shall not be earlier than 12 months prior to the Date of Grant), on an annual
                          basis. Without derogating from the foregoing, the Board shall have the exclusive authority to accelerate the periods for exercising Restricted Shares, including Performance Based Awards, or to initially include an acceleration
                          provision in an Award Agreement (including a &#8220;double trigger&#8221; acceleration).</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zfe9181d24725488dbba4b292874bc74d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">10.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>PERFORMANCE BASED AWARDS</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z067f5bc4e08a408bb5ca64febd4f10a6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">10.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Subject to the sole and absolute discretion and determination of the Board, the Board may decide to grant Awards under the Plan, the vesting of which shall be conditional upon the performance of the Company and/or a division or
                          other business unit of the Company and/or upon the performance of the Participant, over such period and measured against such objective criteria as shall be determined by the Board and detailed in the Award Agreement (&#8220;<font style="font-weight: bold;">Performance Based Awards</font>&#8221;). In granting each Performance Based Award, the Board shall establish in writing the applicable performance period (&#8220;<font style="font-weight: bold;">Performance Period</font>&#8221;),


                          performance formula (&#8220;<font style="font-weight: bold;">Performance Formula</font>&#8221;) and one or more performance goals which, when measured at the end of the Performance Period, shall determine on the basis of said Performance
                          Formula the extent to which the Performance Based Awards have vested and become exercisable (collectively, the &#8220;<font style="font-weight: bold;">Performance Conditions</font>&#8221;). It is clarified that Performance Conditions may be
                          determined for an Award either in addition to, or in substitution for, a vesting schedule.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z360f01eccd964889b9e38b2d9563cd40" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">10.2</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>After a Performance Based Award has been granted, the Board may, in appropriate circumstances and subject to any other approval required in order to comply with mandatory law (for example, shareholders&#8217; approval), amend any
                          Performance Condition, at its sole and absolute discretion. Without derogating from the above, if the Board determines that a change in the business, operations, corporate structure or capital structure of the Company or the
                          manner in which the Company or an Affiliate conducts its business, or other events or circumstances render a Performance Condition to be unsuitable, the Board may modify such Performance Condition in whole or in part, as the Board
                          deems appropriate. If a Participant is promoted, demoted or transferred to a different business unit or function during a Performance Period, the Board may determine that the Performance Condition or Performance Period are no
                          longer appropriate and may: (i) adjust, change or eliminate the Performance Condition or the applicable Performance Period as it deems appropriate to make such conditions and period comparable to the initial conditions and period;
                          or (ii) make a cash payment to the Participant in an amount determined by the Board. Performance Conditions shall not be automatically waived merely due to an event of a Transaction (as defined below) or any other adjustment under
                          Section 11 below.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 12</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="zf4346423e2d74d16a160404314dc492e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">11.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>ADJUSTMENTS; CORPORATE TRANSACTIONS</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zad3f5ccd51644a4cbb62c3daed922c07" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">11.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Upon the occurrence of any of the following described events, any Awards granted under the Plan to Participants shall be adjusted as hereafter provided (and with respect to Shares held by the Participant&#8217;s the applicable
                          provisions below shall apply):</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z94e002e7f8db4cc2850c63a09963a3a9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">11.2</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>If the outstanding shares of the Company shall at any time be changed or exchanged by declaration of a share dividend, share split, consolidation of share capital, reclassification, combination or exchange of shares,
                          recapitalization, distribution of bonus shares, or any other like event of the Company, then in such event, then the Committee shall make, without the need for a consent of any holder of an Award, such adjustments as determined by
                          the Committee to be appropriate, in its discretion, in order to equitably adjust (i) the number and class of shares reserved and available for grants of Awards, (ii) the number and class of shares covered by outstanding Awards,
                          (iii) the exercise price per share covered by any Award, (iv) the terms and conditions concerning vesting and exercisability and the term and duration of the outstanding Awards, (v) the type or class of security, asset or right
                          underlying the Award (which need not be only that of the Company, and may be that of the surviving corporation or any affiliate thereof or such other entity party to any of the above transactions), and (vi) any other terms of the
                          Award that in the opinion of the Committee should be adjusted. Any fractional shares resulting from such adjustment shall be treated as determined by the Committee, and in the absence of such determination shall be rounded to the
                          nearest whole share, and the Company shall have no obligation to make any cash or other payment with respect to such fractional shares. No adjustment shall be made by reason of the distribution of subscription rights or rights
                          offering to outstanding shares or other issuance of shares by the Company unless the Committee determines otherwise. The adjustments determined pursuant to this Section 11.2 (including a determination that no adjustment is to be
                          made) shall be final, binding, and conclusive.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z66ed4bc7f6a745d482ee7cb700ac7f6d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">11.3</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Notwithstanding anything to the contrary included herein, and subject to applicable law and the applicable accounting standards, in the event of a distribution of cash dividend by the Company to all holders of Shares, the
                          Committee shall have the authority to determine, without the need for a consent of any holder of an Award, that the exercise price of any Award, which is outstanding and unexercised on the record date of such distribution, shall
                          be reduced by an amount equal to the per Share gross dividend amount distributed by the Company, and the Committee may determine that the exercise price following such reduction shall be not less than the par value of a Share (if
                          such Shares bear a par value), subject, in each case, to the approval of the Company&#8217;s shareholders. The application of this Section with respect to any 102 Awards shall be subject to obtaining a ruling from the ITA, to the extent
                          required by applicable law and subject to the terms and conditions of any such ruling.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 13</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="z725e644312d94d4fa301574a9d6112f1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">11.4</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Anything herein to the contrary notwithstanding, in the event of (i) a sale of all or substantially all of the assets of the Company, or a sale (including an exchange) of all or substantially all of the shares of the Company,
                          to any person, or a purchase by a shareholder of the Company or by an Affiliate of such shareholder, of all the shares of the Company held by all or substantially all other shareholders or by other shareholders who are not
                          Affiliated with such acquiring party; (ii) a merger (including, a reverse merger, a reverse triangular merger and a share swap), consolidation, amalgamation, reorganization or like transaction of the Company with or into another
                          corporation; (iii) a scheme of arrangement for the purpose of effecting such sale, merger, consolidation, amalgamation or other transaction; (iv) approval by the shareholders of the Company of a complete liquidation or dissolution
                          of the Company; (v) Change in Board Event; or (vi) such other transaction or set of circumstances that is determined by the Board, in its discretion, to be a transaction subject to the provisions of this Section 11.4, excluding
                          any of the foregoing transactions in clauses (i) through (iv) if the Board determines that such transaction should be excluded from the definition hereof and the applicability of this Section 11.4 (each of the foregoing
                          transactions, a &#8220;<font style="font-weight: bold;">Transaction</font>&#8221;), then, without derogating from the general authority and power of the Board or the Committee under this Plan, without the Participant&#8217;s consent and action and
                          without any prior notice requirement, the Committee may make, in its sole and absolute discretion, any determination as to the treatment of Awards, as provided herein:</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z49a5717556ae44eba69df3e1e921ae25" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 36pt; vertical-align: top;">11.4.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The surviving or the acquiring entity, as the case may be, or its respective parent company or subsidiary (the &#8220;<font style="font-weight: bold;">Successor Entity</font>&#8221;) in a Transaction may either assume the Company&#8217;s rights
                          and obligations under outstanding Awards or substitute the outstanding Awards, without the Participant&#8217;s consent and action and without any prior notice requirement. For purposes of this Section 11.4.1, the outstanding Awards
                          shall be deemed assumed or substituted by the Successor Entity if, following the consummation of the Transaction, the outstanding Awards confer the right to receive, for each share underlying any outstanding Awards immediately
                          prior to the consummation of the Transaction, the same consideration (whether shares, cash or other securities, rights or property) to which an existing holder of a Share on the effective date of consummation of the Transaction
                          was entitled; provided, however, that if the consideration to which such existing holder is entitled comprises of consideration other than or in addition to securities of the Successor Entity, then the Board may determine, with
                          the consent of the Successor Entity, that the consideration to be received by the Participants for their outstanding Awards will comprise solely of securities of the Successor Entity equal in their market value to the per share
                          consideration received by the holders of Shares in the Transaction.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z7859479684a04e80a1aac5df3454d638" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 36pt; vertical-align: top;">11.4.2</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>In the event that the Successor Entity neither assumes nor substitutes all of the outstanding Awards of a Participant, the Board or Committee may in its sole discretion:</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zfb0ce1b015404ca1b2ff874e3fd45195" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 70.9pt;"><br>
                      </td>
                      <td style="width: 49.6pt; vertical-align: top;">11.4.2.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>provide for the Participant to have the right to exercise the Award in respect of Shares covered by the Award which would otherwise be exercisable or vested, under such terms and conditions as the Committee shall determine, and
                          the cancellation of all unexercised Awards (whether vested or unvested) upon or immediately prior to the closing of the Transaction, unless the Committee provides for the Participant to have the right to exercise the Award, or
                          otherwise for the acceleration of vesting of such Award, as to all or part of the Shares covered by the Award which would not otherwise be exercisable or vested, under such terms and conditions as the Committee shall determine;</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zcd89d55ce4ba443585911e8857945c5e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 70.9pt;"><br>
                      </td>
                      <td style="width: 49.6pt; vertical-align: top;">11.4.2.2</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>provide for the cancellation of each outstanding Award at or immediately prior to the closing of such Transaction, and if and to what extent payment shall be made to the Participant of an amount in, shares or other securities
                          of the Company, the acquirer or of a corporation or other business entity which is a party to the Transaction, in cash or other property, in rights, or in any combination thereof, as determined by the Committee to be fair in the
                          circumstances, and subject to such terms and conditions as determined by the Committee. The Committee shall have full authority to select the method for determining the payment (being the intrinsic (&#8220;spread&#8221;) value of the option,
                          Black-Scholes model or any other method). Inter alia, and without limitation of the following determination being made in other circumstances, the Committee&#8217;s determination may provide that payment shall be set to zero if the
                          value of the Shares is determined to be less than the exercise price (&#8220;out-of-the-money Options&#8221;), or in respect of Shares covered by the Award which would not otherwise be exercisable or vested, or that payment may be made only
                          in excess of the exercise price; and/or</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z2bae08deebf848d2ae88af526823aadd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 70.9pt;"><br>
                      </td>
                      <td style="width: 49.6pt; vertical-align: top;">11.4.2.3</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>provide that the terms of any Award shall be otherwise amended, modified, or terminated, as determined by the Committee to be fair in the circumstances.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 14</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="z0a060910146f4b649867e2f3ab775958" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 36pt; vertical-align: top;">11.4.3</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>All Awards, whether vested or not, which are neither assumed, exchanged or substituted by the Successor Entity, nor exercised by the consummation of the Transaction, or canceled by the Board, shall expire effective as of the
                          date of the consummation of the Transaction, whereupon they shall become null and void and shall no longer entitle the Participant to any right in or towards the Company or the Successor Entity.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z51a91170e9104159b7a81c4710a4586c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 36pt; vertical-align: top;">11.4.4</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The Board may determine: (i) that any payments made in respect of Awards shall be made or delayed to the same extent that payment of consideration to the holders of the Shares in connection with the Transaction is made or
                          delayed as a result of escrows, indemnification, earn outs, holdbacks or any other contingencies or conditions; (ii) the terms and conditions applying to the payment made or payable to the Participant, including participation in
                          escrow, indemnification, releases, earn-outs, holdbacks or any other contingencies; and (iii) that any terms and conditions applying under the applicable definitive transaction agreements shall apply to the Participant (including,
                          appointment and engagement of a shareholders or sellers representative, payment of fees or other costs and expenses associated with such services, indemnifying such representative, and authorization to such representative within
                          the scope of such representative&#8217;s authority in the applicable definitive transaction agreements).</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zbd96372a31444999aaaafca01d5a23e3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 36pt; vertical-align: top;">11.4.5</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The Committee may, determine to suspend the Participant&#8217;s rights to exercise any vested portion of an Award for a period of time prior to the signing or consummation of a Transaction.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zf1e2063a6f164dc7b386ea84444838e6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 36pt; vertical-align: top;">11.4.6</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Without limiting the generality of this Section 11, if the consideration in exchange for Awards in a Transaction includes any securities and due receipt thereof by any Participant (or by the Trustee for the benefit of such
                          Participant) may require under applicable law (i) the registration or qualification of such securities or of any person as a broker or dealer or agent with respect to such securities; or (ii) the provision to any Participant of
                          any information under the Securities Act or any other securities laws, then the Committee may determine that the Participant shall be paid in lieu thereof, against surrender of the Shares or cancellation of any other Awards, an
                          amount in cash or other property, or rights, or any combination thereof, as determined by the Committee to be fair in the circumstances, and subject to such terms and conditions as determined by the Committee. Nothing herein shall
                          entitle any Participant to receive any form of consideration that such Participant would be ineligible to receive as a result of such Participant&#8217;s failure to satisfy (in the Committee&#8217;s sole determination) any condition,
                          requirement or limitation that is generally applicable to the Company&#8217;s shareholders, or that is otherwise applicable under the terms of the Transaction, and in such case, the Committee shall determine the type of consideration
                          and the terms applying to such Participants.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zc23c596136d540e19a482a8e00b13c58" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 36pt; vertical-align: top;">11.4.7</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Neither the authorities and powers of the Board under this Section 11.3, nor the exercise or implementation thereof, shall (i) be restricted or limited in any way by any adverse consequences (tax or otherwise) that may result
                          to any holder of an Award, and (ii) as, inter alia, being a feature of the Award upon its grant, be deemed to constitute a change or an amendment of the rights of such holder under this Plan, nor shall any such adverse
                          consequences (as well as any adverse tax consequences that may result from any tax ruling or other approval or determination of any relevant tax authority) be deemed to constitute a change or an amendment of the rights of such
                          holder under this Plan, and may be effected without consent of any Participant and without any liability to the Company or any Affiliate, or to their respective officers, directors, employees and representatives, and the
                          respective successors and assigns of any of the foregoing. The Committee need not take the same action with respect to all Awards or with respect to all Participants. The Committee may take different actions with respect to the
                          vested and unvested portions of an Award. The Committee may determine an amount or type of consideration to be received or distributed in a Transaction which may differ as among the Participants, and as between the Participants
                          and any other holders of shares of the Company.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z6199171c8ccc4ea8bacb0322cb2af494" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 36pt; vertical-align: top;">11.4.8</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Each Participant, upon executing an Award Agreement, shall be deemed to have authorized the Company and each of its officers and to have granted the Company and each of its officers an irrevocable power of attorney to execute
                          in his/her behalf such instruments and documents mentioned in this Section 11.4. For the avoidance of doubt, the Board or the Committee may determine that each such Participant shall be required to execute the Transaction
                          agreements applicable to each holder of shares or awards in the Company, and the Participant hereby agrees to comply with such requirements, and no additional consent of Participant or prior notice to Participant shall be
                          required.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 15</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="z9a458bd1801d443c9b620daeddc12c7c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">11.5</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Notwithstanding the foregoing adjustments, any changes to ISOs pursuant to this Section 11 shall, unless the Company determines otherwise, only be effective to the extent such adjustments or changes do not cause a
                          &#8220;modification&#8221; (within the meaning of Section 424(h)(3) of the Code) of such ISOs or adversely affect the tax status of such ISOs.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zc849b969cb724347b0d49d9638d2b1d8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">11.6</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Notwithstanding the foregoing adjustments, any changes pursuant to this Section 11 to NQSOs or to any Awards that are subject to Section 409A of the Code shall, unless the Company determines otherwise, only be effective to the
                          extent such adjustments or changes do not cause a &#8220;modification&#8221; (within the meaning of Code Section 409A (as defined below)) of such NQSOs or adversely affect the tax status of such NQSOs or other Awards.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z2bda91e2dfde490ab03190073a20c004" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">12.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>TERMINATION OF AWARDS; CONDITIONS OF ISSUANCE</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zf4e892307e90488c8f1fdc619c213f5e" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">12.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Upon the termination of a Participant&#8217;s Service, for any reason whatsoever, any Awards granted in favor of such Participants which are not vested Awards, shall immediately expire and terminate and become null and void.
                          Restricted Shares which have not yet completed the Restriction Period will be forfeited to the Company in accordance with Section 9 above.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zdfc334c0e4924cef8f8e72e32bf085a1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">12.2</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Notwithstanding anything to the contrary in Sections 7.6 and 11 above, and unless otherwise prescribed by the Committee or the Board and specified in the Award Agreement, an Option may be exercised after the date of termination
                          of Participant&#8217;s Service only with respect to the number of Options already vested and unexpired at the time of such termination according to the vesting and expiration periods of the Options set forth in this Plan, or under a
                          different period prescribed by the Committee or by the Board and specified in Participant&#8217;s Award Agreement, provided however, that;</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zed9edcd5529d4b1db3d474f1528442cc" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 72pt; vertical-align: top;">12.2.1.</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>such termination is without Cause (as defined below) and not the result of death or Disability in which case the Options shall be exercisable within the earlier of: (i) the Expiration Date of such Options; or (ii) not more than
                          three (3) months from the effective date of such termination, unless the Participant is a director - in such case not more than eighteen (18) months from the effective date of such termination; or</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 16</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="za016effae3de417393d7f0f964ff4ac1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 72pt; vertical-align: top;">12.2.2.</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>such termination is the result of death or Disability of the Participant, in which case the Options shall be exercisable within the earlier of: (i) the Expiration Date of such Options; or (ii) twelve (12) months from the
                          effective date of such termination.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 35.3pt; line-height: 1.25;">The term &#8220;<font style="font-weight: bold;">Cause</font>&#8221; shall mean: (i) conviction of a Participant for any felony involving moral turpitude or affecting the Company
                  or the Affiliates; (ii) a serious breach of trust by a Participant, including but not limited to, theft, fraud, self-dealing and embezzlement of funds of the Company or its Affiliates; (iii) any breach of the Participant&#8217;s fiduciary
                  duties or duties of care to the Company or any Affiliate; including, without limitation, disclosure of confidential information of such entity (including without limitation any disclosure of confidential information of the Company or any
                  Affiliate or any breach of a non-competition undertaking); (iv) any conduct (other than conduct in good faith) reasonably determined by the Board to be materially detrimental to the Company or any Affiliate; (v) any other event classified
                  under any applicable agreement between the Participant and the Company or the Affiliate, as applicable, as a &#8220;Cause&#8221; for termination or by other language of similar substance; (vi) a material breach by the Participant of the terms of any
                  agreement between the Company and the Participant; and (vii) any other circumstance justifying termination or dismissal without severance payment according to Israeli law. For the avoidance of doubt, the determination as to whether a
                  termination is for Cause for purposes of this Plan, shall be made in good faith by the Company and shall be final and binding on the Participant. If a Participant&#8217;s employment or consulting relationship with the Company is suspended
                  pending an investigation of whether the Participant shall be terminated for Cause, all the Participant&#8217;s rights under any Award likewise shall be suspended during the investigation period and the Participant shall have no right to
                  exercise any Option.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; text-indent: -0.7pt; margin-left: 36pt; line-height: 1.25;">The term &#8220;<font style="font-weight: bold;">Disability</font>&#8221; shall mean a condition that renders an individual unable to engage in substantial
                  gainful activity by reason of any medically determinable physical or mental impairment as determined by the Board or the Committee; provided, however, that the Board or the Committee has no obligation to investigate whether Disability
                  exists unless the Participant or representative thereof puts the Company on notice within ninety (90) days after the Participant&#8217;s termination of Service.</div>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zf6a785925f46415e82091f56badd0ccb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">12.3</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Notwithstanding anything to the contrary contained herein or in the Articles of Association, and subject to applicable law, in the event of termination for Cause (whether the facts or circumstances that constitute such Cause
                          occur prior to or after termination of Service), or if facts or circumstances arise or are discovered with respect to the Participant that would have constituted Cause, then all Awards theretofore granted to such Participant
                          (whether vested or not) shall terminate and be subject to recoupment by the Company on the date of such termination (or on such subsequent date on which such facts or circumstances arise or are discovered, as the case may be)
                          unless otherwise determined by the Committee, and any Shares issued upon exercise or (if applicable) vesting of Awards (including other Shares or securities issued or distributed with respect thereto, and including the gross
                          amount of any proceeds, gains or other economic benefit the Participant actually or constructively receives upon receipt or exercise of any Award or the receipt or resale of any Shares underlying the Award), whether held by the
                          Participant or by the Trustee for the Participant&#8217;s benefit, shall be deemed to be irrevocably offered for sale to the Company, any of its Affiliates or any person designated by the Company to purchase, at the Company&#8217;s election
                          and subject to applicable law, either for no consideration, for the par value of such Shares (if such Shares bear a par value) or against payment of the exercise price previously received by the Company for such Shares upon their
                          issuance, as the Committee deems fit, upon written notice to the Participant at any time prior to, at or after the Participant&#8217;s termination of Service. Such Shares or other securities shall be sold and transferred within 30 days
                          from the date of the Company&#8217;s notice of its election to exercise its right. If the Participant fails to transfer such Shares or other securities to the Company, the Company, at the decision of the Committee, shall be entitled to
                          forfeit or repurchase such Shares and to authorize any person to execute on behalf of the Participant any document necessary to effect such transfer, whether or not the share certificates are surrendered.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 17</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company shall have the right and authority to effect the above either by: (i) repurchasing all of such Shares or other securities held by the Participant or by the
                  Trustee for the benefit of the Participant, or designate the purchaser of all or any part of such Shares or other securities, for the exercise price paid for such Shares, the par value of such Shares (if such Shares bear a par value) or
                  for no payment or consideration whatsoever, as the Committee deems fit; (ii) forfeiting all or any part of such Shares or other securities; (iii) redeeming all or any part of such Shares or other securities, for the exercise price paid
                  for such Shares, the par value of such Shares (if such Shares bear a par value) or for no payment or consideration whatsoever, as the Committee deems fit; (iv) taking action in order to have all or any part of such Shares or other
                  securities converted into deferred shares entitling their holder only to their par value (if such Shares bear a par value) upon liquidation of the Company; or (v) taking any other action which may be required in order to achieve similar
                  results; all as shall be determined by the Committee, at its sole and absolute discretion, and the Participant is deemed to irrevocably empower the Company or any person which may be designated by it to take any action by, in the name of
                  or on behalf of the Participant to comply with and give effect to such actions (including, voting such shares, filling in, signing and delivering share transfer deeds, etc.).</div>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="ze48763f79f53454c929ffa55f975857c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">12.4</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Notwithstanding anything to the contrary herein, upon the issuance of a court order declaring the bankruptcy of a Participant, or the appointment of a receiver or a provisional receiver for a Participant over all of his/her
                          assets, or any material part thereof, or upon making a general assignment for the benefit of his/her creditors, any outstanding Awards issued in favor of such Participant (whether vested or not) shall immediately expire and
                          terminate and become null and void and shall entitle neither the Participant nor the Participant&#8217;s receiver, successors, creditors or assignees to any right in or towards the Company or any Affiliate in connection with the same,
                          and all interests and rights of the Participant or the Participant&#8217;s receiver, successors, creditors or assignees in and to the same, shall expire.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z0a069b58510c454a973d41ad3066bcbb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">12.5</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>In the event that the Company is liquidated or dissolved while unexercised or unsettled Awards remain outstanding under the Plan, then the Board shall have the right to resolve with respect to certain Participants that all or
                          part of such Participants&#8217; outstanding Awards may be exercised in full by the Participants as of immediately prior to the effective date of such liquidation or dissolution of the Company, without regard to the vesting terms
                          thereof.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z12a91b653acf40e4b9bf651445b3f5c2" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">12.6</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The holders of Awards shall not have any of the rights or privileges of shareholders of the Company unless and until, they become shareholders of the Company following exercise/settlement Awards and in case of Awards held by
                          the Trustee, subject always to the provisions of Section 3 and 6 of the Plan.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z26478e523a8647b3967299743b7f64c8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">12.7</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Any form of Award Agreement authorized pursuant to this Plan may contain such other provisions as the Board may, from time to time, deem advisable.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z44bb8d2a7e754e5b81570ed5768c96df" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">12.8</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>An Award may not be converted into a fraction of a Share. In lieu of issuing fractional Shares, the Company shall convert any such fraction of an Award, which represents a right to receive 0.5 or more of a Share, to one Share
                          and shall extinguish any such fraction of an Award, which represents a right to receive less than 0.5 of a Share without issuing any Shares.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z2469eb510fe14bb0a32b124dfe472feb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: -0.7pt;"><br>
                      </td>
                      <td style="width: 36pt; vertical-align: top;">12.9</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Blackout<u> Periods</u>. In the event that the exercise period under Section 12.2.1 above, begins following the commencement of any Company trading blackout period pursuant to the Company&#8217;s Insider Trading Policy (referred to
                          as a &#8220;<font style="font-weight: bold;">Blackout Period</font>&#8221;) such exercise period shall be extended automatically and shall conclude 14 days or three months, as the case may be, following the end of any such Blackout Period in
                          accordance with this Section.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 18</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                </div>
                <table cellspacing="0" cellpadding="0" id="z08e739ab7a484dceb082db988e165cc8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">13.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>PURCHASE FOR INVESTMENT</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zcf8e97b8b46f4bce90715096c6e6704c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">13.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The Company&#8217;s obligation to issue Share Awards or Shares upon exercise of an Option granted under the Plan is expressly conditioned if so required under the applicable law, and as supported by the opinion of the Company&#8217;s
                          counsel, upon the following terms: (a) the Company&#8217;s completion of any registration or other qualifications of such Shares under any applicable law, rulings or regulations or (b) representations and undertakings by the Participant
                          (or his legal representative, heir or legatee, in the event of the Participant&#8217;s death) to assure that the sale of the Shares complies with any registration exemption requirements which the Company in its sole discretion shall
                          deem necessary or advisable. Such required representations and undertakings may include representations and agreements that such Participant (or his legal representative, heir, or legatee): (x) is purchasing such Shares for
                          investment and not with any present intention of selling or otherwise disposing thereof; and (y) agrees to have placed upon the face and reverse of any certificates evidencing such Shares a legend setting forth (i) any
                          representations and undertakings which such Participant has given to the Company or a reference thereto, (ii) that, prior to effecting any sale or other disposition of any such Shares, the Participant must furnish to the Company
                          an opinion of counsel, satisfactory to the Company, that such sale or disposition will not violate the applicable requirements of State and federal laws and regulatory agencies, and (iii) any other legend deemed reasonably
                          necessary or appropriate by the Company.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zd6f55e499e974cefbd21706ad35c4f82" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">14.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>DIVIDENDS</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z25ad4c7019ec4ecd8fd9430130997707" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">14.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>It is hereby clarified that a Participant which has not exercised its Options into Shares, shall not, by virtue of this Plan, or the applicable Award Agreement or any Option granted to the Participant, have any of the rights or
                          privileges of a shareholder with respect to the Shares underlying the Options, until the Options have been exercised. In addition, the Participant shall not be deemed to be a class of shareholders or creditors of the Company for
                          the purpose of all applicable law, until registration of the Participant as holder of such Shares in the Company&#8217;s register of shareholders upon exercise of the Options in accordance with the provisions of the Plan.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z02b9ff0ff8c64452b3f7fd3eda81ee75" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">14.2</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>With respect to all Shares (in contrast to Options not exercised into Shares) issued to a Participant under this Plan, the Participant shall be entitled to receive dividends in accordance with the quantity of such Shares, and
                          subject to any applicable taxation on distribution of dividends. Notwithstanding the foregoing, in the absence of a Board action to the contrary, any Shares or any other property (other than regular cash distributions) distributed
                          as a dividend or otherwise with respect to any Restricted Shares as to which the restrictions have not yet lapsed shall be subject to the same restrictions as the shares covered by such Restricted Shares, as further detailed in
                          the applicable Award Agreement.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z12df4d527c114b7a921cf7a0d05172ed" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">14.3</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>During the period in which Shares, issued to the Trustee on behalf of a Participant upon exercise of a 102(b) Award, are held by the Trustee, the cash dividends paid with respect thereto may be paid directly to the Participant;
                          all subject to the provisions of applicable law and Section 6 above.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zf01fe3a02f9546878af9a720a5c92df1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">15.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>TRANSFERABILITY OF AWARDS</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z22565d6af11b43cab1e5ba604c2d5574" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">15.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Other than by will or laws of descent, no Award, whether fully paid or not, shall be assignable, transferable, or given as collateral or any right with respect to them given to any third party whatsoever, and during the
                          lifetime of the Participant each and all of such Participant&#8217;s rights to purchase Shares hereunder shall be exercisable only by the Participant. Notwithstanding the foregoing, however, to the extent permitted by the Board in its
                          sole discretion, an NQSO may be transferred by the Participant to a revocable trust or to one or more family members or a trust established for the benefit of the Participant and/or one or more family members to the extent
                          permitted by Rule 701 of the United States Securities Act of 1933, as amended (the &#8220;<font style="font-weight: bold;">Securities Act</font>&#8221;) and Section&#160;260.140.41(c) of Title 10 of the California Code of Regulations (to the
                          extent applicable).</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 19</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="z9562aeab3deb44f6af84a04fc7be2e6d" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">15.2</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Shares issued under Share Awards or following the exercise of the Options into Shares shall be transferable; provided, however, that Shares may be subject to applicable securities regulations, market stand-off provisions, lock
                          up periods, and such other conditions and restrictions as may be included in the Company&#8217;s Articles of , any shareholders&#8217; agreement to which the holders of Shares are bound, the Plan, any applicable sub-plan, the Award Agreement,
                          and/or any conditions and restrictions included in the Company&#8217;s securities law compliance manual/insider trade policy, or similar document, if any, all as determined by the Board at its sole discretion.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z5c0f7ef7263146c2938947275c977026" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">15.3</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Subject to any other restriction as to transferability of the Shares and/or Options provided hereunder, and for the avoidance of any doubt, any Shares sold or transferred by Participant in accordance with the provisions
                          hereunder shall be held by transferee and/or his successors, executors, administrators and assigns (each, &#8220;<font style="font-weight: bold;">Transferee</font>&#8221;) subject to the terms and conditions hereof, and any restrictions,
                          obligations and/or waivers which apply to the Participant&#160; shall apply, <font style="font-style: italic;">mutatis mutandis</font>, also to such Transferee.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z4197d6d5fee244febc599001cc76685f" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">16.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>TERM OF THE PLAN</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Plan shall become effective on the date that it is adopted by the Board. Subject to Section 17 below the Plan shall terminate at the end of ten (10) years from such
                  day of adoption provided, however, that Awards theretofore issued under an applicable Award Agreement may extend beyond such date in accordance with their terms. No ISO grant shall be effective unless the Plan shall have been approved by
                  the shareholders of the Company within twelve (12) months after this Plan is adopted by the Board.</div>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z75311f849af3430ba45fcedf9936b89b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">17.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>AMENDMENTS OR TERMINATION</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zac090e73966b4c828d489d6f68ed7152" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">17.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The Board may, at any time and from time to time, amend, alter or discontinue the Plan, except that no amendment or alteration shall be made which would impair the rights of the holder of any Award granted, if and to the extent
                          such rights are specifically set forth under the applicable Award Agreement, without such Participant&#8217;s consent.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="ze1a63fd46ad64bfe81bf1a02cd11e1a6" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">17.2</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Additionally, the following changes to the Plan shall be made subject to the approval of the shareholders of the Company, if such approval is required and necessary to satisfy (i) with regard to ISOs, any requirements under the
                          Code relating to ISOs, (ii) any applicable law, regulation or rule, or (iii) any provision specified under the Articles of Association:</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zc288c5ad00f0436998aeb3952abde3cd" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 36pt; vertical-align: top;">(a)</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>except as is provided in Section 11, increase the maximum number of Shares which may be sold or awarded under the Plan;</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z847d38e1f21d43829b816b6f3afd23b3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 36pt; vertical-align: top;">(b)</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>except as is provided in Section 11 decrease the minimum Option exercise price requirements under the Plan;</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z24caccce604246babf78df5d621e710a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 36pt; vertical-align: top;">(c)</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>change the class of persons eligible to receive Awards under the Plan; or</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zde571a3af7f54e67874867d53ef11135" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt;"><br>
                      </td>
                      <td style="width: 36pt; vertical-align: top;">(d)</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>extend the duration of the Plan under Section 16 or the period during which ISOs may be exercised under Section 7.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 20</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25;"><br style="line-height: 1.25;">
                </div>
                <table cellspacing="0" cellpadding="0" id="z67c46419176246d8953b43793080abff" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">17.3</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Notwithstanding any provision of this Plan to the contrary, the Company (and the Participant) intends that this Plan shall satisfy the applicable requirements of Section 409A of the Internal Revenue Code of 1986, as amended (&#8220;<font style="font-weight: bold;">Code Section 409A</font>&#8221;) in a manner that will preclude the imposition of additional taxes described in Code Section 409A. The Company shall have the right to amend the Plan to the extent necessary
                          to comply with Code Section 409A and the regulations, notices and other guidance of general applicability issued thereunder.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z99455587cea64f5d88a71ffff51b34f1" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">18.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>GOVERNMENT REGULATIONS; ISRAELI RESIDENTS</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z69577c4c4e1b450ba622a98b850e2d68" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">18.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Subject to Section 28 below, the Plan, the granting and exercise of Awards hereunder, and the obligation of the Company to sell and deliver Shares under such Awards, shall be subject to all applicable laws, rules, and
                          regulations, whether of the State of Israel or of the United States or any other State having jurisdiction over the Company and the Participant, including the Securities Act, and to such approvals by any governmental agencies or
                          national securities exchanges as may be required.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z59d7850eab9f4fa5b4116ce1cd85ffc9" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">18.2</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>This subsection shall apply only to Participants who are residents of the State of Israel or those who are deemed to be residents of the State of Israel for the payment of tax. Notwithstanding anything herein to the contrary,
                          the Plan shall be governed by the provisions of the Ordinance, the rules promulgated thereunder, and any other applicable Israeli laws with respect to service providers or employees who are Israeli residents. Following the grant
                          of Awards under the Plan and in any case in which the Participant shall stop being considered as an &#8220;Israeli Resident&#8221;, as defined in the Ordinance, the Company may, if and to the extent the Ordinance and/or the rules promulgated
                          thereunder shall impose such obligation on the Company, to withhold all applicable taxes from the Participant, to remit the amount withheld to the appropriate Israeli tax authorities and to report to such Participant the amount so
                          withheld and paid to said tax authorities.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zf99d9752d6bf4367b65f10f256394def" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">19.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>DATA PRIVACY; DATA TRANSFER</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="za928629a336b49189640057992ee0e09" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">19.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>Information related to Participants and Awards hereunder, as shall be received from Participant or others, and/or held by, the Company or its Affiliates from time to time, and which information may include sensitive and
                          personal information related to Participants (&#8220;<font style="font-weight: bold;">Information</font>&#8221;), will be used by the Company or its Affiliates (or third parties appointed by any of them, including a trustee) to comply with
                          any applicable legal requirement, or for administration of the Plan as they deems necessary or advisable, or for the respective business purposes of the Company or its Affiliates (including in connection with transactions related
                          to any of them). The Company and its Affiliates shall be entitled to transfer the Information among the Company or its Affiliates, and to third parties for the purposes set forth above, which may include persons located abroad
                          (including, any person administering the Plan or providing services in respect of the Plan or in order to comply with legal requirements, or a trustee, their respective officers, directors, employees and representatives, and the
                          respective successors and assigns of any of the foregoing), and any person so receiving Information shall be entitled to transfer it for the purposes set forth above. The Company shall use commercially reasonable efforts to ensure
                          that the transfer of such Information shall be limited to the reasonable and necessary scope. By receiving an Options hereunder, Participant acknowledges and agrees that the Information is provided at Participant&#8217;s free will and
                          Participant consents to the storage and transfer of the Information as set forth above.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z500b450981ef4b7a81475f9c482802e3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">20.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>CONTINUANCE OF EMPLOYMENT OR HIRED SERVICES</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Neither the Plan nor the Award Agreement with the Participant shall impose any obligation on the Company or an Affiliate thereof, to continue any Participant in its
                  employ, or the hiring by the Company of the Participant&#8217;s services and nothing in the Plan or in any Award granted pursuant thereto shall confer upon any Participant any right to continue in the employ or service of the Company or an
                  Affiliate thereof or restrict the right of the Company or an Affiliate thereof to terminate such employment or service at any time.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 21</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="zd838483b7b7242fca537d0db6ab5f9ed" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">21.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>TAX CONSEQUENCES</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zac5f418c7c3e44d69125f4f65f05fb61" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">21.1</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>To the extent permitted by applicable law, any tax consequences arising from the grant or exercise of any Award, from the payment for Shares covered thereby, the transfer of Shares from the Trustee to the Participant, the sale
                          or transfer of the Shares by the Participant, or from any other event or act (of the Company, the Trustee or the Participant) hereunder shall be borne solely by the Participant, including without limitation, in the event that the
                          Awards do not qualify under the tax classification in which they were intended. The Company, Affiliate and/or the Trustee (where applicable) may withhold taxes according to the requirements under the applicable laws, rules, and
                          regulations, including the withholding of taxes at source. Furthermore, the Participant shall agree to indemnify the Company and the Trustee (where applicable) and hold them harmless against and from any and all liability for any
                          such tax or interest, or penalty thereon, including without limitation, liabilities relating to the necessity to withhold, or to have withheld, any such tax from any payment made to the Participant.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z5f5d4a869acb467795dd0dd0345a296c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">21.2</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The Company shall not be obligated to allow the exercise of any Award by or on behalf of a Participant until all tax consequences arising from the exercise of such Award are resolved in a manner acceptable to the Company.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zc201c5a77abf46fea0bdf6a0f583c0ac" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">21.3</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The Company does not undertake and shall be under no duty to ensure, and no representation or commitment is made, that any of the Awards qualifies or will qualify under any particular tax treatment (such as Capital Gain Award
                          or ISO), nor shall the Company be required to take any action for the qualification of any of the Awards under such tax treatment. The Company shall have no liability of any kind or nature in the event that, for any reason
                          whatsoever, the Awards do not qualify for any particular tax treatment. The Participant is advised to consult with a tax advisor with respect to the tax consequences of receiving and exercising/settling Awards or disposing of
                          Shares hereunder. The Company does not assume any responsibility to advise the Participant on such matters, which shall remain solely the responsibility of the Participant.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zb52e2b93d28c4db2a3b118cf5eaf559b" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">21.4</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>The Board, the Committee and/or the Trustee shall not be required to release any Share certificate issued upon exercise of a 102 Award and/or a 3(i) Award to a Participant until all required payments have been fully made.
                          Therefore, the Company shall be entitled to require each Participant, as a condition to the exercise of the Awards or the sale of the Shares (including without limitation, sale of Shares as part of a Transaction), to provide the
                          Company with confirmation or certificate by the applicable tax authorities regarding tax withholding treatment (any such certificate, if applicable, to be satisfactory to the Company and the Trustee). If the Company is required to
                          withhold taxes in connection with the exercise or sale as provided above, the Company shall be entitled to require as a condition of issuance/transfer that the Participant remit an amount sufficient to satisfy all governmental
                          withholding tax requirements related thereto. A determination of the Company&#8217;s counsel that a withholding tax is required in connection with the exercise of Awards or transfer of Shares shall be conclusive for the purposes of this
                          requirement condition. With respect to Other 102 Awards, if the Participant ceases to be employed by the Company or any Affiliate, the Participant shall extend to the Company and/or its Affiliate with whom the Participant is
                          employed a security or guarantee for the payment of taxes due at the time of sale of Shares, all in accordance with the provisions of Section 102 of the Ordinance and the Rules.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="za35bd14d1c0b48dc9ea0f0972fcc2619" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">21.5</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>If an Option is intended to qualify as an ISO, then if the Participant makes a disposition, within the meaning of Section 424(c) of the Code and the regulations promulgated thereunder, of any Share issued to the Participant
                          pursuant to his exercise of the Option within the later of two (2) -year period commencing on the Date of Grant or within the one (1) -year period commencing on the date after the date of transfer of such Share to the Participant
                          pursuant to such exercise, the Participant shall, within ten (10) days after such disposition, notify the Company thereof, by delivery of a written notice to the Secretary of the Company.</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 22</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="z9cdb812973464f1d9b776181591f4beb" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">22.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>NON-EXCLUSIVITY OF THE PLAN</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The adoption of the Plan by the Board shall not be construed as amending, modifying or rescinding any previously approved incentive arrangements or as creating any
                  limitations on the power of the Board to adopt such other incentive arrangements as it may deem desirable, including, without limitation, the granting of Awards otherwise than under the Plan, and such arrangements may be either applicable
                  generally or only in specific cases.</div>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="za8e3b9423cc643dd9d3c6a9369fb8b1a" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">23.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>MULTIPLE AGREEMENTS</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The terms of each Award may differ from other Awards granted under the Plan at the same time, or at any other time. The Committee or the Board may also grant more than
                  one Award to a given Participant during the term of the Plan, in addition to one or more Awards previously granted to that Participant.</div>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="zfa5cdab4a94c4902a2ee783689fa71a3" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">24.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>NO REPRESENTATION</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">The Company does not and shall not, through this Plan or the applicable Award Agreement, make any representation towards any Participant with respect to the Company,
                  its business, its value or either its shares in general or the Shares issued hereunder in particular.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Each Participant, upon entering into the applicable Award Agreement, shall represent and warrant toward the Company that his/her consent to the grant of the Awards
                  issued in its favor and the exercise (if so exercised) thereof, neither is nor shall be made, in any respect, upon the basis of any representation or warranty made by the Company or by any of its directors, officers, shareholders or
                  employees, and is and shall be made based only upon his/her examination and expectations of the Company, on an &#8220;as is&#8221; basis. Each Participant shall waive any claim whatsoever of &#8220;non-conformity&#8221; of any kind, and any other cause of action
                  or claim of any kind with respect to the Awards and/or their underlying Shares.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">This Plan and the Awards granted from time to time pursuant thereto constitute the sole understanding of the Company and the Participants with respect to the subject
                  matter hereof.</div>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z0f82e7c1dbd34f2b91c6ba1013958e51" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">25.</td>
                      <td style="width: auto; vertical-align: top;">
                        <div>NO INTERFERENCE</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Neither the Plan nor applicable Award Agreement shall affect, in any way, the rights or powers of the Company or its shareholders to make or to authorize any sale,
                  transfer or change whatsoever in all or any part of the Company&#8217;s assets, obligations or business, or any other business, commercial or corporate act or proceeding, whether of a similar character or otherwise; any adjustments,
                  recapitalizations, reorganizations or other changes in the Company&#8217;s capital structure or business; any merger or consolidation of the Company; any issue of bonds, debentures, shares (including preferred or prior preference shares ahead
                  of or affecting the existing shares of the Company including the Share Awards or Shares into which the Awards granted hereunder are exercisable or the Shares issued upon the exercise of the Options or the rights thereof, etc.); or the
                  dissolution or liquidation of the Company; and none of the above acts or authorizations shall entitle the Participant to any right or remedy, including without limitation, any right of compensation for any dilution resulting from any
                  issuance of any shares or of any other securities in the Company to any person or entity whatsoever.</div>
                <div style="line-height: 1.25">&#160;</div>
                <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
                  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal; font-family: 'Times New Roman',Times,serif;" class="BRPFPageNumber">B - 23</font></div>
                  <div style="page-break-after: always;" class="BRPFPageBreak">
                    <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
                </div>
                <div style="line-height: 1.25"> <br>
                </div>
                <table cellspacing="0" cellpadding="0" id="ze9cfe3699d7141c3afe404ff977a7000" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">26.</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>PROHIBITION ON EXECUTIVE OFFICER LOANS</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">Notwithstanding any other provision of the Plan to the contrary, no Participant who is a member of the Board or an &#8220;executive officer&#8221; of the Company within the meaning
                  of Section 13(k) of the Exchange Act shall be permitted to make payment with respect to any Awards granted under the Plan or continue any extension of credit with respect to such payment, with a loan from the Company or a loan arranged by
                  the Company in violation of Section 13(k) of the Exchange Act.</div>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z6e4db72b38e5465484f5660f749542b8" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">27.</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>CLAWBACK PROVISIONS</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">All Awards (including the gross amount of any proceeds, gains or other economic benefit the Participant actually or constructively receives upon receipt or exercise of
                  any Award or the receipt or resale of any Shares underlying the Award) will be subject to recoupment by the Company to the extent required to comply with applicable law or any policy of the Company (subject to applicable law) providing
                  for the reimbursement of incentive compensation, whether or not such policy was in place at the time of grant of an Award.</div>
                <div style="line-height: 1.25">&#160;</div>
                <table cellspacing="0" cellpadding="0" id="z3cca6df178644b64b09b76d41e87fb6c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

                    <tr>
                      <td style="width: 36pt; vertical-align: top;">28.</td>
                      <td style="width: auto; vertical-align: top; text-align: justify;">
                        <div>GOVERNING LAW &amp; JURISDICTION</div>
                      </td>
                    </tr>

                </table>
                <div style="line-height: 1.25">&#160;</div>
                <div style="text-align: justify; margin-left: 36pt; line-height: 1.25;">This Plan and the rights and obligations of the Company and the Participants hereunder shall be governed by and construed and enforced in accordance with the laws of
                  the State of Israel without giving effect to choice or conflict of law provision that would cause the application of the domestic substantive laws of any other jurisdiction. Any suit, action or proceeding with respect to this Plan or any
                  Award granted hereunder, or any entered by any court in respect of any thereof, shall be brought in the competent courts of Tel-Aviv, Israel, as a condition to accepting any Award, the Company and the Participant submit to the exclusive
                  jurisdiction of such courts for the purpose of any such suit, action, proceeding or judgment.</div>
                <div style="line-height: 1.25">&#160;</div>
              </div>
              <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-weight: normal; font-style: normal;" class="BRPFPageNumber">B - 24</font></div>
            </div>
            <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
        </div>
      </div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>3
<FILENAME>exhibit_b.htm
<DESCRIPTION>EXHIBIT B
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: ZKG
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"></div>
  <div>
    <div style="line-height: 1.25; text-align: right;"><u><font style="font-weight: bold;">Exhibit B</font></u><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">FORM OF PROXY CARD</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERAGON NETWORKS LTD.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">ANNUAL GENERAL MEETING OF SHAREHOLDERS</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">May 23, 2024</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">The shareholder(s) hereby appoint/s Ronen Stein and Hadar Vismunski Weinberg, Adv., or either one of them, as proxies, each with the power to appoint his substitute, and hereby authorize/s them to
      represent and to vote as designated on the reverse side of this Proxy, all of the ordinary shares of Ceragon Networks Ltd. (the &#8220;<font style="font-weight: bold;">Company</font>&#8221;)&#160;held of record in the name of the undersigned at the close of business
      on Tuesday, April 23, 2024, that the shareholder(s) is/are entitled to vote at the annual general meeting of shareholders to be held at 4:00 PM (Israel time), on Thursday, May 23, 2024, at the offices of the Company, 3 Uri Ariav st., Rosh Ha&#8217;Ayin,
      Israel 4810002 and any adjournment or postponement thereof (the "<font style="font-weight: bold;">Meeting</font>").</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25; font-weight: bold;">THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED AS DIRECTED BY THE SHAREHOLDER(S).&#160; IF NO SUCH DIRECTIONS ARE MADE BY THE SHAREHOLDER, THIS PROXY WILL BE VOTED FOR EACH PROPOSAL,
      AND AS SUCH PROXIES DEEM ADVISABLE WITH DISCRETIONARY AUTHORIZATION ON SUCH OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE MEETING AND ANY ADJOURNMENT OR ADJOURNMENTS THEREOF. ABSTENTIONS WILL BE COUNTED AS PRESENT FOR PURPOSES OF DETERMINING A
      QUORUM BUT WILL NOT BE COUNTED IN CONNECTION WITH THE VOTE ON ANY PROPOSAL AS TO WHICH THE SHAREHOLDER HAS ABSTAINED.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">&#160;(Continued and to be signed on the reverse side)</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">ANNUAL GENERAL MEETING OF SHAREHOLDERS OF</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">CERAGON NETWORKS LTD.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">May 23, 2024</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25;">Please date, sign and mail your proxy card in the envelope provided as soon as possible</div>
    <div style="text-align: center; line-height: 1.25;"> <br>
    </div>
    <div style="text-align: center; line-height: 1.25;">_________________________________________________________________________</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">THE BOARD OF DIRECTORS (THE &#8220;BOARD&#8221;) RECOMMENDS A VOTE &#8220;FOR&#8221; PROPOSALS NO. 1 TO 6 OF THE PROXY STATEMENT.</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PLEASE SIGN, DATE AND RETURN PROMPTLY IN THE ENCLOSED ENVELOPE.</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">PLEASE MARK YOUR VOTE IN BLUE OR BLACK INK AS SHOWN HERE &#9746;</div>
    <div style="text-align: center; line-height: 1.25; font-weight: bold;">_________________________________________________________________________</div>
    <table cellspacing="0" cellpadding="0" id="ze1d0343861d84437b80f48f329cb3218" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 67.04%; vertical-align: top;">
            <div style="line-height: 1.25; font-weight: bold;">1. Re-election and election of seven directors for a term of approximately three (3)</div>
            <div style="line-height: 1.25; font-weight: bold;"> years ending on the date of the Annual General Meeting that will be held in 2027:</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 11.18%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">FOR</div>
          </td>
          <td style="width: 10.17%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">AGAINST</div>
          </td>
          <td style="width: 11.61%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25; font-weight: bold;">ABSTAIN</div>
          </td>
        </tr>
        <tr>
          <td style="width: 67.04%; vertical-align: top;">
            <div style="line-height: 1.25;">1.A. Ilan Rosen.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 11.18%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 10.17%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 11.61%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 67.04%; vertical-align: top;">
            <div style="line-height: 1.25;">1.B. Efrat Makov.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 11.18%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 10.17%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 11.61%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 67.04%; vertical-align: top;">
            <div style="line-height: 1.25;">1.C. Yael Shaham.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 11.18%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 10.17%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 11.61%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 67.04%; vertical-align: top;">
            <div style="line-height: 1.25;">1.D. Shlomo Liran.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 11.18%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 10.17%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 11.61%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 67.04%; vertical-align: top;">
            <div style="line-height: 1.25;">1.E. Rami Hadar.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 11.18%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 10.17%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 11.61%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 67.04%; vertical-align: top;">
            <div style="line-height: 1.25;">1.F. David Ripstein.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 11.18%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 10.17%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 11.61%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 67.04%; vertical-align: top;">
            <div style="line-height: 1.25;">1.G. Robert Wadsworth.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 11.18%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 10.17%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 11.61%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">2</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 67.04%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">2. Approval of certain compensation terms of the company&#8217;s non-executive directors, including the grant of equity consideration, all, as part of their compensation for
              service as such:</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 11.18%; vertical-align: top;">&#160;</td>
          <td style="width: 10.17%; vertical-align: top;">&#160;</td>
          <td style="width: 11.61%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 67.04%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">2.A. To approve the payment of the Chairman Annual Fee to Mr. Ilan Rosen, Ceragon&#8217;s chairman of the Board.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 11.18%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 10.17%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 11.61%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 67.04%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">2.B. to approve the payment of Mr. Wadsworth&#8217;s Participation Fee to Mr. Robert Wadsworth, non-executive director.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 11.18%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 10.17%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 11.61%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 67.04%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25;">2.C. To approve the grant of the Directors Equity Grant to the Company&#8217;s non-executive directors.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 11.18%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 10.17%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 11.61%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 67.04%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">3. Approval of certain compensation terms for Mr. Doron Arazi, the Company&#8217;s Chief Executive Officer, including the CEO Revised Base Salary, the CEO Cash Bonus Plan and the
              Annual CEO Equity Grant.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 11.18%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 10.17%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 11.61%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 67.04%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">4. Approval of the Amended Articles, in the form attached as Exhibit A to the Proxy Statement for the 2024 Annual General Meeting of Shareholders, including without
              limitation, the Share Capital Increase, such that the Company's Current Articles be reinstated and replaced by such Amended Articles.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 11.18%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 10.17%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 11.61%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 67.04%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">5. To adopt and approve the 2024 Equity Incentive Plan, in the form attached as Exhibit B to the Proxy Statement for the 2024 Annual General Meeting of Shareholders, under
              which an initial 500,000 ordinary shares will be reserved for issuance in the form of Incentive Stock Options.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 11.18%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 10.17%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 11.61%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 67.04%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">6. To re-appoint Kost Forer Gabbay &amp; Kasierer, A Member of EY Global, as the Company&#8217;s independent auditor for the fiscal year ending December 31, 2024 and for the year
              commencing January 1, 2025 and until immediately following the next annual general meeting of shareholders, and to authorize the Board (with power of delegation to its Financial Audit Committee), to set the annual compensation of the
              independent auditor in accordance with the volume and nature of its services, as described in Proposal 6 of the Proxy Statement.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
          </td>
          <td style="width: 11.18%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 10.17%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
          <td style="width: 11.61%; vertical-align: top;">
            <div style="text-align: center; line-height: 1.25;">&#9744;</div>
          </td>
        </tr>
        <tr>
          <td style="width: 100%; vertical-align: top;" colspan="4">
            <div style="text-align: center; line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">By executing this proxy card, the undersigned hereby confirms and declares that he, she, or it is not a &#8220;controlling shareholder&#8221; and does not have a &#8220;personal interest&#8221; in
              any of the above proposals, except if he, she, or it has notified the Company in writing and in advance on the existence of a &#8220;personal interest&#8221; in the approval of any of the above proposals.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">3</font></div>
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 100%; vertical-align: top;">
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">If the undersigned or a related party of the undersigned is a controlling shareholder of the Company or has such &#8220;personal interest&#8221; in any of the above proposals, please
              notify the Company immediately in writing.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            <div style="text-align: justify; line-height: 1.25;">Under the Companies Law, 5759-1999 (the &#8220;Companies Law&#8221;), a person will be deemed to be a "Controlling Shareholder" if that person has the power to direct the activities of the company, other
              than by reason of serving as a director or other office holder of the company.</div>
            <div style="text-align: justify; line-height: 1.25;">Under the Companies Law, a person is deemed to have a personal interest if he/she or any member of his or her immediate family, or the immediate family of his or her spouse, has a personal
              interest in the adoption of the proposal; or if a company, other than Ceragon, that is affiliated with such person or affiliated with his or her spouse, has a personal interest in the adoption of the proposal. A company is deemed to be
              affiliated with a person if such company is a company in which such person or a member of such person&#8217;s immediate family serves as a director or chief executive officer, has the right to appoint a director or the chief executive officer, or
              owns 5% or more of the outstanding shares.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            <div style="text-align: justify; line-height: 1.25; font-weight: bold;">PLEASE NOTE THAT IT IS HIGHLY UNLIKELY THAT YOU HAVE A PERSONAL INTEREST IN ANY OF THE ABOVE PROPOSALS.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            <div style="text-align: justify; line-height: 1.25;">You are not deemed to have a personal interest in the adoption of a proposal if your interest in such proposal arises solely from your ownership of our shares.</div>
            <div style="line-height: 1.25;"><font style="line-height: 1.25;">&#160;</font></div>
            <div style="text-align: justify; line-height: 1.25;">For further information regarding the definition of &#8220;Controlling Shareholder&#8221; or "Personal Interest", please see the explanation under Proposal 2 of the Proxy Statement.</div>
          </td>
        </tr>

    </table>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">To change the address on your account, please check the box at right and indicate your new address in the address space above.&#160; &#9744;</div>
    <div style="text-align: justify; margin-right: 1.3pt; line-height: 1.25;">Please note that changes to the registered name(s) on the account may not be submitted via this method.</div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Signature of Shareholder ________________&#160; Date ___________<br>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="text-align: justify; line-height: 1.25;">Signature of Shareholder ________________&#160; Date ___________ <br>
    </div>
    <div style="line-height: 1.25;"><br style="line-height: 1.25;">
    </div>
    <div style="line-height: 1.25;"><font style="font-weight: bold;">NOTE:&#160; </font>Please sign exactly as your name or names appear on this Proxy.&#160; When shares are held jointly, each holder should sign. When signing as executor, administrator, attorney,
      trustee or guardian, please give full title as such.&#160; If the signer is a corporation, please sign full corporate name by duly authorized officer, giving full title as such. If signer is a partnership, please sign in partnership name by authorized
      person.</div>
  </div>
  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-weight: normal; font-style: normal;" class="BRPFPageNumber">4</font>
    <hr align="center" style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;"></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ! !,# 2(  A$! Q$!_\0
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*_P"I@**** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image00002.jpg
<TEXT>
begin 644 image00002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" 0Y!X,# 2(  A$! Q$!_\0
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MV@MH(HE^(/\ A[%_P5-_Z26?M_\ _B9'[17_ ,\:C_@K%_RE-_X*6?\ 9_\
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M&KX HH ^_P#_ (>Q?\%3?^DEG[?_ /XF1^T5_P#/&H_X>Q?\%3?^DEG[?_\
MXF1^T5_\\:O@"B@#[_\ ^'L7_!4W_I)9^W__ .)D?M%?_/&H_P"'L7_!4W_I
M)9^W_P#^)D?M%?\ SQJ^ ** /O\ _P"'L7_!4W_I)9^W_P#^)D?M%?\ SQJ/
M^'L7_!4W_I)9^W__ .)D?M%?_/&KX HH ^__ /A[%_P5-_Z26?M__P#B9'[1
M7_SQJ/\ A[%_P5-_Z26?M_\ _B9'[17_ ,\:O@"B@#[_ /\ A[%_P5-_Z26?
MM_\ _B9'[17_ ,\:C_A[%_P5-_Z26?M__P#B9'[17_SQJ^ ** /O_P#X>Q?\
M%3?^DEG[?_\ XF1^T5_\\:C_ (>Q?\%3?^DEG[?_ /XF1^T5_P#/&KX HH ^
M_P#_ (>Q?\%3?^DEG[?_ /XF1^T5_P#/&H_X>Q?\%3?^DEG[?_\ XF1^T5_\
M\:O@"B@#[_\ ^'L7_!4W_I)9^W__ .)D?M%?_/&H_P"'L7_!4W_I)9^W_P#^
M)D?M%?\ SQJ^ ** /O\ _P"'L7_!4W_I)9^W_P#^)D?M%?\ SQJ/^'L7_!4W
M_I)9^W__ .)D?M%?_/&KX HH ^__ /A[%_P5-_Z26?M__P#B9'[17_SQJ/\
MA[%_P5-_Z26?M_\ _B9'[17_ ,\:O@"B@#[_ /\ A[%_P5-_Z26?M_\ _B9'
M[17_ ,\:C_A[%_P5-_Z26?M__P#B9'[17_SQJ^ ** /O_P#X>Q?\%3?^DEG[
M?_\ XF1^T5_\\:C_ (>Q?\%3?^DEG[?_ /XF1^T5_P#/&KX HH ^_P#_ (>Q
M?\%3?^DEG[?_ /XF1^T5_P#/&H_X>Q?\%3?^DEG[?_\ XF1^T5_\\:O@"B@#
M[_\ ^'L7_!4W_I)9^W__ .)D?M%?_/&H_P"'L7_!4W_I)9^W_P#^)D?M%?\
MSQJ^ ** /O\ _P"'L7_!4W_I)9^W_P#^)D?M%?\ SQJ/^'L7_!4W_I)9^W__
M .)D?M%?_/&KX HH ^__ /A[%_P5-_Z26?M__P#B9'[17_SQJ/\ A[%_P5-_
MZ26?M_\ _B9'[17_ ,\:O@"B@#[_ /\ A[%_P5-_Z26?M_\ _B9'[17_ ,\:
MC_A[%_P5-_Z26?M__P#B9'[17_SQJ^ ** /O_P#X>Q?\%3?^DEG[?_\ XF1^
MT5_\\:C_ (>Q?\%3?^DEG[?_ /XF1^T5_P#/&KX HH ^_P#_ (>Q?\%3?^DE
MG[?_ /XF1^T5_P#/&H_X>Q?\%3?^DEG[?_\ XF1^T5_\\:O@"B@#[_\ ^'L7
M_!4W_I)9^W__ .)D?M%?_/&H_P"'L7_!4W_I)9^W_P#^)D?M%?\ SQJ^ **
M/O\ _P"'L7_!4W_I)9^W_P#^)D?M%?\ SQJ/^'L7_!4W_I)9^W__ .)D?M%?
M_/&KX HH ^__ /A[%_P5-_Z26?M__P#B9'[17_SQJ/\ A[%_P5-_Z26?M_\
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M6?M__P#B9'[17_SQJ/\ A[%_P5-_Z26?M_\ _B9'[17_ ,\:O@"B@#[_ /\
MA[%_P5-_Z26?M_\ _B9'[17_ ,\:C_A[%_P5-_Z26?M__P#B9'[17_SQJ^ *
M* /O_P#X>Q?\%3?^DEG[?_\ XF1^T5_\\:C_ (>Q?\%3?^DEG[?_ /XF1^T5
M_P#/&KX HH ^_P#_ (>Q?\%3?^DEG[?_ /XF1^T5_P#/&H_X>Q?\%3?^DEG[
M?_\ XF1^T5_\\:O@"B@#[_\ ^'L7_!4W_I)9^W__ .)D?M%?_/&H_P"'L7_!
M4W_I)9^W_P#^)D?M%?\ SQJ^ ** /O\ _P"'L7_!4W_I)9^W_P#^)D?M%?\
MSQJ/^'L7_!4W_I)9^W__ .)D?M%?_/&KX HH ^__ /A[%_P5-_Z26?M__P#B
M9'[17_SQJ/\ A[%_P5-_Z26?M_\ _B9'[17_ ,\:O@"B@#[_ /\ A[%_P5-_
MZ26?M_\ _B9'[17_ ,\:C_A[%_P5-_Z26?M__P#B9'[17_SQJ^ ** /O_P#X
M>Q?\%3?^DEG[?_\ XF1^T5_\\:C_ (>Q?\%3?^DEG[?_ /XF1^T5_P#/&KX
MHH ^_P#_ (>Q?\%3?^DEG[?_ /XF1^T5_P#/&H_X>Q?\%3?^DEG[?_\ XF1^
MT5_\\:O@"B@#[_\ ^'L7_!4W_I)9^W__ .)D?M%?_/&H_P"'L7_!4W_I)9^W
M_P#^)D?M%?\ SQJ^ ** /O\ _P"'L7_!4W_I)9^W_P#^)D?M%?\ SQJ/^'L7
M_!4W_I)9^W__ .)D?M%?_/&KX HH ^__ /A[%_P5-_Z26?M__P#B9'[17_SQ
MJ/\ A[%_P5-_Z26?M_\ _B9'[17_ ,\:O@"B@#[_ /\ A[%_P5-_Z26?M_\
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M ,\:C_A[%_P5-_Z26?M__P#B9'[17_SQJ^ ** /O_P#X>Q?\%3?^DEG[?_\
MXF1^T5_\\:C_ (>Q?\%3?^DEG[?_ /XF1^T5_P#/&KX HH ^_P#_ (>Q?\%3
M?^DEG[?_ /XF1^T5_P#/&H_X>Q?\%3?^DEG[?_\ XF1^T5_\\:O@"B@#[_\
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M_I)9^W__ .)D?M%?_/&H_P"'L7_!4W_I)9^W_P#^)D?M%?\ SQJ^ ** /O\
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M&KX HH ^_P#_ (>Q?\%3?^DEG[?_ /XF1^T5_P#/&H_X>Q?\%3?^DEG[?_\
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M_I)9^W__ .)D?M%?_/&KX HH ^__ /A[%_P5-_Z26?M__P#B9'[17_SQJ/\
MA[%_P5-_Z26?M_\ _B9'[17_ ,\:O@"B@#[_ /\ A[%_P5-_Z26?M_\ _B9'
M[17_ ,\:C_A[%_P5-_Z26?M__P#B9'[17_SQJ^ ** /O_P#X>Q?\%3?^DEG[
M?_\ XF1^T5_\\:C_ (>Q?\%3?^DEG[?_ /XF1^T5_P#/&KX HH ^_P#_ (>Q
M?\%3?^DEG[?_ /XF1^T5_P#/&H_X>Q?\%3?^DEG[?_\ XF1^T5_\\:O@"B@#
M[_\ ^'L7_!4W_I)9^W__ .)D?M%?_/&H_P"'L7_!4W_I)9^W_P#^)D?M%?\
MSQJ^ ** /O\ _P"'L7_!4W_I)9^W_P#^)D?M%?\ SQJ/^'L7_!4W_I)9^W__
M .)D?M%?_/&KX HH ^__ /A[%_P5-_Z26?M__P#B9'[17_SQJ/\ A[%_P5-_
MZ26?M_\ _B9'[17_ ,\:O@"B@#_8Z_X-P_BS\4_CC_P1C_8V^*7QK^)?Q ^,
M'Q-\4?\ #0W_  DOQ%^*7C+Q'\0/'?B+^Q/VJ_CEX=T;^W?%WBS4M6\0:O\
MV1X?TC2M"TS^T-0N/L&CZ9I^F6OE65E;01E>?_\ !KC_ ,H*/V&?^[F?_6P_
MV@J* /\ ,$_X*Q?\I3?^"EG_ &?_ /MD?^M%?$:O@"OO_P#X*Q?\I3?^"EG_
M &?_ /MD?^M%?$:O@"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /]?K_@
MUQ_Y04?L,_\ =S/_ *V'^T%11_P:X_\ *"C]AG_NYG_UL/\ :"HH _S!/^"L
M7_*4W_@I9_V?_P#MD?\ K17Q&KX K[__ ."L7_*4W_@I9_V?_P#MD?\ K17Q
M&KX H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_7Z_P"#7'_E!1^PS_W<
MS_ZV'^T%11_P:X_\H*/V&?\ NYG_ -;#_:"HH _S!/\ @K%_RE-_X*6?]G__
M +9'_K17Q&KX K[_ /\ @K%_RE-_X*6?]G__ +9'_K17Q&KX H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH _P!?K_@UQ_Y04?L,_P#=S/\ ZV'^T%11_P &N/\ R@H_89_[
MN9_];#_:"HH _P P3_@K%_RE-_X*6?\ 9_\ ^V1_ZT5\1J^ *^__ /@K%_RE
M-_X*6?\ 9_\ ^V1_ZT5\1J^ * "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M _U^O^#7'_E!1^PS_P!W,_\ K8?[05%'_!KC_P H*/V&?^[F?_6P_P!H*B@#
M_,$_X*Q?\I3?^"EG_9__ .V1_P"M%?$:O@"OO_\ X*Q?\I3?^"EG_9__ .V1
M_P"M%?$:O@"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /]?K_ (-<?^4%
M'[#/_=S/_K8?[05%'_!KC_R@H_89_P"[F?\ UL/]H*B@#_,$_P""L7_*4W_@
MI9_V?_\ MD?^M%?$:O@"OO\ _P""L7_*4W_@I9_V?_\ MD?^M%?$:O@"@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /]?K_@UQ_P"4%'[#/_=S/_K8?[05
M%'_!KC_R@H_89_[N9_\ 6P_V@J* /\P3_@K%_P I3?\ @I9_V?\ _MD?^M%?
M$:O@"OO_ /X*Q?\ *4W_ (*6?]G_ /[9'_K17Q&KX H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#_ %^O^#7'_E!1^PS_ -W,_P#K8?[05%'_  :X_P#*
M"C]AG_NYG_UL/]H*B@#_ #!/^"L7_*4W_@I9_P!G_P#[9'_K17Q&KX K[_\
M^"L7_*4W_@I9_P!G_P#[9'_K17Q&KX H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#_7Z_X-<?^4%'[#/_ '<S_P"MA_M!44?\&N/_ "@H_89_[N9_];#_
M &@J* /\P3_@K%_RE-_X*6?]G_\ [9'_ *T5\1J^ *^__P#@K%_RE-_X*6?]
MG_\ [9'_ *T5\1J^ * "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _U^O\
M@UQ_Y04?L,_]W,_^MA_M!44?\&N/_*"C]AG_ +N9_P#6P_V@J* /\P3_ (*Q
M?\I3?^"EG_9__P"V1_ZT5\1J^ *^_P#_ (*Q?\I3?^"EG_9__P"V1_ZT5\1J
M^ * "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /\ 7Z_X-<?^4%'[#/\ W<S_ .MA_M!44?\
M!KC_ ,H*/V&?^[F?_6P_V@J* /\ ,$_X*Q?\I3?^"EG_ &?_ /MD?^M%?$:O
M@"OO_P#X*Q?\I3?^"EG_ &?_ /MD?^M%?$:O@"@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** /]?K_@UQ_Y04?L,_\ =S/_ *V'^T%11_P:X_\ *"C]AG_N
MYG_UL/\ :"HH _S!/^"L7_*4W_@I9_V?_P#MD?\ K17Q&KX K[__ ."L7_*4
MW_@I9_V?_P#MD?\ K17Q&KX H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#_7Z_P"#7'_E!1^PS_W<S_ZV'^T%11_P:X_\H*/V&?\ NYG_ -;#_:"HH _S
M!/\ @K%_RE-_X*6?]G__ +9'_K17Q&KX K[_ /\ @K%_RE-_X*6?]G__ +9'
M_K17Q&KX H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_7Z_X-<?\ E!1^
MPS_W<S_ZV'^T%11_P:X_\H*/V&?^[F?_ %L/]H*B@#_,$_X*Q?\ *4W_ (*6
M?]G_ /[9'_K17Q&KX K[_P#^"L7_ "E-_P""EG_9_P#^V1_ZT5\1J^ * "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _P!?K_@UQ_Y04?L,_P#=S/\ ZV'^
MT%11_P &N/\ R@H_89_[N9_];#_:"HH _P P3_@K%_RE-_X*6?\ 9_\ ^V1_
MZT5\1J^ *^__ /@K%_RE-_X*6?\ 9_\ ^V1_ZT5\1J^ * "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH _U^O^#7'_E!1^PS_P!W,_\ K8?[05%'_!KC_P H
M*/V&?^[F?_6P_P!H*B@#_,$_X*Q?\I3?^"EG_9__ .V1_P"M%?$:O@"OO_\
MX*Q?\I3?^"EG_9__ .V1_P"M%?$:O@"@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** /]?K_ (-<?^4%'[#/_=S/_K8?[05%'_!KC_R@H_89_P"[F?\ UL/]
MH*B@#_,$_P""L7_*4W_@I9_V?_\ MD?^M%?$:O@"OO\ _P""L7_*4W_@I9_V
M?_\ MD?^M%?$:O@"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_ %^O^#7'_E!1^PS_ -W,
M_P#K8?[05%'_  :X_P#*"C]AG_NYG_UL/]H*B@#_ #!/^"L7_*4W_@I9_P!G
M_P#[9'_K17Q&KX K[_\ ^"L7_*4W_@I9_P!G_P#[9'_K17Q&KX H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#_7Z_X-<?^4%'[#/_ '<S_P"MA_M!44?\
M&N/_ "@H_89_[N9_];#_ &@J* /\P3_@K%_RE-_X*6?]G_\ [9'_ *T5\1J^
M *^__P#@K%_RE-_X*6?]G_\ [9'_ *T5\1J^ * "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH _U^O\ @UQ_Y04?L,_]W,_^MA_M!44?\&N/_*"C]AG_ +N9
M_P#6P_V@J* /\P3_ (*Q?\I3?^"EG_9__P"V1_ZT5\1J^ *^_P#_ (*Q?\I3
M?^"EG_9__P"V1_ZT5\1J^ * "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /\ 7Z_X-<?^4%'[
M#/\ W<S_ .MA_M!44?\ !KC_ ,H*/V&?^[F?_6P_V@J* /\ ,$_X*Q?\I3?^
M"EG_ &?_ /MD?^M%?$:O@"OO_P#X*Q?\I3?^"EG_ &?_ /MD?^M%?$:O@"@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** /]?K_@UQ_Y04?L,_\ =S/_ *V'
M^T%11_P:X_\ *"C]AG_NYG_UL/\ :"HH _S!/^"L7_*4W_@I9_V?_P#MD?\
MK17Q&KX K[__ ."L7_*4W_@I9_V?_P#MD?\ K17Q&KX H **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#_7Z_P"#7'_E!1^PS_W<S_ZV'^T%11_P:X_\H*/V
M&?\ NYG_ -;#_:"HH _S!/\ @K%_RE-_X*6?]G__ +9'_K17Q&KX K[_ /\
M@K%_RE-_X*6?]G__ +9'_K17Q&KX H **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#_7Z_X-<?\ E!1^PS_W<S_ZV'^T%11_P:X_\H*/V&?^[F?_ %L/]H*B
M@#_,$_X*Q?\ *4W_ (*6?]G_ /[9'_K17Q&KX K[_P#^"L7_ "E-_P""EG_9
M_P#^V1_ZT5\1J^ * "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _P!?K_@U
MQ_Y04?L,_P#=S/\ ZV'^T%11_P &N/\ R@H_89_[N9_];#_:"HH _P P3_@K
M%_RE-_X*6?\ 9_\ ^V1_ZT5\1J^ *^__ /@K%_RE-_X*6?\ 9_\ ^V1_ZT5\
M1J^ * "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _U^O^#7'_E!1^PS_P!W
M,_\ K8?[05%'_!KC_P H*/V&?^[F?_6P_P!H*B@#_,$_X*Q?\I3?^"EG_9__
M .V1_P"M%?$:O@"OO_\ X*Q?\I3?^"EG_9__ .V1_P"M%?$:O@"@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** /]?K_ (-<?^4%'[#/_=S/_K8?[05%'_!K
MC_R@H_89_P"[F?\ UL/]H*B@#_,$_P""L7_*4W_@I9_V?_\ MD?^M%?$:O@"
MOO\ _P""L7_*4W_@I9_V?_\ MD?^M%?$:O@"@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** /]?K_@UQ_P"4%'[#/_=S/_K8?[05%'_!KC_R@H_89_[N9_\
M6P_V@J* /\P3_@K%_P I3?\ @I9_V?\ _MD?^M%?$:O@"OO_ /X*Q?\ *4W_
M (*6?]G_ /[9'_K17Q&KX H **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_
M %^O^#7'_E!1^PS_ -W,_P#K8?[05%'_  :X_P#*"C]AG_NYG_UL/]H*B@#_
M #!/^"L7_*4W_@I9_P!G_P#[9'_K17Q&KX K[_\ ^"L7_*4W_@I9_P!G_P#[
M9'_K17Q&KX H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_7Z_X-<?^4%'
M[#/_ '<S_P"MA_M!44?\&N/_ "@H_89_[N9_];#_ &@J* /\P3_@K%_RE-_X
M*6?]G_\ [9'_ *T5\1J^ *^__P#@K%_RE-_X*6?]G_\ [9'_ *T5\1J^ * "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH _U^O\ @UQ_Y04?L,_]W,_^MA_M
M!44?\&N/_*"C]AG_ +N9_P#6P_V@J* /\P3_ (*Q?\I3?^"EG_9__P"V1_ZT
M5\1J^ *^_P#_ (*Q?\I3?^"EG_9__P"V1_ZT5\1J^ * "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /\ 7Z_X-<?^4%'[#/\ W<S_ .MA_M!44?\ !KC_ ,H*/V&?^[F?_6P_
MV@J* /\ ,$_X*Q?\I3?^"EG_ &?_ /MD?^M%?$:O@"OO_P#X*Q?\I3?^"EG_
M &?_ /MD?^M%?$:O@"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /]?K_@
MUQ_Y04?L,_\ =S/_ *V'^T%11_P:X_\ *"C]AG_NYG_UL/\ :"HH _S!/^"L
M7_*4W_@I9_V?_P#MD?\ K17Q&KX K[__ ."L7_*4W_@I9_V?_P#MD?\ K17Q
M&KX H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_7Z_P"#7'_E!1^PS_W<
MS_ZV'^T%11_P:X_\H*/V&?\ NYG_ -;#_:"HH _S!/\ @K%_RE-_X*6?]G__
M +9'_K17Q&KX K[_ /\ @K%_RE-_X*6?]G__ +9'_K17Q&KX H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M _U^O^#7'_E!1^PS_P!W,_\ K8?[05%'_!KC_P H*/V&?^[F?_6P_P!H*B@#
M_,$_X*Q?\I3?^"EG_9__ .V1_P"M%?$:O@"OO_\ X*Q?\I3?^"EG_9__ .V1
M_P"M%?$:O@"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /]?K_ (-<?^4%
M'[#/_=S/_K8?[05%'_!KC_R@H_89_P"[F?\ UL/]H*B@#_,$_P""L7_*4W_@
MI9_V?_\ MD?^M%?$:O@"OO\ _P""L7_*4W_@I9_V?_\ MD?^M%?$:O@"@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** /]?K_@UQ_P"4%'[#/_=S/_K8?[05
M%'_!KC_R@H_89_[N9_\ 6P_V@J* /\P3_@K%_P I3?\ @I9_V?\ _MD?^M%?
M$:O@"OO_ /X*Q?\ *4W_ (*6?]G_ /[9'_K17Q&KX H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#_ %^O^#7'_E!1^PS_ -W,_P#K8?[05%'_  :X_P#*
M"C]AG_NYG_UL/]H*B@#_ #!/^"L7_*4W_@I9_P!G_P#[9'_K17Q&KX K[_\
M^"L7_*4W_@I9_P!G_P#[9'_K17Q&KX H **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#_7Z_X-<?^4%'[#/_ '<S_P"MA_M!44?\&N/_ "@H_89_[N9_];#_
M &@J* /\P3_@K%_RE-_X*6?]G_\ [9'_ *T5\1J^ *^__P#@K%_RE-_X*6?]
MG_\ [9'_ *T5\1J^ * "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _U^O\
M@UQ_Y04?L,_]W,_^MA_M!44?\&N/_*"C]AG_ +N9_P#6P_V@J* /\P3_ (*Q
M?\I3?^"EG_9__P"V1_ZT5\1J^ *^_P#_ (*Q?\I3?^"EG_9__P"V1_ZT5\1J
M^ * "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** /\ 7Z_X-<?^4%'[#/\ W<S_ .MA_M!44?\
M!KC_ ,H*/V&?^[F?_6P_V@J* /\ ,$_X*Q?\I3?^"EG_ &?_ /MD?^M%?$:O
M@"OO_P#X*Q?\I3?^"EG_ &?_ /MD?^M%?$:O@"@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** /]?K_@UQ_Y04?L,_\ =S/_ *V'^T%11_P:X_\ *"C]AG_N
MYG_UL/\ :"HH _S!/^"L7_*4W_@I9_V?_P#MD?\ K17Q&KX K[__ ."L7_*4
MW_@I9_V?_P#MD?\ K17Q&KX H **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#_7Z_P"#7'_E!1^PS_W<S_ZV'^T%11_P:X_\H*/V&?\ NYG_ -;#_:"HH _S
M!/\ @K%_RE-_X*6?]G__ +9'_K17Q&KX K[_ /\ @K%_RE-_X*6?]G__ +9'
M_K17Q&KX H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH _P!?K_@UQ_Y04?L,_P#=S/\ ZV'^
MT%11_P &N/\ R@H_89_[N9_];#_:"HH _P P3_@K%_RE-_X*6?\ 9_\ ^V1_
MZT5\1J^ *^__ /@K%_RE-_X*6?\ 9_\ ^V1_ZT5\1J^ * "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH _U^O^#7'_E!1^PS_P!W,_\ K8?[05%'_!KC_P H
M*/V&?^[F?_6P_P!H*B@#_,$_X*Q?\I3?^"EG_9__ .V1_P"M%?$:O@"OO_\
MX*Q?\I3?^"EG_9__ .V1_P"M%?$:O@"@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** /]?K_ (-<?^4%'[#/_=S/_K8?[05%'_!KC_R@H_89_P"[F?\ UL/]
MH*B@#_,$_P""L7_*4W_@I9_V?_\ MD?^M%?$:O@"OO\ _P""L7_*4W_@I9_V
M?_\ MD?^M%?$:O@"@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /]?K_@UQ
M_P"4%'[#/_=S/_K8?[05%'_!KC_R@H_89_[N9_\ 6P_V@J* /\P3_@K%_P I
M3?\ @I9_V?\ _MD?^M%?$:O@"OO_ /X*Q?\ *4W_ (*6?]G_ /[9'_K17Q&K
MX H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_ %^O^#7'_E!1^PS_ -W,
M_P#K8?[05%'_  :X_P#*"C]AG_NYG_UL/]H*B@#_ #!/^"L7_*4W_@I9_P!G
M_P#[9'_K17Q&KX K[_\ ^"L7_*4W_@I9_P!G_P#[9'_K17Q&KX H **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#_7Z_X-<?^4%'[#/_ '<S_P"MA_M!44?\
M&N/_ "@H_89_[N9_];#_ &@J* /\P3_@K%_RE-_X*6?]G_\ [9'_ *T5\1J^
M *^__P#@K%_RE-_X*6?]G_\ [9'_ *T5\1J^ * "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH _U^O\ @UQ_Y04?L,_]W,_^MA_M!44?\&N/_*"C]AG_ +N9
M_P#6P_V@J* /\P3_ (*Q?\I3?^"EG_9__P"V1_ZT5\1J^ *^_P#_ (*Q?\I3
M?^"EG_9__P"V1_ZT5\1J^ * "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /\ 7Z_X-<?^4%'[
M#/\ W<S_ .MA_M!44?\ !KC_ ,H*/V&?^[F?_6P_V@J* /\ ,$_X*Q?\I3?^
M"EG_ &?_ /MD?^M%?$:O@"OO_P#X*Q?\I3?^"EG_ &?_ /MD?^M%?$:O@"@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** /]?K_@UQ_Y04?L,_\ =S/_ *V'
M^T%11_P:X_\ *"C]AG_NYG_UL/\ :"HH _S!/^"L7_*4W_@I9_V?_P#MD?\
MK17Q&KX K[__ ."L7_*4W_@I9_V?_P#MD?\ K17Q&KX H **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@#_7Z_P"#7'_E!1^PS_W<S_ZV'^T%11_P:X_\H*/V
M&?\ NYG_ -;#_:"HH _S!/\ @K%_RE-_X*6?]G__ +9'_K17Q&KX K[_ /\
M@K%_RE-_X*6?]G__ +9'_K17Q&KX H **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@#_7Z_X-<?\ E!1^PS_W<S_ZV'^T%11_P:X_\H*/V&?^[F?_ %L/]H*B
M@#_,$_X*Q?\ *4W_ (*6?]G_ /[9'_K17Q&KX K[_P#^"L7_ "E-_P""EG_9
M_P#^V1_ZT5\1J^ * "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _P!?K_@U
MQ_Y04?L,_P#=S/\ ZV'^T%11_P &N/\ R@H_89_[N9_];#_:"HH _P P3_@K
M%_RE-_X*6?\ 9_\ ^V1_ZT5\1J^ *^__ /@K%_RE-_X*6?\ 9_\ ^V1_ZT5\
M1J^ * "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _U^O^#7'_E!1^PS_P!W
M,_\ K8?[05%'_!KC_P H*/V&?^[F?_6P_P!H*B@#_,$_X*Q?\I3?^"EG_9__
M .V1_P"M%?$:O@"OO_\ X*Q?\I3?^"EG_9__ .V1_P"M%?$:O@"@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** /]?K_ (-<?^4%'[#/_=S/_K8?[05%'_!K
MC_R@H_89_P"[F?\ UL/]H*B@#_,$_P""L7_*4W_@I9_V?_\ MD?^M%?$:O@"
MOO\ _P""L7_*4W_@I9_V?_\ MD?^M%?$:O@"@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** /]?K_@UQ_P"4%'[#/_=S/_K8?[05%'_!KC_R@H_89_[N9_\
)6P_V@J* /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
